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Abstract 
 
The objective of this thesis is to evaluate the potential of applying chiral solvents for 
crystallization-based resolution of racemates. In general, it can be expected that a 
chiral solvent can discriminate two enantiomers by creating some weak interactions 
between the solvent and the substrate molecules forming diastereomeric complexes 
with different physical properties. This may lead to either asymmetry in the solubility 
phase diagrams or selective kinetic effects which can be employed for resolution 
purposes. To evaluate the prospect of using chiral solvents for crystallization based 
enantioseparation and to evaluate the potential of this approach, systematic 
experimental work is required.  
The chosen model systems studied experimentally in this work are two 
pharmaceutically interesting substances (mandelic acid and N-methylephedrine) 
which belong to the compound and conglomerate forming systems, respectively. 
Three different types of chiral solvents were studied: (a) a “classical” chiral solvents, 
(b) a chiral ionic liquids and (c) a tailor-made chiral solvents. 
Three different tests have been investigated; (i) the determination of the ternary 
solubility phase diagrams for the selected model compounds, (ii) the determination of 
“nucleation points”, i.e. metastable zone widths with regard to primary nucleation and 
induction time, and (iii) the design of suitable crystallization processes.  
In the experimental work, preliminary investigations were performed to identify 
appropriate “classical” chiral solvents for the discrimination of enantiomers with the 
aid of nuclear magnetic resonance (NMR) spectroscopy. The screening of the 
“classical” chiral solvents was particularly performed with mandelic acid, since this 
component belongs to the class of compound forming systems which are particularly 
difficult to be resolved. 1H NMR screening measurements and Raman spectra showed 
that the chosen nine “classical” chiral solvents had no measurable selective influence 
on the chiral system studied. Since the results obtained from screening were similar, 
the selection of the chiral solvents for subsequent work was mainly based on the 
availability and the price. 
The ternary solubility phase diagrams determined for the “classical” chiral solvents 
and the chosen model systems were found to be symmetrical. However, in the case of 
the chiral ionic liquid (1R, 2S)-(-)-dimethylephedrinium bis (trifluoromethylsulfonyl) 
amide with N-methylephedrine there was asymmetry found in the ternary solubility 
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phase diagram. Furthermore, in the case of mandelic acid and the tailor-made chiral 
solvents (S)-propyl mandelate and (S)-isopropyl mandelate systems, there was also an 
asymmetry in the phase diagram observed. 
Although most of the chiral solvents did not show any quantifiable chiral recognition 
in terms of solution thermodynamics, regarding kinetics pronounced selective effects 
were observed as indicated by differences in metastable zone widths and induction 
times. These important observations made in this thesis work were supported also by 
the results of molecular modeling calculations and solvation enthalpies evaluations 
performed in parallel. Thus, the determination of the solvation enthalpies and 
molecular modeling calculations could be also employed as a useful ،،screening toolۥۥ 
to estimate the degree of interaction between the solvent and the solute molecules and, 
thus, to screen for appropriate chiral solvents. 
On the basis of the observed pronounced kinetic effects and the chiral recognition in 
solution thermodynamics, successful enantioselective crystallization processes were 
finally demonstrated in this work. 
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1.1 Project background 
 
Separation technologies such as crystallization processes are very important to 
chemical and pharmaceutical industries. Crystallization is a separation and 
purification technique used to generate a broad collection of chemicals for examples 
pharmaceuticals, agricultural products, flavors, fragrances and other chiral products. 
Manufacturing of high-value products (fine chemicals and pharmaceuticals) are 
mostly performed by crystallization processes. Other separation processes are 
normally more expensive compared with crystallization.1 This has increased the use 
of crystallization as one of the major separation processes in the resolution of 
pharmaceutical products such as enantiomers. 
Enantiomers exist in two different forms. These two forms are structured like non-
superimposable mirror images of each other. They have identical physical and 
chemical properties such as solubilities and viscosities, but these compounds can also 
have very different properties, for example smell, taste, and efficacy. In the extreme 
case, one enantiomer can be a potent drug and the other a poisonous substance. A case 
in point is the notorious drug Thalidomide, which was prescribed worldwide in the 
late 1950s to stop symptoms associated with morning sickness of pregnant women. 
While the (R)-enantiomer has safe sleep-inducing effects, the coexisting (S)-
enantiomer is believed to be responsible for thousands of cases of birth defects. The 
majority of the drugs synthesized in the pharmaceutical industry are in the form of 
racemate, i.e. 50:50 mixtures of both enantiomers.2 
With such pronounced differences in biological activities, it is not surprising that the 
demand of single enantiomers is on the rise2. Moreover, Food and Drug 
Administration (FDA) demands for enantiopure substances rather than racemates.3 
This has necessitated the resolution of racemic mixtures and compounds into single 
enantiomers, since often only one enantiomer exhibits the desired physiological 
effect. Enantioselective crystallization is considered to be an appropriate move 
towards separation of enantiomers. In view of this, crystallization from chiral 
solvents4,5 is an attractive technique in enantioselective crystallization processes, 
based on the expectation that the solvent can create selective interactions to the chiral 
molecules leading to differences in solubilities or rates of crystallization. These 
differences might be employed for resolution purposes.  
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A literature search shows that there are a few studies in this area of research.6-10 
Moreover, available solubility data of chiral substances in chiral solvents are limited 
to distinct measurements with the pure enantiomers. Also there is a deficit in 
systematic experimental work evaluating the application of chiral solvents and 
quantifying the corresponding solubility data. For example, Yamamoto et al.6 reported 
pure enantiomer solubilities for a chiral cobalt salt in (2R,3R)-(+)-diethyl tartrate and 
described measurable differences between them. Furthermore, Bosnich et al7 and 
Mizumachi8 reported that the solubilities of the pair of enantiomers of cis 
[Co(en)2Cl2]Cl04 in l-2,3-butanediol and Tri-α-diimine Ruthenium (II) complexes 
respectively, were different. However, in all cases no systematic experimental support 
was presented. Amaya9 provided a theoretical framework to account for the 
differences in solubility between D- and L-optical isomers in a chiral solvent, without 
presenting any experimental evidence.  
Therefore, to evaluate the prospect of the concept of applying chiral solvents for 
crystallization based enantioseparation and to evaluate the generality of this approach, 
a comprehensive methodical experimental work is required, which is the focus of this 
work.  
 
1.2 Project objectives and thesis structure 
 
The goal of this project is to evaluate the potential of applying chiral solvents for 
crystallization-based resolution of racemates. Generally, it is expected that a chiral 
solvent can create selective interactions to a chiral solute, which facilitates 
discrimination between two single enantiomers. This discrimination can provide 
selective kinetic or thermodynamic effects which can be useful for the separation of 
racemates. A literature search for crystallization processes using chiral solvents shows 
that there is a deficiency of systematic experimental work for evaluating the 
application of chiral solvents and also for quantifying the corresponding solubility 
data. The chosen systems to be studied experimentally in this work are two 
pharmaceutical interesting substances which belong to the compound and 
conglomerate forming systems. Three different possible ways have been employed to 
achieve this aim; (i) determination of the ternary solubility phase diagrams for the 
selected model compounds, (ii) determination of “nucleation points” i.e., metastable 
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zone widths with regard to primary nucleation and induction time, and (iii) suggestion 
and design of suitable crystallization processes.  
Therefore, the present work is concerned with systematic experimental investigations 
on three different types of chiral solvents, namely “classical” chiral solvents, chiral 
ionic liquids, and tailor-made chiral solvents, with some chosen as model chiral 
solvents. Based on the acquired ternary solubility phase diagrams and the metastable 
zone widths or induction times, racemate resolutions via crystallization processes will 
be suggested and conducted. Finally, generalized conclusions regarding the potential 
of chiral solvents for crystallization-based racemate resolution are derived and will be 
discussed.  
Chapter 2 gives details about the background, a literature review and some theoretical 
aspects of the thesis. Preliminary investigations were carried out to identify 
appropriate chiral solvents for the discrimination of enantiomers with the aid of 
nuclear magnetic resonance (NMR) spectroscopy (see chapter 3). Afterward, two 
fundamental experiments, of data were determined, i.e. solubility and kinetic 
measurements were conducted to support the design of the enantioselective 
crystallization experiments (see chapter 3). Fundamental experiments were performed 
by applying the two chosen chiral substances and the three main chiral solvents 
(“classical” chiral solvents), chiral ionic liquids, and specially synthesized “tailor-
made” chiral solvents. Based on the attained solubility and kinetic data preferential 
nucleation, preferential crystallization and selective crystallization processes were 
designed and performed (see chapter 3 and 4). 
Molecular modeling and calorimetric measurements (dissolution enthalpies) were 
conducted to get a deeper understanding of the solvent-solute interactions in the 
system (see 3 and 4). Molecular modeling was realized with the commercial 
MATERIALS STUDIO® software to derived enthalpy of formation for the various 
dimers (solute and solvent dimers) systems studied. 
The solid and liquid phases during measurements were characterized with many 
techniques (see chapter 3 and Appendix section): Raman spectroscopy, FT-IR 
spectroscopy, X-ray powder diffraction (XRPD) and HPLC.  
Chapter 5 gives a summary of the whole work and also enumerates some suggestions 
for future work, i.e. how a certain solvents such as tailor-made chiral solvents and 
chiral ionic liquids could be applied more efficiently for chiral discrimination.  
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2.1 What is chirality and what is its biological and economic 
significance 
 
The term chirality is derived from the Greek word for hand, χειρ (cheir), as the right 
and left hand can not be superimposed on each other. A chiral molecule is a type of 
molecule that lacks an internal plane of symmetry and has a non-superimposable 
mirror image. The human hands are possibly the most commonly known example of 
chirality: The left hand is a non-superimposable mirror image of the right hand; no 
matter how the two hands are oriented, it is impossible for all the major features of 
both hands to coincide. So, enantiomers are defined as a pair of chiral isomers that are 
absolute mirror images of each other and are not superimposable on one another. 
Normally object that has no inverse symmetry, or object that are non-superimposed on 
their mirror images are termed chiral.11  
 
mirror plane
 
Figure 1: Typical example of chirality of two enantiomers of bromochlorofluoromethane (a tetrahedral 
arrangement of four substituents bonded to the stereocentre atom. 
 
Figure 1 illustrates a tetrahedral arrangement as a consequence of the central carbon 
atom (stereocentre or chiral centre) is saturated with four different functional groups. 
This tetrahedral arrangement was proposed by both Van’t Hoff12,13 and Le Bel14. The 
concept of chirality was established long ago when Pasteur in 1848 15 through his 
effort by using manual hand sorting to separate conglomerate crystals of sodium 
ammonium tartrate and in the process brought to light the fundamentals of 
stereochemistry. Based on the fact that enantiomers have structural similarity, they 
have identical physical and chemical properties such as solubility, viscosity etc. The 
only observable differences between enantiomers are chiraloptical properties such as 
circular dichroism, optical rotation and optical rotation dispersion.16 
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Based on the specific optical rotation, a classification of chiral species into (+)- and (-
)-enantiomers is made. The (+)- sign is denoted for the chiral species when it rotates 
the polarized light in the positive direction (clockwise direction), and the contrary is 
the case for (-)- sign. There exists another method of assigning a configuration 
classification which is commonly used to distinguish between optical isomers for 
sugars and amino acid. This is the distinction between L- and D-isomers which was 
proposed by Emil Fischer17. Both of these methods mentioned are sometimes 
confusing, so a much simpler and explicit method was devised by Cahn-Ingold-Prelog 
(CIP).18 Here, assigning the absolute configuration is solely based on the order in 
which the substituents are arranged around the stereo-centre. It differentiates between 
(S)- and (R)-enantiomers. The procedure is that the substituents bonded to the chiral 
centre atom are given priorities according to their atomic numbers in such a way that 
the highest atomic number is assigned the highest priority while the lowest atomic 
number is assigned the lowest priority. Afterward to assign the absolute configuration 
to the chiral molecule the orientation of the molecule should be placed such that the 
lowest priority substituents point away from the viewer. The final assignment is made 
by considering the order for the remaining three substituents. If the priority increases 
in the clockwise direction then the molecule is assigned (R)-configuration, and (S)-
configuration if the priority increases in anticlockwise route.  
Diastereoisomers are stereoisomers with more than one chiral centre, and they are not 
related through reflection operation.19 Diastereomers have different chemical and 
physical properties, for instance melting point, boiling point, absolute optical rotation 
and spectra. Hence they behave in all aspects as different compounds. If the number 
of stereocentres increases in the molecules, the number of possible stereoisomers also 
increases. For example, (2R, 3R)-diethyl tartrate has two such centres. There are 2n = 
4 different stereoisomers, with n representing the number of stereocentres. 
 
Biological significance 
 
Biological system chirality is not only natural, but necessary for life. Generally, DNA 
and RNA and most carbohydrates exist as a D-type. Consequently, essential 
physiological processes employ exclusively only one of the possible stereoisomers of 
each substance concerned. Therefore proteins, sugars, and other biological target 
Chapter 2 Background and literature survey  
  
 8
receptors of most drugs are chiral. The two enantiomers of a drug thus bind differently 
to these receptors, which often causes them to have different biological effects. 
For instance, of an enzyme made up of a 99 amino acid polypeptides chain, HIV-1 
protease, synthesized from D-amino acids only, has been illustrated to cleave only D-
amino acid peptides. On the other hand the same type of enzyme synthesized from L-
amino acids cleaves only L-amino acid peptides.16,20 This two enantiomers of chiral 
inhibitor show similar stereospecific behavior toward the subsequent enzyme forms.  
Generally, one of the enantiomers represents the more active isomer (eutomer), 
whereas the other one might give side-effects, display toxicity or act as antagonist.3,21 
On the molecular level, it also illustrates that the chirality of amino acid and sugars 
are stereospecific in terms of enzymatic reactions and drug. receptor interactions. This 
also holds for various types of messenger molecules such as neurotransmitters, 
hormones, allosteric modulators of enzyme activity as well as for xenobiotic, 
exogenous, messenger molecules such as drugs, insecticides and weedicides. This 
transfer of stereo-specific information is chemically coded in appropriate molecular 
carriers into biological systems.22 Furthermore, stereoisomer discriminate in odor 
perception is well known23,24. For instance it is evident that chirality plays a major 
role in the olfactory properties of perfumes and fragrance; there are cases where two 
enantiomers of a pair have significantly different olfactory properties25. Moreover, 
there are some interesting practical examples of carvone and limonene enantiomers 
showing differences in odor26. (S)-(+)-carvone possesses the odor of caraway and the 
counter enantiomer (R)-(-)-carvone has spearmint odor. Same is true for (R)-(+)-
limonene has an orange odor whilst the other enantiomer (S)-(-)-limonene has that of 
lemon. Additional specific case is that only (-)-menthol enantiomer used in tobacco 
gives a cooling effect during smoking and also provides a lower concentration at 
which the effect is perceived.27 An important consequence of the above is that 
biological systems show stereospecificity toward stereoisomers (enantiomers and 
diastereomers), which means that it is very necessary for drugs made to be in 
enantiopure form.  
The next section will describe how the high demand for a single enantiomer has 
increased revenues for pharmaceutical companies. 
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Economic significance 
 
The fact that biological systems are stereospecific towards chiral substances and also 
coupled with US Food and Drug Administration (FDA) regulatory demand for single 
enantiomers has resulted in the high demand for enantiopure drugs from the 
pharmaceutical companies. So, FDA has demanded a stringent prerequisite to patent 
new racemic drugs, demanding a full documentation of separate pharmacological and 
pharmacokinetic profiles of the individual enantiomers as well as their combination.28 
Single enantiomers drug sales increment from 1997 and many top-selling drugs are 
marketed as single enantiomer (269 out of top 500 drugs)29. Since the focus of 
pharmaceutical companies are to produce drugs for chronic disease such as 
Alzheimer, Cancer, Obesity, AIDS, Asthma etc. most of this drugs contact one or 
more chiral centres. There is the need to obtain an enantiomerically pure drug by the 
means of enantioseparation. Economic interests are obvious and important driving 
forces in the development of single enantiomers.  
Table 1 depicts a detailed summary of annual distribution of worldwide approved 
drugs in the period of 1990-2002 and of the FDA approved drugs New Molecular 
Entity (NMEs), i.e. an active ingredient that has never been sold in US.  
 
Table 1: Summary of the annual distribution of worldwide and FDA approved drugs (NMEs) 
according to chirality character in the period 1990-2002. Data from2 
Year 
Racemates 
Worldwide          FDA 
(%)                   (%) 
Single enantiomers 
Worldwide             FDA 
(%)                         (%) 
Achiral 
Worldwide              FDA 
(%)                           (%) 
1990 33                           na 35                             na 32                               na 
1992 21                          33 44                             42 35                               25 
1994 38                             5 38                             57 24                              38 
1998 15                            9 50                             41 35                              50 
2000  9                             19 62                             37 29                                44 
2002 6                             0 55                             53 39                                 47
aIncluding of diastereomeric mixtures; Abbreviations: na, not applicable. 
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According to Table 1, the trends of the annual distribution of single enantiomer drugs 
increase along the years against that of the racemic drugs. 
There is an outstanding world drug (proportion of single enantiomeric drugs among 
the top-selling drugs) sales of about $300 billion in 1997. This value increased over 
the years steadily till 2000 as reported by Maier et al.3 According to this high demand 
and good sales for single enantiomers, has triggered in ‘racemic switch’ a new market 
strategy of the pharmaceutical companies to change racemic drugs (already approved 
patent) into single enantiomers ones. In this case the companies can patent also the 
enantiopure form of the drug, creating more revenues for them. 
 
2.2 Crystal science 
2.2.1 What is crystallization? 
 
Crystallization is widely used for manufacturing drug substances and for purification 
and separation. 1,30 Crystallization is a potent separation technique due to the highly 
selective nature of crystal surfaces, creating a reproducibility of the assembly of 
molecules possible. For instance only same growth units are allowed to join the 
growing crystal lattice, making crystals exceptionally successful in their separating 
ability. This is why crystallization is such a popular separation method. Crystallization 
is essential to the resolution of enantiomers, as it is one of the most cost-effective 
methods, where high enantiomeric excesses can be obtained. In this region other 
methods fail to deliver. Crystallization can occurs in several ways such as; from melt, 
from solution, from the gaseous phase or from a supercritical fluid. The most common 
and useful method for chiral compounds is the crystallization from solution, and so 
we will concentrate below on this particular method. 
In order to understand the crystallization process and the formation of different 
crystalline phases, one must understand the thermodynamics linked to the 
fundamental phase equilibrium. For a case in point, a saturated aqueous solution of 
mandelic acid has 3 different phases; crystal, solution and vapour, and 2 components 
for the system (the number of constituents required to describe any phase), namely 
mandelic acid and water. In 1876 J. W. Gibbs31 derived a famous relationship 
between the number of phases P, the degrees of freedom F and the number of 
components C and formulated the phase rule as: 
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PCF −+= 2                                                                Equation 1 
 
Applying the phase rule to the mandelic acid and water system, shows that a system 
with 2 components and 3 phases (crystal, liquid and vapour), has 1 degree of freedom: 
F = 2 + 2 – 3 = 1. This phase rule permits the computation of the number of variables 
(T, p or x) that must be fixed in order to define an equilibrium state. Hence, the 
correlation between the variables and the crystalline solid phase is usually 
characterized using a phase diagram. This information about the phase diagram is 
obtained by preliminary measurement of solubility, together with thermal data such as 
melting temperature and enthalpy of fusion measurable for example by DSC. 
However, it is necessary to gain an understanding of the crystallizing system under 
consideration. In crystallization the concentration range over which the process can 
occur is limited by the solubility isotherm of the phase diagram. 
 
2.2.2 Supersaturation 
 
A prime requirement for crystallization from solution is that the concentration of the 
solute in the solvent exceeds its equilibrium solubility to provide a driving force. The 
driving force for crystallization is supersaturation, which is possibly the most 
important quantity in crystal nucleation and growth processes. Supersaturation can be 
generated in several ways, for example by cooling a saturated solution, by evaporation 
of the solvent from a saturated solution. Other less common methods are; by addition 
of miscible non-solvent to a saturated solution, by the use of common ion effect (for 
ionic salts), by salting out and by reaction to form the solute in situ. 
Supersaturation is frequently expressed as the difference between concentrations, and 
has therefore the same unit as used for concentrations. Supersaturation can be defined 
as  
*CCC −=Δ                                                                Equation 2 
where ∆C is the supersaturation in concentration units, C* is the saturation 
concentration and C is the actual concentration. A common way to express 
supersaturation is also the supersaturation ratio defined as  
*C
CS =                                                              Equation 3 
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 The supersaturation ratio, σ is expressed as; 
*
*
C
CC −=σ                                                                Equation 4 
is for all times > 1 for a supersaturated solution. It is essential to note that these 
definitions of supersaturation assume ideal solution activity coefficients of 1. 
 
 2.2.3 Kinetics 
 
The spontaneous crystallization of a supersaturated solution comprises of two main 
steps: (a) the appearance of crystalline seeds (nucleation), and (b) the development of 
crystals from these seeds. Thus, nucleation is a process of making a new solid phase 
from a supersaturated homogeneous mother phase. It is fundamental to all types of 
crystallizations. Once nucleation has taken place to form nuclei which act as surfaces 
for crystal growth, these grow into macroscopic crystals. Nucleation is divided into 
two main types; primary and secondary. Primary nucleation occurs in the absence of 
crystalline surfaces, and can be homogeneous or heterogeneous.32  
 
2.2.3.1 Primary and secondary nucleation 
 
Homogeneous nucleation seldom does happen in practice, but it forms the basis for 
nucleation theories. Heterogeneous nucleation is usually caused by the presence of 
dissolved impurities. In general the birth of new crystals is called nucleation. Before 
real nucleation is observed, clusters (embryos) are formed in solution.33  
 
r
↔
↔
r < rc r > rc
 
Figure 2: Illustration of the process of nucleation.33 
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Therefore Figure 2 shows the mechanism involves in the process of nucleation. 
According to the classical theory of nucleation the molecules first undergoes collision 
to form very small clusters of several molecules (embryos) via a reversible process 
(see Figure 2). In Figure 3 gives an illustration of the free energy versus size of 
nucleus (cluster size). The change in free energy associated with the formation of 
these clusters increases with size, and reaches a maximum at a critical radius, rc, and 
then diminishes or decreases.  
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Figure 3: Free energy of nucleation as a function of size of nucleus. 34 
 
This implies that the clusters smaller than rc, would eventually fall apart rather than 
growing, whereas the clusters whose radius are bigger than the critical radius will 
grow to become nuclei. The free energy change for the formation of the nucleus 
surface (positive quantity) and the free energy change for the phase transformation (a 
negative quantity) are expressed as;34  
vvs GLLGGG Δ+=Δ+Δ=Δ 32 ασβ                                                            Equation 5 
where σ is the surface tension, and β and α are the area and volume shape factors 
(based on the characteristic length L), respectively. In the case of spherical nuclei, the 
area factor πβ = , and the volume factor is 6πα =  based on the diameter, d, of the 
nuclei. Then Equation 5 becomes; 
vGrrG Δ+=Δ 32 3
44 πσπ                                                              Equation 6 
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It is obvious from Figure 3 that clusters greater than the critical size result in a 
decrease in free energy and will take part in the nucleation process. So, the critical 
size can be obtained by minimizing the free energy function with respect to the radius.  
( )
vcc Grrdr
Gd Δ+=Δ 248 πσπ                                                              Equation 7 
becomes Equation 8; 
v
c G
r Δ−=
σ2                                                                 Equation 8 
Substituting for ∆Gv from Equation 8 into Equation 6 results in  
3
4 2σπ c
crit
rG =Δ                                                                Equation 9 
The growth of the clusters is controlled by the Gibbs-Thompson equation32,34 
kTrvSIn
C
CIn σ2* ==                                                            Equation 10 
where C is the concentration of the clusters with size r. Consequently, the smaller 
clusters dissolve, as larger cluster grow until they reach a critical size, rc, and a new 
phase is made. Substituting for rc in Equation 9 by Equation 10 gives; 
( )2
23
3
16
SInkT
vGcrit
σπ=Δ                                                             Equation 11 
Now considering the fact that the classical nucleation theory assumes that clusters are 
formed in solution by the addition mechanism which continues until a critical size of 
nuclei is obtained. In this case the nucleus formation by this mechanism is given by 
Arrhenius type of expression; 
⎟⎠
⎞⎜⎝
⎛ Δ−=
kT
GAB critexp0                                                             Equation 12 
where A is the preexponential factor which typically has a theoretical value of 1030 
nuclei/cm3 s.34 
The nucleation rate (B0) can be obtained by putting Equation 11 into Equation 12; 
( ) ⎟⎟⎠
⎞
⎜⎜⎝
⎛−= 233
23
0 3
16exp
SInTk
vAB πσ                                                           Equation 13 
The induction period (tind) can be considered to be inversely proportional to the rate of 
nucleation. Thus;  
1
0
−Btind α                                                               Equation 14 
so Equation 13 eventually becomes; 
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( ) ⎟⎟⎠
⎞
⎜⎜⎝
⎛
23
3
SInT
tind
σα                                                             Equation 15 
 
Secondary nucleation results from the presence of crystals in the supersaturated 
solution. These parent crystals have a catalyzing effect on the nucleation phenomena, 
and hence, nucleation happens at a lower supersaturation than required for 
spontaneous nucleation. Shear nucleation can be sufficient to produce secondary 
nuclei from the crystal surface by the shear force inflicted on a crystal face due to 
solution flowing past it. The appearance of crystals may be as a result of one or a 
permutation of crystal-crystal, crystal-impeller or crystal-crystallizer collisions. 
 
2.2.3.2 Crystal growth 
 
Crystal growth involves the integration of growth units into the crystal lattice, once 
the lattice has developed from a nucleus. These growth units can be molecules, atoms 
or ions, based on the type of substance. The crystal growth rate is dependent on the 
supersaturation and the area of the crystal exposed to growth. There are several 
projected mechanisms of crystal growth.31,32 The diffusion theory, presumes that 
matter is placed incessantly on a crystal face at a rate proportional to the difference in 
concentration between deposition surface and the bulk solution. While the 
‘adsorption-layer’ theory assumes that growth takes place in a layer-wise manner and 
that molecules arrive at the layer by diffusion through the bulk. This can be 
understood by viewing Figure 4. A molecule in a supersaturated solution must de-
solvate to be absorbed on the crystal surface. In Figure 4 there are three possible sites 
for the molecule to incorporate into the crystal surface; sites A, B, and C.  
 
B
C
A
 
Figure 4: Surface structure of a growth crystal, where A, B and C are the impurities. 
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These sites are distinguished by the number of bonds the molecule will form with the 
crystal surface on which it incorporates. At site A, the molecule will be attached only 
to the surface of a growing layer (flat site) while at site B, the molecule is attached to 
both the surface and to a growing step (step site). At site C, the molecule is attached at 
three surfaces, known as a kink site. The mechanism for the incorporation of a 
molecule into a crystal face is adsorption onto the surface, followed by its diffusion 
along the surface (A-type) to a step (B-type) or kink (C-type) site for integration.32 
Considering the energetic for this process, C is more preferable than B, as it makes 
more interactions, and B is more favorable than A as molecules have a propensity to 
bond at locations where they have the maximum number of nearest neighbors to 
exploit their interaction potential. Also, molecules prefer to bond to an accessible step 
that is spreading over a surface than to create a new one. In this case it is clear why 
crystals grow in a layer by layer manner. The pace at which these different crystal 
faces grow will affect the crystal morphology. This gives the overall shape of a 
crystal, illustrated as plate-like, needle-like, or prismatic etc. A difference between the 
equilibrium and growth morphologies needs to be made. The previous is the shape 
taken up by a crystal when permitted to equilibrate with its surroundings and match 
up with the minimization of the surface free energy of the crystal, at the same time as 
the latter is the shape that the crystal generates during the growth when kinetics may 
control the process. Morphology is decided based on two factors, the relative growths 
of the faces adjoining the crystal, and the symmetry of the internal crystal structure, 
evident in the point group symmetry of the crystal form.31 This is linked to the 
energetics of the molecule attachment to the crystal surfaces. The surface specific 
nature of this attachment process means that the morphology of a crystal can be 
affected by external factors, such as the level of supersaturation, growth solvent, 
temperature, and solution purity (additives can dramatically affect the morphology, 
section 2.5.2.2 and section 2.6.2). 
 
2.2.4 Induction period for crystallization 
 
The time period usually elapsing between the attainment of supersaturation and the 
appearance of the first crystals is called the induction time. The induction time can be 
considered to be inversely proportional to the nucleation rate (relationship between 
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induction time and nucleation rate, section 2.2.3.1, Equation 14). The first changes in 
the system's physical properties due to the formation of the solid phase may be 
followed by the appearance of the first visible crystals. The measured induction time 
is generally a complex quantity made up of several components. It is often measured 
by visual observation or by particle size analyzer. In reality, the induction time 
consists of three components: the transient period, which is the relaxation time (tr) 
needed to achieve a quasi-steady-state distribution of molecular clusters; the period 
for the formation of the stable nuclei (tn, i.e. the nucleation/induction time); and the 
time needed for these critical nuclei to grow to a macroscopic size where they can be 
detected (i.e. the growth time, tg). The induction time then can be expressed as: 
gnrind tttt ++=                                                              Equation 16 
However, in reality, it is impracticable to detach these separate terms. The nucleation 
time depends on supersaturation which affects the size of the critical nuclei, but its 
evaluation is a subject of speculation. The growth time is dependent on the size at 
which nuclei are detectable and the growth rate applicable to this early stage of 
development. This latter stage is difficult to forecast as the growth rate of a nucleus 
cannot be assumed to be in the same order of magnitude as the macro-crystal; the 
mechanism and rates of which may be different. As a result of this the induction time 
is normally taken as the time at which nuclei are noticed, and as these are often 
visually observed, measurement of tind by sensitive methods such as laser light 
scattering, can result in a different induction time being recorded. This inconsistency 
highlights that experimentally determined tind is not, alone, a fundamental 
characteristic of a crystallizing system. 
 
2.2.5 Metastable zone width 
 
The metastable zone width (MSZW) is extremely important in understanding the 
kinetic aspects in crystallization processes and in particular of enantioselective 
crystallization processes.35 The MSZW with respect to primary nucleation is the 
region where no significant nucleation occurs after a saturated solution is subjected to 
cooling, and is given as a maximum possible subcooling (∆Tmax) or maximum 
possible supersaturation (∆Cmax). Consider a case where solution at the concentration 
and temperature represented by point A in Figure 5. This point lies beneath the 
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solubility curve and so represents an undersaturated solution. If this solution is now 
cooled, the system will travel along a horizontal line on the diagram until at point B, 
the system becomes just saturated. Further cooling causes the system to become 
supersaturated, but nucleation to form crystals does not usually occur immediately the 
system becomes supersaturated. Only when cooling is continued to some point C does 
ample supersaturation exist for the nucleation to occur. The gap between B and C is 
designated as the MSZW. 
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Figure 5: Solubility curve and metastable zone. 
 
2.3 Basic types of racemates 
 
The distinction of the different types of racemates remained controversial as long as it 
was based only on visual or microscopic comparison of crystal forms or the densities 
of racemates with those of the single enantiomers.5 The easiest way of determining 
the racemate type is by examining the binary phase diagram. This was only realized 
when it became clear that enantiomers mixtures were specific type of binary phase or 
ternary system when the solvent is included, and its properties can be described by the 
phase rule which was initially proposed by J. W. Gibbs in 1876.31 A phase diagram is 
used to represent the relationship between temperature, pressure and concentration 
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and the crystal structure of solid phases. Roozeboom36 characterized in 1899 three 
types of enantiomers mixtures by their melting point (fusion) diagrams, which are 
depicted in Figure 6. 
 
 
Figure 6: Binary phase diagrams illustrating the three fundamental types of crystalline racemates; (A) 
conglomerate system, (B) racemic compound, (C) solid solution; (1) ideal, (2) with a maximum, (3) 
with a minimum. Taking from Anett Perlberg37 
 
There are three main types of enantiomers mixtures that have been recognized and 
characterized well by their binary fusion diagram. The melting phase diagram of the 
mixtures of enantiomers (S) and (R) is illustrated in Figure 6. Figure 6(A) shows a 
binary phase diagram where the racemates crystallizes as a homochiral mixture of the 
two enantiomers.  
 
 
Figure 7: Solid-state racemate types; (a) conglomerates, (b) racemic compound, (c) solid solution 
 
Figure 7 shows how the single enantiomers of (S) and (R) are arranged in the solid 
state of the various racemates types, i.e. (a) conglomerate, (b) racemic compound and 
(c) solid solution, respectively. A conglomerate is an equimolar mixture of two 
crystalline enantiomers that are in principle, mechanically separable5 (see Figure 
7(a)). The binary phase diagram in this case depicts a simple common eutectic at (x = 
0.5), since the mixture melts just like a pure substance and this fit the classification of 
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eutectic. Conglomerate systems can be resolved easily by spontaneous crystallization 
based on the fact that the racemates crystallized in homochiral form. Unfortunately, 
only approximately 5-10% of the enantiomeric systems exhibit this behaviour5. 
Actually, the racemate and the enantiomers have most of their chemical and physical 
properties as the same, for instance the XRPD pattern, infra-red and Raman spectra of 
the enantiomers and the racemate are identical. The most obvious differences that 
exist between the enantiomers and racemates of a conglomerate system are the 
melting point and their solubility. According to Meyerhoffer’s ‘double solubility 
rule’38 the conglomerate solubility is in an ideal case the sum of the corresponding 
enantiomers solubility. The liquidus line in Figure 6(A) can be estimated by using the 
Schröder and van Laar equation5, if the binary mixtures in the liquid phase act ideally. 
The equation makes use of the enthalpy of fusion and the specific heat of the two 
enantiomers both in the liquid and the solid phase, the melting point for two single 
enantiomers and the universal gas constant. The general Schröder and van Laar 
equation of the liquidus is given by;5 
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fus 1ln11ln γ  
                                       Equation 17 
     
where fusHΔ  is the enthalpy of fusion at a melting temperature Tm, R is the universal 
gas constant (8.314 J mol-1 K-1), Sp
L
p CandC , are the heat capacities of the 
enantiomers at liquid and the solid state and x represents the mole fraction in excess 
(0.5 ≤ x ≤ 1) of the mixture where melting ends at T. A simplified form of the 
Schröder and van Laar equation without the contribution of the heat capacity terms is 
often applied since the heat capacities for the liquid and the solid often compensate 
each other. For an ideal mixture the activity coefficient is unity. In this case the 
Schröder and van Laar equation becomes; 
⎟⎟⎠
⎞
⎜⎜⎝
⎛ −ΔΗ=
TTR
x
enanm
enan
fus 11ln
,
  
                                                        Equation 18 
 
where enanfusHΔ , Tm, enan, are the enthalpy of fusion and the melting point of the single 
enantiomers, respectively. 
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The second type of racemate is the racemic compound which is the most abundant 
occurring type of racemate, constituting about 90-95% of racemates. These racemates 
are characterized by a crystal form in which the two enantiomers coexist in the same 
unit. The (S) and (R) crystallize in the same crystal (heterochiral) forming a defined 
50:50 compound. Mixtures of enantiomers crystallizing as racemic compounds result 
in a phase diagram which was envisaged by Roozeboom36. A typical example of this 
phase diagram is illustrated in Figure 6(B). A clear description of its arrangement in 
the solid state is given in Figure 7(b). Normally, the solid state XRPD patterns, of the 
enantiomers are different from that of the racemic compound. The melting point of 
the enantiomers can be lower or higher compared to that of the racemic compound. 
The difference between the two temperature seldomly exceeds ±20 °C1 As mentioned 
earlier on that, the Schröder van Laar equation allows the calculation of the liquidus 
curve from the enthalpy of fusion and the melting point of the single enantiomers. In 
the case of racemic compound, the same equation can be used to calculate the liquidus 
line found between the single enantiomers and their corresponding eutectic, while the 
racemic compound curve (part of the curve below which the solid phase is pure 
racemic compound; 0.5 ≤ x ≤ xeu) can be calculated using a comparable Equation 
known as Progogine-Defay equation5,39. 
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                                                      Equation 19 
 
Equation 19 is similar to Equation 18, the only difference is that Equation 19 takes the 
stoichiometric considerations into account, racfusHΔ and Tm, rac are the enthalpy of fusion 
and the melting temperature, respectively, of the racemic compound. 
The third class of racemates is known as solid solution (mixed crystals). An equimolar 
mixture of the enantiomers in the solid state is called a pseudo-racemate. In this case 
(S) and (R) enantiomers co-crystallize arbitrarily. In both Figures 6(C) and 7(c) is 
shown a typical binary phase diagram and the solid state arrangement for this system. 
Figure 6(C) is classified into three different types which were identified by 
Roozeboom36. In type 1 (ideal solid solution) indicated in Figure 6(C) as 1, is made up 
of mixture of (S) and (R) enantiomers in all proportions melt at the same temperature 
as the single enantiomer . In the second type (with maximum melting point), shown in 
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Figure 6(C) as 2, the phase diagram exhibits a maximum melting point for the 
racemate and in the third case (with minimum melting point) is the contrary.  
The next section will discuss various techniques capable to separate enantiomers. 
 
2.4 Chiral separation techniques 
 
Basically, techniques for acquiring chiral compounds can be classified into three main 
areas: generating chiral substances from starting material via the “chiral pool” of 
nature, asymmetric synthesis (making chiral substances from achiral starting 
material), and resolution of racemates. On the industrial scale, enantiomers are 
produced mainly by enantioselective synthesis or from the resolution of racemates. In 
the first case substances are synthesized by using biological and chemical catalysis to 
make desired molecules from pure chiral building blocks that are already accessible. 
The second category is also classified as asymmetric synthesis. Herein, the desired 
enantiomer is synthesized by a selective synthesis with achiral starting material. In 
most cases an asymmetrical mixture of both enantiomers is obtained. The third 
category involves first the unselective production of the racemate followed by the 
resolution process. The third class is frequently employed on commercial level in the 
industry. A comprehensive description of enantioselective syntheses has been 
reported in.40 Most of the production of enantiomers in the industry involves racemate 
synthesis and subsequent resolution processes.  
In the next section, the various resolution methods that are commonly used in the 
industry are discussed.  
 
Chromatographic techniques. Chromatographic separation involves different 
distribution of the compounds to be separated between a mobile phase (eluent) and a 
stationary phase (adsorbent). In the case of enantioselective chromatography, chiral 
selectors are attached to the surface of the stationary phase (chiral stationary phase, 
CSP) so as to offer a chiral milieu necessary for selective interactions. Currently there 
are several types of CSPs in use, for instance cyclodextrins, proteins and 
polysaccharides. There are a couple of reasons for the growing number of applications 
of chromatography, for example the relatively short time necessary to develop a 
chromatographic method, simplicity in scale up and the availability of several 
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possible CSPs for many separation systems. There are different types of 
chromatographic techniques, based on its mobile and stationary phases applied for 
interaction e.g. Liquid chromatography, Subcritical or Supercritical fluid 
chromatography and Gas chromatography. High-pressure liquid chromatography 
(HPLC) separation in one of the most essential fields in the preparative resolution of 
enantiomers 41 Herein, enantiomers are discriminated with the aid of different 
molecular interactions with the chiral stationary phase, which separate the two 
enantiomers by employing the chirality of the stationary phase. However, this method 
applies typically a large amount of solvent and requires sufficient capital investment 
in the form of expensive stationary phases and high pressure equipments.42 In the last 
years, the execution of the Simulated Moving Bed (SMB) expertise proved to reduce 
separation costs.  
Kinetic resolution. Generally, a chemical material capable of enantiomeric 
discrimination is used to catalyze a chemical transformation of the two enantiomers at 
substantially different rates. Preferably, the rate of conversion is zero for one of the 
enantiomers whilst its counter enantiomer is readily converted. This concept is based 
on chemical reactions of various types, and mainly divided into two sections: 
enzymatic and inorganic catalyzed systems. Though, it gives very high selectivity, 
usually in practice a compromise needs to be made between conversion and 
enantiomeric purity. It has been reported that enzymatic reagents often deliver higher 
optical purities.43 Although it is effective, powerful and capable of producing in some 
cases very high enantiomeric excesses, application is limited due to lengthy 
development times and limited availability of enantio-discriminating substances.42 
Reaction/resolution combinations.42 This involves reactions to form a 
diastereomeric salt which is subsequently introduced into classical resolutions. 
Diastereomeric salt resolutions are widely employed in chemistry and are often 
considered as the most cost effective technique. However, racemization of the 
separated enantiomers can frequently occur during the elimination of the salt, 
rendering this method then ineffective for chiral separation. Another, new technique 
applied here is the usage of enzymes to catalyze the reaction of one enantiomer into 
different chemical species. For instance pig liver esterase is used to catalyze the 
esterification of an undesired enantiomer, followed by the application of standard 
physical techniques such as crystallization, evaporation, etc. Though, this gives a 
suitable separation there are a couple of limitations such as inability of the enzymes to 
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survive typical organic solvents which are being used in pharmaceutical processing. 
Also, high cost and lengthy development time limit the application of this method. 
Membrane-based separations. There are two main kinds of membrane processes for 
enantioseparation; either by direct separation using an enantioselective membrane, or 
separation in which a non-selective membrane aids an enantioselective process. 
Enantioselective membranes offer barriers, allowing selective transport of one of the 
enantiomers of a racemic mixture. There are two types of such membranes; dense 
polymers or liquid membranes. In the latter case a selective carrier is usually added to 
the liquid membrane. Therefore liquid membranes have been considered promising 
for the selective transport of enantiomeric solutes across membrane. Larger scale 
application has been very restricted due to the extreme poor stability of the supported 
liquid membranes. If the liquid membrane is suitably developed then would require 
lowest capital and lowest operating cost process to realize chiral purity via 
separation.41,42,44 . Recently, Seebach et al.45 also reported the application of 
molecularly imprinted polymeric membranes as an alternative way of chiral 
separation. 
Crystallization. This is often the preferred method due to its easiness of operation, 
minimal cost of manufacture and its effectiveness. Crystallization methods are 
extensively used by large industrial scales for the separation of chiral substances and 
diastereomeric salts, since they are more straightforward and more economical 
relative to the other methods.1 A chiral compound can be obtained directly via 
crystallization of the desired enantiomer from the racemic mixture. Generally, 
enantioselective crystallization occurs by adding seed crystals of the preferred 
enantiomer to a supersaturated solution of racemic mixture. Moreover, 
enantioselective crystallization can also occur by using a chiral environment to carry 
out the crystallization. A chiral environment can be produced by using a chiral solvent 
or a chiral additive. These ingredients might create selective interactions with the 
chiral solutes, which can facilitate differentiation between the two single 
enantiomers.4,5,46 Unfortunately, most of the enantioselective crystallization processes 
are only suitable for conglomerate systems, which are not so common. Racemic 
compounds are more frequently encountered in nature1. Based on this fact, efforts are 
currently focused on developing resolution processes capable to resolve compound 
forming systems.  
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The next section will discuss options for racemate resolution by various 
enantioselective crystallization processes.  
 
2.5 Separation of racemates by enantioselective crystallization 
 
The following sections summarize different enantioselective crystallization techniques 
capable to provide pure enantiomers. The possibility of enantioselective 
crystallization strongly depends on the whims of nature, generating the shapes of the 
solubility isotherms in the ternary solubility phase diagram. Since this type of 
resolution method is effectively used for conglomerate systems, there had been the 
need to find out other ways for applying it also to racemic compound. Herein, this 
technique can also be employed to compound forming systems by starting with a 
solution having (almost) eutectic composition of the racemic compound and one of 
the pure enantiomers.47,48  
 
2.5.1 Classical resolution 
 
Actually, this technique was discovered by Pasteur in 1853. This is a method which 
entails the combination of a racemate with one enantiomers of another chiral 
substance (resolving agent) to give a 50:50 mixture of (p, n)-diastereomeric salts. The 
diastereomers have different properties, aiding a physical separation. Thus, 
separations of the diastereomeric salts are feasible. A schematic example of this 
method is illustrated in Figure 8. 
 
 
Figure 8: Classical resolution of diastereomeric salts. The racemic mixture RS-D is converted into two 
diastereomeric salts applying the homochiral resolving agent (S)-A. The diastereomers are separated, 
and the single enantiomer, (S)-D is released. The resolving agent is regenerated via recycle. 
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Diastereomeric salt crystallization is widely used industrially. Approximately 65% of 
the enantiomeric drugs are obtained in this way, and hence it plays a major role in the 
industrial production of enantiomers.49 Collet1 reported that DSM Company has 
resolved DL-phenylglycine by crystallization of its diastereoisomeric salts with (+)-
10-camphorsulphonic acid, to produce at a scale of more than 1000 tonnes per year. 
The D-enantiomer is applied in the manufacture of antibiotic ampicillin. Moreover, 
thousands of tonnes per year of (S)-naproxen50, are produced by diastereomeric salt 
resolution, rather than other methods such as asymmetric synthesis. The reasons of 
this preference are that crystallization is a more straightforward and economical 
method compared to other techniques.  
However, this technique has some limitations regarding the availability of resolving 
agent and the yield. For instance, decision on what is cheap to be used, available, 
optically active and chemically and optically stable along with many other 
restrictions. Another shortcoming of this method is that the maximum yield that can 
be realized is only 50%. Mostly only 33% yield1 is achieved. However, unless 
racemization is localized into the process so that complete conversion to the desired 
enantiomers is attained.  
In 1998 Vries et al.51 reported an improved way of dealing with this technique. These 
authors employed a smart combinatorial approach to ease the cumbersome selection 
of the appropriate resolving agent. This method is known as “Dutch Resolution”. 
They observed that the simultaneous addition of several resolving agents of the 
identical family (normally three) to a racemate led to a fast precipitation of the 
crystalline diastereomeric salt; moreover, the diastereomeric salts obtained had high 
enantiomeric purities. Furthermore, the use of multiple resolving agents speeded up 
the process of finding the best resolving agent. The use of a family of resolving agents 
rendered in the last years trial-and-error method of resolution into an acceptable 
practice. Leusen et al.52 presented a thermodynamic approach which shows that the 
resolution efficiency is related to the lattice energy differences of the pair of 
diastereomeric salts.  
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2.5.2 Resolution by direct crystallization 
 
The precondition of enantioseparations by direct crystallization is that the racemate of 
the respective enantiomers crystallizes as conglomerate form (see Figure 6(A)). Direct 
crystallization which is an economical resolution technique has been discussed 
comprehensively by Jacques et al.5 In the case of racemic compound system, the 
method can only apply when the racemic compound is converted into conglomerate, 
and this can be made through changing it to derivative.16 Thus, when the two 
enantiomers crystallize as a conglomerate, then two resolution methods (preferential 
nucleation/crystallization) are feasible. Before these resolutions methods may be 
applied it is obviously necessary to establish the existence of the conglomerate; this 
may be done in a number of ways: (i) determination of binary (Figure 6(A)), or 
ternary phase diagrams, (ii) effecting resolution by direct crystallization (confirmatory 
test); (iii) powder X-ray or solid state IR spectra (enantiomers give spectra 
indistinguishable with those of racemic conglomerate but differ for racemic 
compounds)49.  
Direct crystallization can be performed in two main ways, i.e. simultaneous and 
preferential crystallization.  
 
2.5.2.1 Resolution by simultaneous crystallization 
 
The process consists of seeding the racemic supersaturated solution with 
comparatively large seeds of one of the enantiomers which eventually grows larger. 
At the same time, the spontaneous crystallization of the counter enantiomers by the 
small seeds will create small crystals which can be separated from the larger 
enantiomeric crystal by sieving.5  
In 1848, Louis Pasteur successfully performed enantioseparation of racemic sodium 
ammonium tartrate by visually distinguishing between the levorotatory and 
dextrorotatory crystals and manually sorted them out.15 This manual crystal sorting 
approach of Pasteur’s by utilizing the hemihedral faces is laborious and not 
commercially or industrially appropriate. Since only well-defined morphological 
characteristics that can distinguish between the left and right crystals, a situation that 
does not always attain constant if large crystals is present. On the other hand, an 
alternative technique (schematically shown in Figure 9) uses two crystallizers which 
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are seeded with the corresponding enantiomer. Herein, the crystallization proceeds 
with a supersaturated solution, and after the crystals are collected the solution is 
resaturated and this cycle continues.  
 
 
Figure 9: Schematic diagram showing process for the resolution of α-methyldopa by seeding with 
individual enantiomers within metastable zone width. t1, t2 and t3 represents the temperatures44 
 
The principle used here is that a supersaturated solution is created within the 
metastable zone width and then seeded with the single enantiomers. This method has 
been used commercially by Merck to produce tonnes of antihypertensive drug 
methyldopa.44,49 For instance, Doki et al.53 used preferential crystallization in the 
presence of a “tailor-made” additive to resolve DL-asparagine. They applied a novel 
combined natural cooling and pulse heating technique where both enantiomers 
crystallized simultaneously but could be separated by their different sizes. 
 
2.5.2.2 Resolution by preferential crystallization 
 
The resolution of enantiomers by preferential crystallization is a kinetically controlled 
separation process that is terminated before thermodynamic equilibrium is attained. 
This technique is also known as resolution by entrainment.5 Crystals of the desired 
enantiomer are obtained from a supersaturated solution enriched in example one-
enantiomer by seeding with this enantiomers, say the (S)-enantiomer when enriched 
with the (S)-enantiomer. Crystals of (S)-enantiomer are crystallized and the solution is 
now enriched in the (R)-enantiomer, to which equal amount of racemate is added, i.e. 
equal to the mass of the (S)-enantiomer that crystallized. Afterward supersaturation is 
restored with the solution now further enriched in the (R)-enantiomer and crystals of 
(R)-enantiomer are collected. This process can be carried out repeatedly by 
crystallizing both enantiomers alternatively.  
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The application of a cyclic mode of preferential crystallization for a conglomerate 
system is illustrated in Figure 10. At the start, the solution is saturated at temperature 
Tstart, with an enantiomeric composition of point A (enriched in (S)-enantiomer). 
Afterward the solution is cooled down to Tend and the solution then becomes 
supersaturated. 
 
Solvent
A
B
C
D
L R D
Eut.
TEnd
Tstart
Metastable zone
S RRac
TStart
 
Figure 10: Preferential crystallization conducted in a cyclic operation mode for a conglomerate system. 
 
The clear solution (free from any particles of crystals) is seeded with crystals of the 
enantiomer S. As a consequence, the pure enantiomer S crystallizes along the 
trajectory A to B. At the point B, the process is stopped; the solid enantiomer S is 
cropped and predetermined amount of the racemic mixture is added to the remaining 
mother liquor. After complete dissolution of the solid feed, the solution has a new 
composition which is represented by point C. Here, solution is cooled down to 
temperature Tend and subsequently seeded with crystals of enantiomer R, so pure 
enantiomer R crystallizes along the trajectory C to D. After reaching the point D the 
process is interrupted once again to be able to harvest the pure enantiomer R. All 
seeding processes are done only in the metastable zone width (see section 2.2.5, 
Figure 5), which is demarcated in Figure 10 in grey color. 
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Although most of preferential crystallization process can be applied conveniently to 
conglomerate system, there are few cases where it has been used for racemic 
compound systems. Recently, Lorenz el al.47 have illustrated the possibility of 
preferential crystallization for such systems starting with a solution having 
approximately eutectic composition (made up of the racemic compound and one of 
the pure enantiomers). Figure 11 shows the application of a cyclic operation mode for 
preferential crystallization of a racemic compound system.47 
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Figure 11: Preferential crystallization conducted in a cyclic operation mode for a racemic compound.47 
  
Analogously to conglomerates, preferential crystallization is performed in the 3-phase 
region of the conglomerate forming system. The same concept of preferential 
crystallization for racemic compounds can be described by Figure 11. The same 
procedure and techniques as in the case of Figure 10 is employed, except that after 
seeding the supersaturated solution at point A crystals of pure enantiomer S. The 
composition of the solution shifts from point A to B as (S)-enantiomer crystallizes 
from the solution. At point B, the process is stopped, and the (S)-enantiomer crystals 
are filtered off. Later, a predetermined amount of, eutectic mixture (Eut) is added to 
the remaining mother liquor. After dissolving entirely the solid feed, the solution 
assumes a new composition represented by point C. When reaching Tend and seeding 
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with crystals of the racemic compound (Rac), then the racemic compound starts to 
crystallize along the trajectory C to D. At point D the process is interrupted and the 
crystallized racemic compound is filtered off. Subsequently, new Eut is added into the 
crystallizer to provide a solution having the start composition A to do again the whole 
cycle illustrated.  
Preferential crystallization can be also carried out in the presence of additives. A 
stereochemical way has been applied which involves the growth and dissolution of 
molecular crystals in the presence of tailor made additives.54,55 An additive can be 
adsorbed stereoselectively on the enantiomer of the same absolute configuration. This 
inhibits the growth of the enantiomer and preferential crystallization of the unaffected 
enantiomer (of the opposite chirality, which implies the well known “rule of 
reversal”) Hence the existence of the incorporated additive differentially affects 
growth directions. 
Additives are used for the control of nucleation and growth of molecular crystals and 
are classified broadly as inhibitors and promoters.56 Tailor made inhibitors which are 
used for crystal growth can be applied for a number of functions such as 
morphological engineering57 and also etching, reduction of crystal symmetry (from 
the occlusion of additive into the crystal)58, explaining the effects of solvents on 
crystal growth, crystallization of the preferred polymorph and assignment of absolute 
configuration of chiral molecules and polar crystals.59 Figure 12 illustrate the 
influence of additive on the morphology of crystal during crystal growth process. 
 
+ additive
A A
B B
B B
unaffected crystal growth 
(rate of growth of B >A )
stereospecific adsorption 
of additive inhibits the 
growth of B faces 
affected crystal 
rate of growth 
A >B  
Figure 12: Influence of additive on the morphology of crystal during crystal growth.54 
 
 Tailor made additives have been used at length to control crystal polymorphism by 
selectively hindering the nucleation of the undesired polymorph by the selective 
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adsorption of the additive on certain surfaces of the growing crystal.54,56,60 This is due 
to the hypothesis that in supersaturated solutions, some molecular clusters are present 
which bear a resemblance to the structure of the macroscopic crystals into which they 
eventually grow. There are many instances where additives have been successfully 
been used to crystallize one of the enantiomers from a conglomerate solution.55,60-64 
The method of inhibition requires no resolving agents and is conducted under explicit 
conditions designed such that the undesired enantiomer does not suddenly crystallize 
out. In a strict thermodynamic sense, preferential crystallization can be attained only 
for substances that are conglomerates. But, it might be possible with compound 
existing either as conglomerates or racemic compounds within available temperature 
range under kinetic control, stirring, variable temperature and seeding. Resolution by 
entrainment is based on the differences in solubility of the racemate and the pure 
enantiomers.65 Resolution of racemic conglomerates by preferential crystallization is 
the easiest and cheapest method available for the generation of enantiomerically pure 
products.1,5 The preferential crystallization process as a method for commercial 
resolution of racemates has great potential and real economic importance in both 
pharmaceutical and chemical industries. However, understanding of the underlying 
fundamentals processes such as thermodynamics and kinetics of this technique in the 
crystallization process is rather restricted. To optimize the resolution technique, the 
behavior of chiral crystals under varied conditions must be understood.65 
 
2.5.3 Resolution by preferential nucleation 
 
In preferential nucleation66,67 the nucleation rates of both enantiomers are different. 
This behavior can be attained by e.g. addition of a suitable additive that selectively 
inhibits nucleation of one of the enantiomers. This promotes the other enantiomer to 
nucleate. The nucleation rates of the two enantiomers can be sometimes altered even 
with addition of small amount of a suitable additives (<< 1%). The method is 
illustrated on Figure 13. Figure 13 shows the principle of preferential nucleation in; 
(a) without chiral tailor-made additive, where the enantiomers of R and S have the 
same nucleation and crystal growth rates, (b) after adding chiral tailor-made additive 
such as example R*, the crystallization of R in this case is more strongly inhibited 
than for its counter enantiomer S.  
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(R)Solvent – (S)solvent
<S><R>
(R)Solvent+ (R*solvent) – (S)solvent
<R> <S>
(a) (b)  
Figure 13: Principle of S preferential nucleation. (a) Without chiral tailor-made additive, R and S 
nucleation rate and crystal growth rate are equal. (b) After addition of the chiral tailor-made additive 
R* the crystallization of R is more strongly inhibited than that of ‹S›.67 
 
Thus, the “rule of reversal”55,68,69 applies in this case. It means the additive is 
stereoselectively adsorbed at the surface of growing nuclei of the enantiomer of the 
same absolute configuration, resulting in a strong reduction in their growth rate and 
thus allowing for preferential crystallization of the counter-enantiomer. Herein, the 
solute with identical absolute configuration as that of the chiral tailor-made additive 
experiences the strongest disrupting effect (inhibition) of the nucleation rate. In this 
situation “similar or identical molecules” means species which are able to contribute 
in the same strong bond network in the crystal lattice (ionic bonds if they exist, H-
bonds) but differ by organic substituents involved in the van der Waals interactions.67 
Ndzié et al.66 demonstrated a successful enantiomeric resolution of (±)-5-Ethyl-5-
Methylhydantoin by means of preferential nucleation. Barton and Kirby70 also 
conducted resolution of (±)-narwedine in the presence of (-)-galanthamine with the 
aid of preferential nucleation to isolate (+)-narwedine. According to Jacques et al.5 
chiral solvents can also play a useful role in modifying the rate of growth of 
enantiomeric crystals, and can be exploited for preferential nucleation/crystallization.  
 
2.5.4 Chiral solvents 
 
Chiral solvents (optically active organic solvents), consisting of chiral molecules 
which rotate the plane of linearly polarized light.71 Generally, diastereomeric solvates 
(complexes) could be formed when a mixture of enantiomers is dissolved in a chiral 
solvent. Consequently, these complexes should possess slightly different physical and 
chemical properties.4  
According to a letter Van’t Hoff wrote to Meyerhoffer in 1893 in which he stated that 
there should be the possibility to find differences in the solubility of enantiomers in 
optical active solvent (chiral solvent)72, predicted the use of this property as a new 
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resolution method. Basically, in the kinetic sense the chiral solvent can modify the 
rate of growth of enantiomeric crystals. More precisely, it probably influences both 
the nucleation/crystal growth rate of the chiral substrate in different ways, depending 
on the nature, stereospecificity, and the effectiveness of solvent-substrate interaction.5 
On the other hand, thermodynamically, the chiral solvent possesses a certain potential 
to discriminate between two enantiomers by creating specific weak interactions and 
forming diastereomeric complexes which gives different physical properties such as 
solubility differences.4 This discrimination can provide selective kinetic or solution 
thermodynamic effects which can be useful for the separation of enantiomers as 
suggested by Van’t Hoff.  
The next section will present a discussion on role of solvent in selective 
crystallization. 
 
2.6 Role of solvent in selective crystallization 
 
Solvents play a major role in crystallization. Generally, solvents are selected based on 
the resulting solubilities, the mode of crystallization and the type of crystals. The main 
point that should be considered in the process of selecting a solvent for crystallization 
is that the solute which has be crystallized must readily be soluble in the solvent. The 
solute used should form desired as a solute crystalline form after cooling, evaporating 
or salting out with an additive. The solvent applied can also have a major influence on 
crystallization, for instance capacity of solute-solvent reactivity, solvate formation, 
the viscosity of solvent, recovery of solvent, and how the freezing point of the solvent 
is related to the operation window and hazardous nature of the solvent.31  
However, in the case of selective crystallization, the kind of solvent applied can 
influence the shape of the solubility isotherms which eventually allow high 
entrainment in a preferential crystallization. This is so because, it might provide a 
wide area for entrainment, i.e. it might be possible to obtain high yields in resolution 
or it may be possible even to enter the two phase region of the phase diagram, which 
would be more lucrative for obtaining enantiopure crystals.5,33 Recently, Kaemmerer 
et al.73 performed experimental studies on two chiral systems (malic acid and 
methionine) and reported that the eutectic composition of the two enantiomers can be 
altered by temperature and choice of solvent.  
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The following section will give a comprehensive discussion on state of research on 
chiral solvent/chiral media being used as means for chiral separation. 
 
2.6.1 State of research 
 
Since a chiral solvent has the potential to discriminate between two enantiomers, 
asymmetry could be induced in a solubility phase diagram. Based on this asymmetry, 
the resolution of a racemate should be feasible by direct crystallization.4,5 On the basis 
of this expectations, several resolution work involving chiral solvents and other chiral 
media have been discussed comprehensively in this section. Literature survey on 
chiral solvent/chiral medium has revealed couple of successful chiral resolutions by 
employing enantioselective crystallization with the help of chiral solvents or chiral 
medium. For instance, Buhse et al.46 demonstrated a successful kinetic resolution of 
racemic glutamic acid by using a chiral solvent derived from lysine and water. Small 
amounts of L- or D-Lysine were used to retard the crystallization rate of the 
corresponding enantiomer of glutamic acid in a stereospecific way, which resulted in 
transient optical resolution of racemic glutamic acid during crystallization. Moreover, 
Lüttringhaus et al.74 and Groen et al.75 reported successful chiral resolutions of some 
racemic conglomerates by crystallization using D-isopropyl tartrate and (-)-α-pinene 
respectively, as chiral solvents. This direct crystallization was feasible due to the 
different rates of nucleation and/or growth of one enantiomer comparative to the 
other. On the other hand, Groen et al. further illustrated that the resolution of a 
racemic compound in (-)-α-pinene was not feasible 75. All the authors observed a 
certain enantiomeric excess. Further work has been done by applying “tailor-made” 
additives in kinetic resolution. For example, Addadi et al.55 conducted efficient 
resolutions of a couple of conglomerates by preferential crystallization with the help 
of “tailor-made” additives. More recently, also Doki et al.53 used preferential 
crystallization in the presence of a “tailor-made” additive to resolve DL-asparagine. 
They applied a novel combined natural cooling and pulse heating technique where 
both enantiomers crystallized simultaneously but could be separated by their different 
sizes. However, the examples given only apply to conglomerate systems. 
Moreover, Mughal et al48 conducted similar work on primary nucleation in the 
mandelic acid/water system by starting with eutectic composition of the mandelic acid 
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enantiomers in water ((S)-enantiomer in excess) using an additive. Additive is used to 
further inhibit the racemate, i.e. delayed the rate of equilibration. The authors could 
demonstrate an enantiomeric enrichment of the (S)-MA in the crystallized material for 
a certain period of time. This is expected since the MSZW (see section 2.2.5) of the 
mandelic acid enantiomers in water is explicitly lower than that of the racemic 
compound in the temperature range studied47. However, this enantioselective 
crystallization process needs to start with a solution containing the enantiomers (more 
or less) in the domain of eutectic composition. Barton and Kirby also conducted 
resolution of (±)-narwedine in the presence of (-)-galanthamine with the aid of 
preferential nucleation to isolate (+)-narwedine.70  
Furthermore, new approaches of chiral resolution based on enantioselective 
separations aided by chiral surfaces are reported. For example , Medina et al.76 
published a new way of chiral separation based on enantioselective crystallization on 
chiral polymeric microspheres. Chiral resolution of DL-valine a racemic compound 
system was carried out and with the help of chiral polymeric micropsheres an 
enantiomeric excess of 25% for L-valine in the chiral microspheres were realized 
during crystallization. Here, basic principle of chiral discrimination aided by 
enantioselective crystallization on chiral mocrospheres is performed. Gabashvili et 
al.77 demonstrated quite similar work by using chiral mesoporous silica based on 
chiral block copolymers of poly (ethylene oxide) and of D-phenylalanine (PEO-b-D-
Phe) as a surfactant template for racemic valine, and preferential chiral selective 
adsorption of D-valine enantiomer was observed. Also, Fireman-Shoresh et al.78 
reported possible discrimination between pairs of enantiomers ((R)- and (S)-
propranolol, and (R)- and (S)-2,2,2-trifluoro-1-(9-anthryl)ethanol, respectively) by 
employing chirally templated sol-gel thin films. In both pairs of enantiomers, the 
chiral templated sol-gel thin films could preferentially adsorb the (R)-enantiomer. 
Moreover, novel methods of chiral resolution based on enantioseparations with the 
help of chiral extraction are demonstrated in some recent publications. Tang et al.79 
reported on a feasible novel method for the separation of mandelic acid enantiomers 
by applying biphasic recognition chiral extraction. Also, Dzygiel et al.80 reported on 
successful resolution of racemic N-Benzyl α-amino acid by liquid-liquid extraction 
with a practical method using lipophilic chiral cobalt (III) salen complex and 
mechanistic studies. 
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Recently, Hüttenhain and Dickerhof reported a comprehensive work on the 
asymmetric induction by means of chiral solvents “Asymmetrische Induktion durch 
Lösungsmittel” to realize enantioselectivity.81 In this work, acetophenone was 
successfully converted to 33% ee of (R)-phenyl ethanol in the liquid phase with the 
aid of the chiral solvent (S)-ethyl lactate at 0 °C. Also, the authors demonstrated that a 
unique reaction pathway at lower temperature -78 °C with a quantifiable conversion 
of acetophenone and (S)-methyl lactate into 60% ee of (R)-phenyl ethanol is possible 
with triple the amount of boron hydride in excess. The authors further investigated the 
theoretical computations in cooperation with professors Schmidt and Rueping of the 
Universitat Frankfurt for the possible transition states and product distributions for the 
reactions with acetophenone occurring at room temperature were calculated by means 
of computer simulation. Initial computational works have shown that there is an 
intensive dependence between the structures of the solvent and the enantioselectivity. 
Hence, molecules with similar structure should better fit the solvent cage and attain 
higher enantiomeric excess (ee). Based on entropy principles, it would be favorable 
for the (S) solvent and its corresponding (R) form of the transition state molecule. 
Additionally, they revealed that the surrounding solvent and its chiral cage have little 
influence on the advancement of the reaction, and only a direct interaction on the 
hydrogen bonds impacts the enantioselectivity. 
 
2.6.2 Effect of additives on crystallization 
 
In this thesis work tailor-made chiral solvents are employed as one of the chiral 
solvents for enantioselective crystallization. So, this section will be used to describe 
how tailor-made additives inhibit crystal growth.  
Tailor-made additives are specially designed to interact in a precise way with selected 
faces of crystalline materials. The molecules of tailor-made additives are composed in 
two parts. One section which belong to for instance the chemical group or moieties, 
and is identical with that of the substrate molecules undergoing crystallization. When 
such molecules are added to a solution undergoing crystallization, by nature of their 
moieties identical to the substrate these segments of the additive imitate the solute 
molecules and are, hence, readily adsorbed at growth sites of the crystal surface. The 
second part of the additives is designed in such a way that the ends of these parts are 
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chemically or structurally different from the host molecules, thus disrupting 
subsequent attachment of the solute molecules. This effect is realized by tailoring the 
additive molecules to introduce steric hindrance. The largest morphological changes 
occur in crystals grown in the presence of additives that interact strongly and 
selectively to one or a few crystal surfaces.57 Figure 14 depicts schematic 
representation of inhibition of growth of benzamide crystals along the b direction by 
adsorption of benzoic acid molecules of the additive. For example, in the presence of 
benzoic acid the morphology of benzamide crystals is altered.56 Hence, the benzamide 
forms plate-like crystals and consists of hydrogen bonded cyclic dimers interlinked by 
NH---O bonds along the b-axis. Since in the presence of benzoic acid, competitive 
binding occurs between the stereochemically identical benzamide and benzoic acid 
along the b-axis. This results in an enhanced surface area of the faces which cut the b-
axis, and leads to wider plate-like crystals compared to the narrow plate-like crystals 
grown in the absence of benzoic acid.82 Hence, additives designed to adsorb onto 
crystal faces can retard the growth of that face to which they bind; whilst crystal faces 
unaffected by the additive continue to grow57 (as also shown in Figure 12). 
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Figure 14: Schematic representation of inhibition of growth of benzamide crystals along the b 
direction by adsorption of benzoic acid molecules of the additive.56 
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2.7 Molecular modeling for solvent-solute interactions 
 
Molecular modeling studies are required to get a deeper understanding of the solute-
solvent interactions in the system studied in this thesis work. Molecular modeling 
techniques are widely used in pharmaceutical research. Crystal structure data such as 
unit cell parameters, solute-solvent interaction, fractional atomic coordinates and 
space group can either be imported as a Crystallographic Information File (CIF file) 
from experimentally solved structures, or extracted from the ConQuest (CCDC) or 
mercury Cambridge Structural Database (CSD)83, where a large number of crystal 
structure solutions are available and imported into MATERIALS STUDIO 4.3 as data 
file, which can be then used for the visualization of hydrogen bonding motifs and for 
various calculations. For the molecular modeling work carried out in this thesis, 
MAETERIALS STUDIO 4.384 (VAMP model) was applied to calculate single energy 
point calculations for solute-solvent interactions.  
In the following sections, specific details on the different molecular modeling studies 
that can be carried out using these applications are summarized.  
 
2.7.1 Hydrogen bonding 
 
One of the strongest of the non-bonded interactions that organize molecules into 
superstructures and hold them together is hydrogen bonds. According to L. Pauling85 
a hydrogen bond is defined as “an interaction that directs the association of a 
covalently bound hydrogen atom with one or more other atoms, groups of atoms, or 
molecules into an aggregate structure that is sufficiently stable to make it convenient 
for a chemist to consider it as an independent chemical species” A hydrogen bond is a 
donor (B) and acceptor (A) interaction exclusively, involving hydrogen atoms. It is 
formed between electronegative atoms such as O and N and electropositive atoms 
such as H atoms. Three parameters (d, θ and r) are employed to illustrate a hydrogen 
bond (see Figure 15). Hydrogen bonds are categorized by using the rule that the 
distance d between the 2 atoms involved is less than or equal to the sum of the van der 
Waals radii for the 2 atoms. 
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Figure 15: Hydrogen bond parameters (where r is the bond length, d is the hydrogen bond length and θ 
is the angle between the bond and the hydrogen bond)85 
 
Hydrogen bonds can be intramolecular, where the donor and acceptor atoms are on 
the same molecule or intermolecular when they are on different molecules. There are 
three main types of intermolecular hydrogen bonds; (i) the simple linear, 1 donor 1 
acceptor hydrogen bond, where the angle (θ) is approximately 180° (characteristic of 
strong hydrogen bonds); (ii) bifurcated also referred to as three centred hydrogen 
bond, involving 2 acceptors and 1 donor atom; (iii) trifurcated hydrogen bond with 3 
acceptor groups and 1 donor atom, which are relatively rare. Figure 16 shows these 
three types of hydrogen bonds.86 
 
B H A B H
A
A
B H
A
A
A
linear bifurcated trifurcated  
Figure 16: The three main hydrogen bond types. 
 
In the case of this work hydrogen bond dimers bond distances (1.8-2.5 Å)87 are very 
necessary as one of the criteria set to perform structural optimizations. 
 
2.7.2 Enthalpy of formation calculations 
 
In this thesis, the enthalpy of formation (∆Hform, is the energy released when 
individual atoms are brought together to form a molecule of a specific conformation) 
calculations have been performed for only mandelic acid, since this component 
belongs to the class of compound forming systems which are particularly difficult to 
be resolved. The calculations of the enthalpy of formation were performed by 
employing the VAMP model in MATERIALS STUDIO from software package 
Chapter 2 Background and literature survey  
  
 41
Accelrys Materials Studio 4.3. VAMP uses semi-empirical calculations to determine a 
molecular wave function. This wave function can then be applied to evaluate 
molecular properties such as energy, dipole moment.88  
In this work the molecular modeling calculations have been performed for the solute-
solvent dimers. Recently, Davey et al.89 demonstrated that mandelic acid in only 
chloroform solutions exhibit self assembly dimers, but in all other solvents mandelic 
acid is strongly solvated. Based on this outcome, all the molecular modeling 
calculations were conducted on solvated dimer systems. The enthalpy of formation 
(∆Hform) was obtained by first performing a geometry optimization of the molecules 
(optimized structures) by setting the charge on each molecule to zero. In order to 
realize global minima or the most optimized structures, it is necessary to obtain 
structures which have hydrogen bonds between the ranges of 1.8-2.5 Ǻ and are 
coupled with more negative enthalpy of formation value. The geometry optimization 
was carried out with the VAMP model together with the Austin model 1 (AM1), and 
also the Neglect of Diatomic Differential Overlap (NDDO). The VAMP model is used 
together with the AM1, which gives good estimation for hydrogen bonding 
calculations. The AM1 was designed to eliminate the problems from MNDO caused 
by the tendency to overestimate repulsion between atoms separated by the sum of 
their van der Waals radii.90 Whiles, the NDDO is a basic approximation for neglecting 
less important integrals. When VAMP model is used from the Materials Studio 
interface, then AM1 is the default NDDO Hamiltonian.91 From the obtained optimized 
structures, the heat of formation is calculated by also using the same procedure as 
explained earlier on. The stability of a conformation is quantified by the stabilization 
enthalpy ( ionStabilizatformHΔ ), where the most stable dimer possesses the largest most 
negative value for the stabilization enthalpy and vice versa. More information with 
regard to the approach used is given in92,93 and the Accelrys software manual.84 
The whole procedure used for the solvent-solute dimer single energy point 
calculations for the enthalpy of formation has been explained in detailed in the flow 
chart in Figure 17.  
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Set total charge 
on a single 
structures to zero
Set hydrogen bonds 
between solvent and 
solute molecules 
(dimers) to 
(1.8-2.5Å)
Optimization for the 
lowest energy 
structure of the dimer
Optimized dimer used 
for single energy point 
calculations
Most negative 
enthalpy of formation 
implies most stable 
case and does not 
crystallize first
Less negative enthalpy 
of formation implies 
less stable case and 
does crystallize first
 
Figure 17: Flow chart for single energy point calculations (at specific molecular geometry) for 
enthalpy of formation by using MATERIALS STUDIO 4.3 (VAMP model). 
 
2.8 Summary 
 
In this chapter basics of the theory of crystallization were summarized, and concepts 
how chiral substances can be resolved. For resolution, crystallization is the most 
economical and easy to use techniques and hence very attractive. In addition, 
crystallization techniques are not only applicable to racemates (50:50 mixtures of both 
enantiomers) but pure enantiomers crystals can be obtained from non-racemic, i.e. 
asymmetric mixtures. However, it is vital to establish whether a substance forms a 
racemic compound, a conglomerate or a solid solution before a resolution 
crystallization based process can be selected. 
For racemic compounds, the separation of the two enantiomers requires the utilization 
of diastereomeric interactions, including the formation of diastereomeric salts with a 
chiral resolving agent, or chromatography using optically active stationary phases or 
possibly by applying chiral solvents which might create diastereomeric interactions 
(complexes)4,5 and can be exploited for enantioselective crystallization. Contrary to 
this, the resolution of conglomerate systems does not require optically active 
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resolving agents as in preferential crystallization the resolution occurs spontaneously 
for the period of crystallization.  
The role of additives and solvents in crystallization processes was discussed in this 
chapter; studies to help elucidate basic scientific questions, such as the molecular 
interactions at interfaces, the role of solvent on the crystal growth. Also, details on 
crystal science have been discussed. Moreover, the current state of research using 
chiral solvent/chiral media to effect enantioselective crystallization has been 
reviewed. Principles of the metastable zone width and induction time have been 
highlighted in this chapter. 
Molecular modeling studies concerning solvent-solute interactions were used to gain a 
deeper understanding into certain interesting experimental observation. The procedure 
applied has been detailed out in this chapter.  
The next chapter will give an in-depth discussion on the experimental techniques and 
two systematic fundamental experiments for solubility and metastable zone width. 
Also, successfully designed resolution experiments will be presented. 
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3.1 Introduction 
 
This chapter will give a description of the fundamental principles of the analytical techniques 
employed for the characterization of liquids and solids phases obtained. A study of the 
fundamental solubility and metastable zone width data (primary nucleation) has been 
performed in order to realize enantioselective crystallization from chiral solvents The 
following analytical techniques have been  used; Fourier transform infra-red (FTIR) 
spectroscopy, Raman spectroscopy, Calorimetry (C80 Calvet Calorimeter), Nuclear magnetic 
resonance (NMR) spectroscopy, HPLC, Refractometer, X-ray powder diffraction (XRPD), 
Polarimeter, Density meter, DV-III ultra rheometer for viscosity measurement, Turbidity 
sensor, Crystal16TM. A description of the different enantioselective crystallization techniques 
(preferential nucleation, preferential crystallization and selective crystallization) applied in 
this work is presented. 
 
3.2 Chiral solutes (mandelic acid and N-methylephedrine) 
 
The pharmaceutical chiral systems chosen are the compound forming system mandelic acid 
(MA) and the conglomerate forming system N-methylephedrine (NME). Mandelic acid is 
common and easily accessible as a chiral resolving agent used in classical resolution for wide 
viariety of racemates. For instance, (S)- and (R)-enantiomers of MA have been used as 
resolving reagents in classical resolution for a wide variety of racemates.94 Additionally, they 
are applied as a chiral products intermediate for the production of optically active drugs and 
agricultural based chemicals such as crop protectants. (R)-mandelic acid and (R)-ortho-
mandelic acid (mandelic acid derivative) belong to BASF’s portfolio for chiral intermediates, 
trademarked as ChiPros® for pharmaceuticals and crop protection agents like herbicides, 
fungicides and insecticides. Presently, BASF is applying in a stereospecific biocatalyst to 
synthesize MA.  
NME belongs to the class of ephedrines, which are possible stimulants drugs for the central 
nervous system.95 In recent times, there has been an increasing interest in drugs that include 
ephedrine alkaloids because these compounds are known to have weak amphetamine-like 
effect on the central nervous system (energy booster) and enhance calorie-burning activity 
when taken together with aspirin and caffeine. It is also commonly used as decongestant 
(relieve nasal congestion) and against hypotension (low blood pressure).96  
Screening experiments were carried out to be able to select appropriate chiral solvents which 
have the potential to create chiral recognition in the chiral system. As the result of this 
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screening of various chiral solvents showed no discrimination for the chiral system (mandelic 
acid) applied. Therefore, selection of the chiral solvents for this project was solely based on 
the availability and the price. In addition tailor-made chiral solvents and chiral ionic liquids 
were specifically synthesized to fit target chiral molecules in order to provide stronger chiral 
interactions. 
 
Mandelic acid 
 
(S)- and (R)-enantiomers of mandelic acid have been used as resolving reagents in classical 
resolution for a wide variety of racemates.94 Furthermore, the pure (R)-mandelic acid is used 
as a precursor for the synthesis of cephalosporin and penicillin.97 Mandelic acid has 
bacteriostatic properties and it is administered for the treatment of urinary tract infections, i.e. 
from either calcium or ammonium salt.98 The racemic form of mandelic acid is also utilized in 
the mandelate (ester) form as a relevant pharmaceutical constituent due to its analgesic, 
antirheumatic and spasmolytic effects (Mandrophine and Spasmocyclon).99 Another feature of 
mandelic acid is that there is a broad data basis available for this compound. Lorenz et al.100 
determined the ratio of the mandelic acid enantiomers in water at the symmetric eutectic 
compositions to be 0.69 and 0.31. Figure 18 shows the molecular structures of (RS)-MA and 
(S)-MA and give some background information. 
 
 
Figure 18: (RS)-MA and (S)-MA data.87 
 
N-methylephedrine 
 
N-methylephedrine belongs to the class of ephedrines, which are possible stimulant drugs for 
the central nervous system.95 In recent times, there has been an increasing interest in drugs 
that include ephedrine alkaloids because these compounds are known to have a weak 
amphetamine-like effect on the central nervous system (energy booster) and enhance calorie-
burning activity when taken together with aspirin and caffeine. It is also commonly used as 
decongestant (relieve nasal congestion) and against hypotension (low blood pressure).96 
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Moreover, N-methylephedrine is extensively applied as a chiral resolving precursor to chiral 
supporting electrolytes, a catalyst for phase transfer and a reducing agent.101 
The physicochemical properties and the crystallization thermodynamics of the pure 
enantiomers and the racemate for N-methylephedrine have been studied intensively by Wang 
et al.102 On the other hand, there exist quiet a number of literature on ephedrine.95,96 The 
chemical structures of both (a) (1S,2R)-(+)-N-methylephedrine, (b) (1R,2S)-(-)-N-
methylephedrine is shown in Figure 19. 
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Figure 19: Chemical structures of: (a) (1S, 2R)-(+)-N-methylephedrine, (b) (1R, 2S)-(-)-N-methylephedrine. 
 
Table 2 gives a summary of some properties and specifications of N-methylephedrine. 
 
Table 2: Properties and specifications of N-methylephedrine [Sigma-Aldrich] 
Name 
(1S,2R)-(+)-N-
methylephedrine 
 
(1R, 2S)-(-)-N-
methylephedrine 
 
Molecular Formula NOHC 1711  NOHC 1711  
Molecular Weight 179.3 g/mol 179.3 g/mol 
Melting point 87-90 °C 86-88 °C 
Optical rotation [ ] )5(29 320 OHCHinCD =°+=α
  
[ ] )5(2.29 321 OHCHinCD =°−=α
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3.3 Materials 
 
Chemical and reagents used in this thesis together with their purities and sources are complied 
in Table 3. 
 
Table 3: Chemicals used with their purities. 
Material Purity 
% 
Source 
(S)-(+)-mandelic acid 
≥99 
Aldrich/Sigma 
Merck, Germany. 
(R)-(-)-mandelic acid ≥99 Sigma-Aldrich 
(RS)-mandelic acid ≥99 Sigma-Aldrich 
(1S,2R)-(+)-N-methylephedrine ≥99 Sigma-Aldrich 
(1R,2S)-(-)-N-methylephedrine ≥99 Sigma-Aldrich 
(S)-2-butanol 98 BASF 
(S)-2-pentanol 97-98 BASF 
(S)-2-hexanol 98 BASF 
(S)-1-phenylethanol ≥99 BASF 
(R)-1-phenylethanol ≥99 BASF 
(R)-2-chloro-1-phenylethanol 98.5 BASF 
(R)-2-chloro-1-(3-
chlorophenyl)ethanol 
98 BASF 
(S)-methyl lactate 97 PURAC 
(S)-ethyl lactate ≥99 Sigma-Aldrich/Fluka 
(S)-propyl lactate 97 PURAC 
(S)-butyl lactate 97 PURAC 
(2R,3R)-diethyl tartrate ≥99 Sigma-Aldrich/Fluka 
Methanol-d4 ≥98 Deutero GmbH 
(S)-propyl mandelate ≥98 Our lab 
(S)-isopropyl mandelate 97 Our lab 
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Continuation of Table 3 
(S)-2-(methoxycarbonyl) 
pyrrolidinium 
bis(trifluoromethylsulfonyl) 
amide 
99 
Aachen 
RWTH  
(ITMC, Aachen, 
Germany.) 
(1R,2S)-(-)-Ephedrinium bis 
(trifluoromethylsulfonyl) amide 
99 Erlangen Universität 
2-propanol 99  Sigma-Aldrich 
methanol 99 Sigma-Aldrich 
 
3.4 Chiral solvents 
 
Optically active organic solvents, consisting of chiral molecules (chiral solvents), which rotate 
the plane of linearly polarized light, have become increasingly important. In principle, 
diastereomeric solvates might form when a mixture of enantiomers is dissolved in an optically 
active solvent.4,5 Consequently, these solvates should possess slightly different physical and 
chemical properties. In principle, it is expected that a chiral solvent can create selective 
interactions to a chiral solute, which facilitates differentiation between the two single 
enantiomers. This discrimination can provide selective kinetic or solution thermodynamic 
effects which can be useful for the separation of enantiomers.4 This idea was proposed in 
1893 by Van’t Hoff in a letter he wrote to Meyerhoffer expressing the possibility to find a 
difference in the solubility of enantiomers in an optically active solvent.5  
In fact, optically active solvents have already found it use in stereospecific syntheses, as NMR 
shift reagents, HPLC analysis, in the evaluation of the optical purity of enantiomers, and in 
the gas chromatographic separation of enantiomers on chiral phases.  
Chiral solvents used in this work are basically classified into “classical” chiral solvents, chiral 
ionic liquid and tailor-made chiral solvents. Additionally, liquid crystals are also considered 
to have similar effects as proposed for chiral solvents. Liquid crystals are known to form 
partially ordered structures. Small anisotropic solute molecules dissolved in liquid-crystalline 
solvents experience partial orientation. Thus rapid tumbling of the solute molecules about 
only two of the three axes is possible. This results in some averaging but still allows coupling 
between the magnetic dipoles of the nuclei as well as chemical shift anisotropies. Though 
liquid crystal might also have the ability to create discrimination between two enantiomers it 
has not been considered in this thesis work. 
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 3.4.1 Characterization of various types of chiral solvents 
3.4.1.1 “Classical” chiral solvents 
 
“Classical” chiral solvent in this work refers to the normal chiral solvents which are listed in 
Table 4. The “classical” chiral solvents were characterized under several physical 
measurements such as boiling point, melting point, and viscosity. Moreover, the FTIR is used 
to characterized the various chiral solvent used. Figure 20 depicts the chemical structures for 
both (S)-alkyl lactate and (2R, 3R)-diethyl tartrate.  
 
(S)
OH
H3C O
O
R
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R=Me, Et, n-Pr, n-Bu
OH
(R) (R)
OH
O
O
O
O
(2R, 3R)-diethyl tartrate  
Figure 20: Chemical structures of the solvents ((S)-alkyl lactate and (2R, 3R)-diethyl tartrate). 
 
The chemical structures for the other lactates are not given since they would have almost 
similar structures with differences originating from differences in chain length. Table 4 gives 
a summary of selected physical properties of all the “classical” chiral solvent used in this 
work. 
 
Table 4: “Classical” chiral solvents and some physical properties.  
Chiral solvents 
Boiling 
point 
(°C) 
Melting 
point 
(°C) 
Viscosity 
mPa s 
 (S)-methyl lactate 144 -44 3.1 (25°C) 
(S)-ethyl lactate 154 -25 3.6 (23°C) 
(S)-propyl lactate 170 -14 3.3 (20°C) 
(S)-butyl lactate 187 - 3.9 (25°C) 
(2R,3R)-diethyl tartrate 280 18 354.4 (25°C) 
 
Nuclear magnetic resonance (NMR), Fourier transform infra-red (FTIR) and Raman 
spectroscopies studies were carried out to investigate interactions which can be exploited in 
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thermodynamically based discriminations of the two enantiomers. The chiral solvents were 
characterized with respect to selected several physical properties such as boiling point, 
melting point, and viscosity. 
 
3.4.1.2 Chiral ionic liquids 
 
Ionic liquids are described as organic salts with melting point below 100 °C. They possess 
characteristics which have recently given much attention in the scientific community. As ionic 
liquids have attracted a lot of attention as a new class of solvents, they have successfully been 
used as solvent for enantioselective asymmetric synthesis.103 Moreover, Reichert et al.104 
reviewed and discussed the possibility of using complex solvents like ionic liquids for 
crystallization. However, this application is still in its infancy. Chiral ionic liquid were studied 
in this work to exploit their potential in enantioselective crystallization. Chemical reaction 
scheme of synthesis of (S)-2-(methoxycarbonyl) pyrrolidinium bis (trifluoromethylsulfonyl) 
amide is shown in Figure 21. 
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Figure 21: Chemical reaction scheme for synthesis of (S)-2-(methoxycarbonyl) pyrrolidinium 
bis(trifluoromethylsulfonyl) amide. 
 
The chemical structure of the other chiral ionic liquid, (1R, 2S)-(-)-Dimethylephedrinium bis 
(trifluoromethylsulfonyl) amide applied in this work is shown in Figure 22. 
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Figure 22: Chemical structure for (1R, 2S)-(-)-dimethylephedrinium bis (trifluoromethylsulfonyl) amide. 
 
Table 5 gives a summary of selected physical properties of the two chiral ionic liquids used in 
this work. 
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Table .5: Chiral ionic liquids and their physical properties. 
Chiral solvents 
Boiling 
point 
(°C) 
Melting 
point 
(°C) 
Viscosity 
mPa s 
(S)-2-(methoxycarbonyl)pyrrolidinium 
bis(trifluoromethylsulfonyl) amide 
305 - 
324.5 
(25.05°C)
(1R,2S)-(-)-Dimethylephedrinium 
bis(trifluoromethylsulfonyl) amide 
- - 
481.6 
(23.10°C)
 
3.4.1.3 Tailor-made chiral solvents 
 
The synthesis of the mandelic acid esters (Mandelates) was adopted from Basavaiah et al.105 
and was slightly modified. Figure 23 illustrates as an example the reaction scheme for the 
synthesis of (S)-isopropyl mandelate. 
 
OH
OH
O
R OH+
(H+)
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O
O
R
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S-Mandelic acid Alcohol Mandelic acid ester
(Mandelate)
Water
 
Figure 23: Typical reaction scheme of Mandelic acid ester (Mandelate) synthesis. 
 
The procedure applied for the synthesis is as follows: 
50 g (S)-mandelic acid was dissolved in a 25-fold excess of the corresponding alcohol, 25 
drops of concentrated sulphuric acid were added and the mixture refluxed for 4 hours. 
Afterwards the remaining isopropanol was removed under reduced pressure. The resulting 
crude ester was taken into 275 mL diethyl ether, washed with aqueous K2CO3, followed by 
saturated aqueous NaCl and finally dried over Na2SO4. After removal of the diethyl ether the 
crude ester was distilled under high vacuum for purification. Yield: 60-65%. The purity was 
determined via DSC and NMR. 
(S)-Mandelic acid n-propyl ester ((S)-propyl mandelate) 
1H NMR (400 Mhz, CDCl3): δ 0.8 (t, 3H), 1.59 (p, 2H), 4.11 (m, 2H), 5.17 (s, 1H), 7.25-7.51 
(m, 5H) 
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(S)-Mandelic acid isopropyl ester ((S)-isopropyl mandelate) 
1H NMR (400 Mhz, CDCl3): δ 1.13 (d, 3H), 1.30 (d, 3H), 5.06-5.12 (p, 1H), 5.14 (s. 1H), 
7.33-7.44 (m, 5H) 
 
In the case of the other forms of the mandelate they were also synthesized based on the same 
reaction scheme except that the alcohol used change to suit the particular mandelate wanted, 
to synthesize (S)-propyl mandelate the alcohol should be propanol. Compilations of selected 
physical properties of the two synthesized tailor-made chiral solvents employed in the thesis 
are listed in Table 6.  
 
Table 6: “Tailor-made chiral solvents” and their physical properties data 
Chiral solvents 
Boiling 
point 
(°C) 
Melting 
point 
(°C) 
Viscosity 
mPa s 
(S)-propyl mandelate 214.6 20.5 99.2 (24°C)  
(S)-isopropyl mandelate 223.6 43.0 solid at R.T  
 
The next section will describe the screening of the “classical” chiral solvents with the aid of 
NMR spectroscopy. In order to study systematically the feasibility of chiral resolution with 
the help of chiral solvents, first investigations have been devoted to screen a variety of 
“classical” chiral solvents eventually suitable for chiral discrimination. Also, mandelic acid 
was selected for the screening of appropriate “classical” chiral solvent for chiral recognition 
because it is a compound forming system which is normally difficult to be resolved. 
 
3.5 Nuclear magnetic resonance spectroscopy-screening of “classical” chiral 
solvents 
 
Nuclear magnetic resonance (NMR) is a technique employed to determine the structure of 
organic and non organic compounds. The nuclei of all elements possess a charge. When the 
spins of the protons and neutrons comprising these nuclei are not paired, the overall spin of 
the charged nucleus generates a magnetic dipole along the spin axis. NMR is based on the 
atomic nuclei having a nuclear spin (I) which makes these nuclei behave like small magnets, 
which when no magnetic field is present are aligned randomly. When a magnetic field (Bo) is 
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used, these nuclear magnets orientate themselves in 2I+1 ways. 1H and 13C have both a spin 
of (-½) and therefore can orientate themselves in two ways, a low energy (N1) orientation 
aligned with the applied magnetic field (spin +½) and a high energy (N2) orientation opposed 
to the applied field (spin -½) (Figure 24). 
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Figure 24: Energy level diagram of a one spin ½ nucleus in the presence and absence of Bo. 
 
The number of nuclei in the low energy state and the number in the high energy state will 
differ by an amount given by the Boltzmann distribution:106 
 
( )kTE
N
N Δ−=exp
1
2                                                                      Equation 20 
 
 
3.5.1 Principle of NMR spectrometer and spectra acquisition  
 
Samples for NMR studies are made from deuterated solvents, providing in deuterium and 
hydrogen in the same sample. Hydrogen has one proton in its nucleus while deuterium has a 
proton and a neutron in its nucleus. This is necessary to “lock” the NMR on a specific 
frequency so that the spectrum will not drift around during acquisition. The sample is then 
place into the spectrometer, where an air jet spins the sample tube to give a more uniform 
sample to scan. In order to acquire spectra, first a radio frequency generator “pulses” the 
sample with a short burst of radio waves. These waves are absorbed and transmitted through 
the sample to the receiver which detects the signal from the sample. This information is then 
transmitted to the computer linked to the spectrometer, where it is translated and analyzed. 
Figure 25 shows a schematic of a NMR spectrometer. 
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Figure 25: Schematic of continuous wave NMR spectrometer.87,106 
 
3.5.2 Apparatus and experimental procedure 
 
In order to study systematically the feasibility of chiral resolution with the help of chiral 
solvents, we first screened a variety of chiral solvents which would be suitable for chiral 
discrimination. (S)- and (R)-mandelic acid were used for the screening experiments. 
1H NMR spectra were recorded on a Bruker AVANCE 600 spectrometer at 600.13 MHz. The 
measurements were done at the Institute of Chemistry, Otto-von-Guericke Universität 
Magdeburg, Germany. The AVANCE 600 is fitted with a 5mm CPTXI-1H-13C/15N/2H 
probe head with z-gradients. The samples were measured in Methanol-d4 deuterated solvent 
as internal lock. Spectra were recorded at T = 293 K with a pulse width of 7.8 µs for 90° 
pulse. The 1H NMR chemical shifts (δ) were reported in ppm downfield from TMS 
(internal).106,107 
The following samples were prepared in NMR tubes:  
Test samples: (a) (S)-mandelic acid (10mM) + (S)-ethyl lactate (50mM) + CD3OD (600µl) 
                       (b) (R)-mandelic acid (10mM) + (S)-ethyl lactate (50mM) + CD3OD (600µl) 
Reference sample: (R)-mandelic acid (10mM) + CD3OD (600µl).  
The same procedure was repeated for the other chiral solvents studied. 
 
3.5.3 Chemical shift and spectra interpretation  
 
The electrons which surround the spinning nuclei are also charged and spin and hence the 
spinning charge makes a magnetic field. The magnetic field at the nucleus is not equal to the 
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applied magnetic field; electrons around the nucleus shield it from the applied field. The 
distinction between the applied magnetic field and the field at the nucleus is termed the 
nuclear shielding. The s-electrons in a molecule possess spherical symmetry and travel in the 
applied field, creating a magnetic field which opposes the applied field. This means that the 
applied field strength must be increased for the nucleus to absorb at its transition frequency. 
This upfield shift is also termed diamagnetic shift. Electrons in p-orbitals do not have 
spherical symmetry. They produce comparatively large magnetic fields at the nucleus, giving 
a low field shift (increasing chemical shift, dH values). This “deshielding” is termed 
paramagnetic shift.  
Chemical shift (δ) is defined as nuclear shielding/applied magnetic field and refers to the 
position of a peak on the spectrum. Chemical shift is a function of the nucleus and its 
environment. It is measured relative to a reference compound. For 1H NMR, the reference is 
usually tetramethylsilane, Si(CH3)4 (TMS) because it is the most shielded molecule and all its 
protons are equivalent. Consequently, gives one peak which can be used to set the zero mark 
on the spectrum. Moreover, single peaks, double peaks, and even larger groups of peaks are 
seen on the sample spectrum; these groups of peaks are each due to one type of nucleus. The 
reason there are a group of peaks instead of just one is that hydrogen on one carbon are tied 
to, or influenced by, the magnetic fields of H’s on adjacent nuclei. This coupling “splits” the 
signal into the multiple or numerous peaks. This splitting follows what is know as the “n+1 
rule”, which states that the number of peaks observed for each and every type of hydrogen is 
equal to the number of H’s on adjacent nuclei (n) plus one in consecutive terms.  
In this work chemical shift was used as a means to discriminate the chiral molecules. A 
methodology was designed to achieve this goal. The screening experiment was devised based 
on discrimination definition of the alpha hydrogen of the reference sample and that of the test 
sample in the chiral solvent, and which is expressed as the difference in alpha hydrogen 
chemical shift (∆δ)107,108 in Equation 21 below. The criteria set for the 1H NMR screening 
measurement was ∆δ > 0.02,107 thus when a chiral solvent meets this requirement then there 
might be some chiral recognition.  
 
samplereference δδδ −=Δ                                                                      Equation 21 
 
In the screening process twelve chiral solvents were used. The screening experiments were 
carried out to be able to identify chiral solvents which eventually have the potential to create 
chiral recognition.108,109 Figures 26 and 27 show exemplarily the 1H NMR spectra for 
mandelic acid in (S)-ethyl lactate and (2R, 3R)-diethyl tartrate, respectively. It can be seen in 
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both Figures that there are no differences in the chemical shifts between the alpha hydrogen 
(5.134 ppm) of the reference and that of the test samples. 
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Figure 26: 1H NMR spectra for mandelic acid in (S)-ethyl lactate 
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Figure 27: 1H NMR spectra for mandelic acid in (2R, 3R)-diethyl tartrate. 
 
Table 7 summarizes the experimental results of mandelic acid in the various screened solvents 
and their respective chemical shifts in ppm.  Unfortunately, none of the twelve chiral solvents 
fulfilled the criterion set (∆δ > 0.02). This reveals that the chiral solvents investigated had no 
significant interactions on the chiral system studied in terms of solution thermodynamics. 
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Table 7: Screened chiral solvents and the resulting chemical shifts. 
Chiral solvents 
(S)-MA 
alpha 
hydrogen 
peak (ppm) 
(R)-MA 
alpha 
hydrogen 
peak (ppm) 
(S)-MA 
∆δ-values 
(ppm) 
(R)-MA 
∆δ-values 
(ppm) 
Reference 
sample alpha 
hydrogen peak 
(ppm) 
(S)-methyl lactate (*) 5.13 5.13 0.00 0.00 5.13 
(S)-ethyl lactate (*) 5.13 5.13 0.00 0.00 5.13 
(S)-propyl lactate (*) 5.13 5.13 0.00 0.00 5.13 
(S)-butyl lactate (*) 5.13 5.13 0.00 0.00 5.13 
(S)-2-butanol 5.05 5.05 0.00 0.00 5.05 
(S)-2-pentanol 5.07 5.06 0.00 0.01 5.07 
(S)-2-hexanol 5.13 5.13 0.00 0.00 5.13 
(S)-1-phenylethanol 5.14 5.14 0.01 0.01 5.13 
(R)-1-phenylethanol 5.14 5.14 0.01 0.01 5.13 
(R)-2-chloro-1-(3-
chlorophenyl)ethanol 5.14 5.14 0.01 0.01 5.13 
(2R,3R)-diethyl tartrate (*) 5.13 5.13 0.00 0.00 5.13 
(R)-2-chloro-1-
phenylethanol 5.14 5.14 0.01 0.01 5.13 
MA, Mandelic acid.                                  (*) selected for further studies 
 
Since the results obtained from screening the various chiral solvents were similar, selection of 
the chiral solvents for further work was solely based on the availability and the price. The 
following five “classical” chiral solvents were selected: (S)-methyl lactate, (S)-ethyl lactate, 
(S)-propyl lactate, (S)-butyl lactate and (2R, 3R)-diethyl tartrate.  
 
3.6 Experimental procedures 
 
This section would present all the experiments that were performed in this thesis work. 
Basically, three types of experimental measurements were conducted, namely solubility 
determination (solution thermodynamic measurement), nucleation points determination, (i.e. 
MSZW and induction time determination) and enantioselective crystallization experiments. 
 
3.6.1 Solubility measurements 
 
In general solubility measurements110 serve as a fundamental prerequisite which is required 
before designing enantioselective crystallization processes. So, in this work reliable solubility 
data have been generated from the solubility experiments. Solubility measurements were 
carried out in different systems;  
1. Mandelic acid and N-methylephedrine in (S)-methyl lactate, (S)-ethyl lactate,  
(S)-propyl lactate and (S)-butyl lactate).  
2. Mandelic acid and N-methylephedrine in (2R,3R)-diethyl tartrate.  
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3. N-methylephedrine in the two chiral ionic liquids ((S)-2-(methoxycarbonyl) 
pyrrolidinium bis (trifluoromethylsulfonyl) amide and (1R,2S)-(-)-
Dimethylephedrinium bis (trifluoromethylsulfonyl) amide).  
4. Mandelic acid and in the tailor-made chiral solvent ((S)-ethyl mandelate, (S)-propyl 
mandelate and (S)-isopropanol mandalate).  
The next section will discuss how the solubilities were measured in a first step with the 
successive solute addition method. 
 
Successive solute addition method 
 
Initially, the solubility experiments were done by the successive solute addition method at 
isothermal conditions (temperature of 25 °C). In this technique small amounts of solute are 
added to the solvent in some time intervals until some non-dissolved crystals remain in the 
solution for a long time until equilibrium is attained in the solution. The samples (solute in 
solvent) were prepared in a small glass vessel with a defined composition and concentration 
of solute or mixtures of solutes in the solvent. A magnetic stirrer was used inside at 500 rpm 
for effective mixing. This glass vessel was immersed in a double or triple walled 
thermostatted apparatus. Defined quantities of solutes were added to the system until 
equilibrium concentration was attained (undissolved solute). The sample was maintained at 
the same conditions for 24 hours for the equilibrium confirmation and then the sample was 
filtered to get the liquid and solid phases for further analysis. A defined amount of liquid 
phase was taken in a 25 mL flat bottom conical flask and was diluted with isopropanol. The 
collected liquid phase sample was analyzed with HPLC. In this way solubility experiments 
were conducted for; (S)-, (R)- and RS-MA and (2R,3R)-diethyl tartrate. The outline is shown 
in the Table 8. 
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Table 8: Pre-experiments for initial solubility determination of solute in solvent at 25°C by using successive 
solute addition method. 
Experiment 
number 
 
Mass of 
(S)-solute 
(g) 
Total mass 
of Solute 
(g) 
Mass of  
Solvent  
(g) 
Mass of 
Solution 
(g) 
Initial 
Concentration 
(wt %) 
Solubility 
(wt %) 
1 
0.5000 
0.2501 
0.7500 
1.5001 5.0539 6.554 22.88 14.42 
 
Mass of 
(R)-solute 
(g) 
Total mass 
of Solute 
(g) 
Mass of 
Solvent  
(g) 
Mass of 
Solution 
(g) 
Initial 
Concentration 
(wt %) 
Solubility 
(wt %) 
2 
0.5002 
0.2501 
0.7502 
1.5005 5.0098 6.5103 23.04 14.62 
 
Mass of 
RS-solute 
(g) 
Total mass 
of Solute 
(g) 
Mass of 
Solvent  
(g) 
Mass of 
Solution 
(g) 
Initial 
Concentration 
(wt %) 
Solubility 
(wt%) 
3 
0.5001 
0.2503 
1.0002 
1.7506 5.0893 6.8399 25.59 18.36 
 
Classical isothermal method 
 
In order to evaluate the minimum time required to establish thermodynamic equilibrium. At 
first a few dissolution kinetics experiments were performed before the solubility 
measurements were carried out for all the systems investigated in this work for the racemate 
and the enantiomers, Liquid phase samples were taken at specific time intervals from the 
suspension, and the concentrations were analyzed by HPLC. In all the systems equilibrium 
was reached after less than 24 hrs. Accordingly, the experimental time was set to be at least 
24 hrs.  
After approximated solubility data were obtained from the successive solute addition method, 
classical isothermal solubility measurements were employed for refined solubility 
measurements. In this method the temperature, pressure and composition (when equilibrium is 
reached) of the system are kept constant. If the solubility of the substance is approximately 
available, the exact value can be obtained by taking an excess of solute in the solution 
(Isothermal excess method). The sample present in the solution is dissolved completely at a 
higher temperature and allowed to recrystallize at the desired solubility temperature. The 
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process is continued until equilibrium is attained. Solubility measurements for enantiomeric 
compositions of mandelic acid and N-methylephedrine were performed in various chiral 
solvents at temperatures ranges depending on the system.  
1. Mandelic acid in (S)-methyl lactate, (S)-ethyl lactate, (S)-propyl lactate and (S)-butyl 
lactate, temperature range from (0 to 35) °C.  
2. N-methylephedrine in (S)-methyl lactate, (S)-ethyl lactate, (S)-propyl lactate and (S)-
butyl lactate, temperatures range from (0 to 25) °C.  
3. Mandelic acid in (2R,3R)-diethyl tartrate, temperature range from (25 to 60) °C 
4. N-methylephedrine in (2R, 3R)-diethyl tartrate, temperature range from (25 to 40) °C 
5. N-methylephedrine in (S)-2-(methoxycarbonyl) pyrrolidinium bis 
(trifluoromethylsulfonyl) amide and (1R,2S)-(-)-Dimethylephedrinium bis 
(trifluoromethylsulfonyl) amide, temperature range from (5 to 35) °C. 
6. Mandelic acid in (S)-ethyl mandelate, (S)-propyl mandelate and (S)-isopropyl 
mandelate, temperature at 50 °C. 
 
The method involved preparing a solvent and solute mixture of known composition with solid 
in excess in a 10 mL glass vessel, which was put into a thermostatted apparatus (RC6 CP 
Lauda, Germany), and magnetically stirred at a constant temperature (within ± 0.01 K) until 
equilibrium was attained. Subsequently, the liquid and solid phases were separated and 
analyzed. For analysis the saturated solution was filtered with a glass filter (pore size, 10 µm), 
and samples of (1-3) mL were withdrawn from the filtrate for double analysis. The 
concentrations and the enantiomeric excess were determined by means of chiral HPLC after 
dilution with 2-propanol. In sections 3.6.4, 3.6.5 and 3.6.9 the analytical devices and methods 
used to analyze the liquid and solid phases will be discussed in detailed. Figure 28 depicts a 
classical solubility measurement apparatus.  
 
Thermostat
Jacketed 
vesselMagnetic stirrer
 
Figure 28: Solubility measurement apparatus. 
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An evaluation of the reproducibility solubility measurements was restricted to mandelic acid 
and N-methylephedrine systems in all the lactates used in this work and (2R,3R)-diethyl 
tartrate. In the other solvents, for instance chiral ionic liquids and the tailor-made chiral 
solvents, it is so expensive that two time measurements were done and the mean solubility 
values were used. 
The reproducibility of the solubility measurements was studied for several repeated 
experiments under the same conditions. The measurements were conducted with racemic 
mandelic acid, (S)-mandelic acid and (R)-mandelic acid in all the lactates and (2R,3R)-diethyl 
tartrate at the lowest and the highest temperatures considered by executing between 3 and 4 
experiments under the same conditions. Also, reproducibility of the solubility measurements 
was studied for N-methylephedrine in all the lactates and (2R,3R)-diethyl tartrate at the lowest 
and the highest temperatures considered by executing between 3 and 6 experiments under the 
same conditions. The standard deviations of the solubilities (SD) were calculated by Equation 
22. 
 
( )∑
=
−−=
n
k
k wwn
SD
1
2
1
1                                                                      Equation 22 
 
with n being the number of experiments and wk and w  being the mass fraction solubility and 
the mean solubility, respectively. Hereby holds: 
∑== zi i
i
i
m
mw
1
                                                                     Equation 23 
 
The summation covered always the two enantiomers for both mandelic acid and N-
methylephedrine and the solvent used. In addition, mass fraction solubilities wi according to 
Equation 23 were used in this work, since this simplifies process design based on graphical 
representations of e.g. a ternary solubility phase diagrams. Herein, mi represents the mass of 
the constituent i.  
In order to assess the solid liquid equilibria comprehensively, we determined the ternary 
solubility phase diagram. Thorough solubility measurements were carried out for different 
temperatures for the single enantiomers, the eutectic and the racemic compositions. Moreover, 
in order to check for asymmetry in the phase diagram various compositions were measured 
along particular isotherms, ranging from the racemic compositions to the single enantiomers.  
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Polythermal method 
 
To apply this method the Crystal16TM equipment from Avantium Research and Technology 
was employed for the solubility measurements of certain systems where small amount was 
available for the experiments. Figure 29 illustrates the Crystal16 TM, it shows the multiple-
reactor system which can hold 16 (4 x 4) standard HPLC glass vials (11.5 mm diameter, flat 
bottomed, 1.8 mL volume). A unit consists of four independently heated aluminum reactor 
blocks encased in a robust bench top setup. The crystal16TM setup is connected to a 
thermostat.  
 
Figure 29: Crystal16TM equipment (16 multiple-reactor system).111 
 
These blocks are electrically heated and cooled by a combination of Peltier elements and a 
cryostat. In order to prevent condensation of water on the reactor blocks and electronics 
during runs at temperatures below 10 °C, the Crystal16™ system provides an inlet for a dry 
purge gas (typically nitrogen). 
The polythermal method was applied with charging into the reactors known concentrations of 
the substance. Then an increasing temperature programme was planned for the experiments. 
The setup was heated until the charged known concentration substance is completely 
dissolved. Subsequently different concentrations were also subjected to the same temperature 
program and it was also identified at which temperatures the solid dissolved completely. 
Afterward, the evaluated temperatures for corresponding concentrations were plotted. A linear 
correlation is then extracted from the linear plot and could be used to determine subsequent 
solubilities. 
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3.6.2 Nucleation points determination 
 
Basically, two nucleation points determination techniques were applied in this work: the 
metastable zone width measurements and induction time measurements.  
In the next section description of both measurements techniques is given. 
 
3.6.2.1 Metastable zone width measurements (MSZW) 
 
Estimates for the widths of metastable zones with regard to primary nucleation were 
determined for the various systems as follows; 
1. Mandelic acid in (S)-methyl lactate, (S)-ethyl lactate, (S)-propyl lactate and (S)-butyl 
lactate. 
2. N-methylephedrine in (S)-methyl lactate, (S)-ethyl lactate, (S)-propyl lactate and (S)-
butyl lactate.  
3. Mandelic acid in (2R,3R)-diethyl tartrate. 
4. Mandelic acid in (S)-propyl mandelate. 
The experiments and the analysis were conducted using the polythermal method as described 
by Nyvlt et al.112 Saturated solutions of ~ 20g were used. The solutions were subjected to 
heating and cooling programs based on the saturation temperature (Tsat) of the system. The 
initial concentrations were adjusted based on the solubility data. Desired solutions were 
prepared and placed into a batch crystallizer of 60 mL volume. Nucleation and dissolution 
were observed by means of an inline-turbidity sensor (QR-System; BASF AG, Ludwigshafen, 
Germany) and a Pt-100 temperature sensor. The metastable zone width for primary nucleation 
is expressed as the maximum possible subcooling: 
nucleationsat TTT −=Δ max                                                                      Equation 24 
 
where Tsat is the saturation temperature and Tnucleation the nucleation temperature. The latter 
was measured at different cooling rates. Finally the values were extrapolated to a cooling rate 
of zero to obtain Tnucleation for a given solution composition. The obtained ∆Tmax data are valid 
for the experimental set up used and depend on, e.g. reactor size and geometry, stirrer type 
and stirring rate. The schematic representation of the experiment is shown in Figure 30. 
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Heat Stir
Magnetic stirrer
Temperature sensor Pt-100
Turbidity sensor
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Double jacketed glass vessel
 
Figure 30: Schematic setup of metastable zone width experimental setup. 
 
3.6.2.2 Induction time measurements 
 
In this method a saturated solution is prepared and the temperature of the solution is quickly 
reduced to a chosen value and maintained. At this point the time taken for first nuclei to 
appear is noted. In this work, the induction time measurements were solely applied to 
situations where it became impossible to carry out the MSZW experiments. The MSZW 
experiments were not possible in a condition where there is either not sufficient temperature 
range or less solvent available (due to the fact that it is very expensive). 
So, in the case of the N-methylephedrine in (S)-2-(methoxycarbonyl) pyrrolidinium bis 
(trifluoromethylsulfonyl) amide system the induction time method was applied because the 
solvent is extremely expensive. The method was applied to N-methylephedrine in (2R,3R)-
Diethyl tartrate system since the solutions were very viscous in nature. 
Primary nucleation (induction time) experiments were performed for racemic-NME, (+)-NME 
and (-)-NME in [(S)-2-Pro-Me] [NTF2] / methanol 70/30 v/v at 35 °C using an isothermal 
method. The experiments were conducted in a magnetically stirred double jacketed glass 
vessel of 50 mL. Saturated solutions of about 10 g (35 °C) were prepared for all the samples. 
The various saturated solutions were crash-cooled to 1.0 °C, and the induction time (tind) at 
this temperature for appearance of first crystals was determined by visual observation. The 
solubility measurement apparatus which is already illustrated in Figure 28 was also employed 
for this measurement. The same experimental procedure was used for N-methylephedrine in 
(2R, 3R)-diethyl tartrate. 
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3.6.3 Enantioselective crystallization experiments 
 
Three different types of enantioselective crystallization experiments were applied in this 
work. These three experiments are preferential nucleation, preferential crystallization and 
selective crystallization experiments. They were chosen based on the acquired fundamental 
solubility and MSZW results. The next section of this thesis will elaborate on how these three 
enantioselective crystallization experiments were conducted. 
 
 3.6.3.1 Preferential nucleation experiments 
 
(a) Preferential nucleation experiments have been performed for racemic-MA in (2R, 3R)-
diethyl tartrate using a 350 mL stirred batch crystallizer (stirring speed: 400 rpm). Figure 31 
depicts the experimental setup used for preferential nucleation.  
 
Stirrer
Pump
Density meter
Pipe linecrystallizer PolarimeterCrystallizer
 
Figure 31: Experimental setup (online measurements) for preferential nucleation.  
 
For an experiment, 250 g initial solutions was prepared according to solubility data at Tsat = 55 
°C, i.e. the concentration was wsat = 31.66 wt %. The prepared initial solutions were heated to 
60 °C to ensure that even the smallest crystals were fully dissolved. Then, the temperature 
was decreased to a crystallization temperature of Tc = 25 °C with a cooling rate of 0.5 K/min. 
The liquid phase concentrations and composition were measured continuously using online 
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polarimetry and densitometry. For this, crystal free solution was conveyed from the 
crystallizer and thermostatted during the transfer to the online polarimeter (PerkinElmer, 
Model 341, Beaconsfield/UK; optical path length of the flow cell: 100 mm; wavelength: 589 
nm; temperature at the cell 62.50 °C) and the density measurement device (Density Meter 
DE40, Mettler Toledo, Giessen/Germany; measurement temperature 60 °C). After the 
measurements, the liquid phase was pumped back into the crystallizer through an insulated 
line (flow rate: 10.8 mL/min). For comparison, samples were collected during the experiment 
for offline HPLC analysis. The HPLC analysis will be described in the analytical techniques 
section. 
Further experiments were conducted using the same method described above with water as 
solvent at a temperature Tsat = 33 °C. These experiments were aimed at comparing the solvent 
influence and finally evaluating the effect of the chiral solvent on preferential nucleation. 
 
(b) Preferential nucleation experiments have been performed also for racemic mixture of N-
methylephedrine in (2R, 3R)-diethyl tartrate. 50 g initial solutions were prepared according to 
solubility data at Tsat = 35 °C, i.e. concentration was wsat = 49.20 wt %. The prepared initial 
solutions were heated to 38 °C to ensure that even the smallest crystals were fully dissolved. 
Then, the temperature was decreased to a crystallization temperature of Tc = 25 °C with a 
cooling rate of 0.16 K/min. Liquid phase samples were collected for offline HPLC analysis. 
An experimental offline setup for both preferential nucleation/crystallization is illustrated in 
Figure 32. 
 
Thermostat
Heat Stir
Magnetic stirrer
Saturated solution
Double jacketed glass vessel
 
Figure 32: Experimental setup (offline measurements) for preferential nucleation/crystallization.  
 
3.6.3.2 Preferential crystallization experiments 
 
An initial solution of 50 mL racemic-MA in (S)-ethyl lactate was prepared according to the 
solubility data at Tsat = 15 °C, i.e. concentration was wsat = 25.10 wt %. This solution was 
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heated up and kept at 25 °C to ensure that all solid material was dissolved. Afterward, the 
sample was cooled down with a cooling rate of 0.3 K/min to the crystallization temperature 
(Tc = -5 °C). At this temperature, 21 mg of (S)-MA seed crystals (purity > 99%) were added. 
Immediately, as crystallization started liquid samples were collected at definite intervals and 
analyzed by HPLC. The HPLC analysis details will be presented in the analytical section. The 
same experimental offline setup for both preferential nucleation/crystallization shown in 
Figure 32 was also applied here.  
 
3.6.3.3 Preliminary preferential crystallization experiments 
 
Firstly, a saturated solution of racemic-MA in (S)-propyl mandelate was prepared according 
to the classical solubility measurement already described in the above section 3.6.1 at Tsat = 
50 °C. Saturated solution of 40 mL was obtained from the solubility experiment. This solution 
was heated up and kept at 52 °C to ensure that all solid material was dissolved. Then, the 
sample was cooled down with a cooling rate of 0.2 K/min to the crystallization temperature 
(Tc = 43 °C). At the Tc, a defined amount of seed crystals 86 mg of (S)-MA seed crystals 
(purity > 99%) were added. After the supersaturated solution was seeded, it took 4 hrs before 
crystallization started. Later on the crystallization product was separated (filter pore size, 10 
µm) and washed with 20 mL of cooled methanol to remove the adhering mother liquor. X-ray 
powder diffraction was used to identify the solid phase present, and HPLC was applied to 
determine the product purity. The HPLC analysis details will be presented in the analytical 
section. The same experimental setup for solubility measurements shown in Figure 28 was 
also applied here. 
In the following section all the various analytical techniques employed in this thesis work are 
elaborated in detailed.  
 
3.6.4 Chiral HPLC analysis 
 
High Pressure Liquid Chromatography (HPLC) is a very good analytical technique for the 
separation of components of a mixture which is diluted with a solvent or mixture of solvents 
(analyte) by using a variety of chemical interactions with the Chromatographic column. When 
a small amount of analyte (mobile phase) is forced through a column packed with micro 
spherical particles (stationary phase) with certain surface chemistry it is retarded by specific 
chemical interactions with the stationary phase. The time taken by the analyte to travel in the 
column is called retention time, and mobile phase plus the analyte comes out as elute. Better 
separation in HPLC analysis is achieved by increasing the pressure which subsequently 
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reduces the retention time. In the case of chiral compounds separations by the HPLC requires 
special column such as Chiralcel OD-H, Eurocel OD and chirobiotic T. In this thesis both 
Chiralcel OD-H and Eurocel OD were used. The fundamental schematic representation of 
separation in chromatographic column is shown in Figure 33.  
 
Column
Eluent Elute
Sample 
injection 
point
Separated 
components  
Figure 33: Schematic setup of separation in chromatographic column.  
 
3.6.4.1 Apparatus and analytical method 
 
Liquid phase analysis  
 
The liquid samples collected from the solubility experiments were diluted with 2-propanol. 
The concentration of the solution and the enantiomeric excess were determined with HPLC: 
An Agilent HP 1100 unit with a Chiralcel OD-H column (Astec, 250x4.6mm/5µm) for 
mandelic acid analyses and a Eurocel OD column (Knauer, 250x4.6mm/5µm) for N-
methylephedrine analyses was used. The column temperature was 25 °C and the flow rate 
1.0mL/min. A UV diode array detector was used for peak detection at a wavelength of 
254nm. The eluent compositions were as follows: 
(a).Mandelic acid in (S)-ethyl lactate: 84% n-hexane, 16% 2-propanol and 0.1% 
trifluoroacetic acid. 
(b).Mandelic acid in (2R,3R)-diethyl tartrate: 90% n-hexane, 10% 2-propanol and 0.1% 
trifluoroacetic acid. 
(c).N-methylephedrine in (S)-ethyl lactate and (2R,3R)-diethyl tartrate: 85% n-hexane, 15% 2-
propanol and 0.1% diethylamine. 
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(d).N-methylephedrine in (S)-2-(methoxycarbonyl) pyrrolidinium bis 
(trifluoromethylsulfonyl) amide and (1R,2S)-(-)-Dimethylephedrinium: 85% n-hexane, 15% 
2-propanol and 0.1% diethylamine. 
The same eluent compositions used for mandelic acid and (S)-ethyl lactate, was also 
employed for the other lactates. 
 
3.6.5 Refractometer 
 
A refractometer was employed in rapid measurements of solution concentration (solubility 
concentration) in terms of Refractive Index (n). Basically, the liquid samples concentration 
can be obtained by the refractometer by initially preparing a calibration curve which is later 
used to evaluate the concentration. Refractive Index of a substance is the ratio of the velocity 
of a ray of light in vacuum to its velocity in a medium. When a ray of light passes from one 
medium to another less dense medium, for instance water to air illustrated in Figure 34 at an 
angle other than vertical, it changes its angle. This can be explained by using Snell’s law; 
 
Water 
n1
α α α α
β
β
Air n2
Critical 
angle Total 
reflection
 
Figure 34: Systematic setup of critical angle and total reflection for medium of Air and Water. 
 
αβ Sin
n
nSin
2
1=                                                                      Equation 25 
 
 
If a ray of light passes into an optically less dense medium from an optically denser medium, 
then it changes its direction. If the incidence ray α is increased, it later reaches a critical value 
(angle of refraction β= 90°) at which the ray of light no longer passes into optically less dense 
medium. Subsequently, the critical angle α is used to calculate the refractive index from the 
Equation 25 resulting in Equation 26. 
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αββ Sin
nnSin 21190 =⇒=⇒°=                                                                    Equation 26 
 
 
3.6.5.1 Apparatus and analytical method 
 
In the thesis a refractometer Mettler-Toledo RE40 was used. The solubility concentrations 
were determined also with the refractometer. The data obtained from the evaluation of the 
solubility concentrations with the refractometer compared well with HPLC.  
The measuring principle is based on light from the source passes through the prism and 
reaches the sample. Then this light partially refracts and reflects. This reflected light is 
recorded by an optical sensor (CCD). The dark and light areas are divided by a boundary 
which gives the critical angle, which is required to calculate the refractive index ( 1n ) as 
expressed in Equation 26. The setup of the refractometer system RE40 describing the 
measurement principle is shown below in Figure 35(a). 
The reflection is dependent on the wavelength of the light and temperature of the medium. 
Here sodium light of constant wavelength 589.3 was used and a constant temperature was 
maintained while measuring. Figure 35(b) depicts the setup of the measurement system with 
light source from a light emitting diode (LED). 
 
(a) (b)
 
Figure 35: Schematic setup of the refractometer setup of the measurement system.113 
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3.6.6 Density meter 
 
In this thesis the density meter DE40 from Mettler Toledo, Germany was applied in the online 
preferential nucleation experiments to quantify concentration. The density (ρ) of a solution is 
the mass (m) of the solution per unit volume (V) at constant temperature because the density 
of a substance is dependent on temperature.  
 
3.6.6.1 Apparatus and analytical method 
 
This density meter works based on the principle of electromagnetically induced oscillations of 
a glass tube. A magnet is attached to the U-tube and the transmitter subsequently induces the 
oscillation. The period of oscillation is measured by a sensor. Generally, period is seen as one 
complete back and forth motion of a vibration. Its duration is the period of oscillation T. 
Moreover, the number of periods per second is the frequency f. Each glass tube vibrates at its 
characteristic or natural frequency. There are changes that occur when the tube is filled with 
gas or liquid. Then the oscillation frequency (f) would depend on the mass of the gas/liquid 
which is introduced in it. Thus the density of the required gas/liquid can be calculated by 
using the formula. 
T
f 1=                                                                       Equation 27 
 
 
The period of oscillation T is obtained from the Equation 28. 
K
mVT cc += ρπ2                                                                      Equation 28 
 
where ρ = Density of the sample in measurement tube [g/cm3], Vc= Volume of the sample 
(capacity of the tube) [cm3], mc= Mass of measurement tube [g], and K= Measurement tube 
constant [g/s2]. 
It follows that, 
c
c
c V
m
V
KT −= 2
2
4πρ  
                                                                    Equation 29 
 
The density and the period of oscillation T are related as follows: 
BAT += 2ρ                                                                      Equation 30 
A and B are constants which are determined by the elasticity, structure and mass of the 
measurement tube. Since the mass varies from tube to tube, it must be determined by 
measurement (factor determination). The factor of determination of the measurement tube is 
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calculated by measuring the period of oscillation T of two standard substances of known 
density, for instance water and air. 
2224 wA
wA
c TTV
KF −
−== ρρπ  
                                                                    Equation 31 
 
where ρA= Density of air [g/cm3], ρw= Density of water [g/cm3], TA= Period of oscillation of 
the air measurement [s], and Tw= Period of oscillation of the water measurement [s]. 
Therefore the density can be measured based on Equation 31, and water can be substituted by 
other substances in the equation. Figure 36 illustrates the schematic representation of the 
measuring cell showing the U-tube and temperature control of the density meter. 
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Peltier element
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Temperature 
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(block temperature)
Temperature 
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(cell temperature)
Temperature controller 
Measurement tube
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Temperature sensor 3 
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Figure 36: Schematic setup of the measuring cell and temperature control for a density meter.114 
 
3.6.7 Turbidity sensor 
 
Turbidity is defined as an expression of the optical property that causes light to be scattered 
and absorbed rather than transmitted in straight lines through the sample. Also turbidity can 
be seen as measure of relative sample clarity. The turbidity sensor used in this thesis is a fiber 
optic QR-sensor is a system received from the BASF Company in Germany. In this a mono- 
or polychromatic light is projected into the solution. The LED is built in continuous operation 
with 150 mA maximum load. A part of light may reflect or scatter to other directions due to 
the presence of solids, which reduce the reflection quantity of the light. The reflected light is 
received from another glass fiber cable connected to the detector. The detector is a 
Photomultiplier which converts the received light quantity into a voltage signal. Figure 37 
shows the interaction of a light beam and finely distributed nuclei around the sensor  
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Figure 37: Schematic setup of turbidity measuring sensor. 
 
3.6.8 Polarimeter 
 
The polarimeter used in the present work was a PerkinElmer, Model 341, Beaconsfield/UK 
(optical path length of the flow cell: 100 mm). The polarimeter was employed in online 
preferential nucleation experiments. It is very effective and sensitive equipment for analyzing 
the rotation magnitude and sign of optically active substances. In a polarimeter a 
monochromatic light passes through a polarizer, the sample cell and the analyzer to a 
photomultiplier. When the polarized light beam passes through the optically active sample 
(placed in the sample cell), it changes the analyzer position which is perpendicular to the 
direction of polarization. By the principle of null position this analyzer automatically rotates 
to its original position. The schematic setup of the Polarimeter is shown in the Figure 38. 
 
Lamp
optical filter
modulator
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analyzer
filter
detector
 
Figure 38: Schematic setup of the polarimeter. 
Chapter 3 Experimental techniques and procedures 
 
75
3.6.9 X-ray powder diffraction (XRPD) methods 
 
X-ray powder diffraction (XRPD) analysis106,115,116 is used increasingly in the pharmaceutical 
and other chemical industry for a wide range of applications, ranging from polymorph 
screening to analysis and optimization of final dosage forms. X-ray powder diffraction 
methods are extensively employed for the identification of solid phases, and in cases where 
single crystals cannot be grown or the bulk identity of a powder, i.e. a polycrystalline 
substance, has to be confirmed. XRPD is a fingerprint technique, as every compound has a 
unique powder pattern permitting polymorphs, solvates, racemates and enantiomers to be 
identified decisively. Powder patterns or reflexes can also be matched with the calculated 
patterns from single crystal data. XRPD studies are normally carried out at room temperatures 
under ambient conditions, although it is possible to carry out analysis under variable 
temperature, wherein powder patterns are acquired whilst the sample is heated or cooled. 
Such studies are very useful for identifying thermally induced or sub-ambient phase 
transitions. 
 
Theory 
 
Generally, a single crystal gives a diffraction pattern with discrete diffracted beams, each in a 
definite direction relative to the orientation of the crystal and the incident beam, according to 
the Bragg’s law (Equation 32).  
θλ sin2dn =                                                                      Equation 32 
where n is the refractive index; λ represents wavelength; d is the lattice distance represent the 
diffraction angle. If the diffraction reflection of several single crystals is taken, each crystal 
would give its own diffraction pattern, superimposed on one another. Reflections generated 
by the rotation of the composite sample, would all satisfy the Bragg’s equation with the 
reflections occurring along the single 2θ axis. The angle and intensity of the reflection would 
be the same for each reflection produced as a result of the individual single crystals. On the 
detector this set of corresponding reflections from multiple crystals appear as identical spots 
on a circle. As the number of randomly orientated crystals is increased more such spots 
appear, all lying on the same circle, where a cone of diffracted radiation hits the detector. A 
microcrystalline powder consists of essentially an infinite number of tiny crystals and this 
produces a complete circle for a particular reflection. The same occurs for every Bragg 
reflection, each one giving a cone of radiation with angle 2θ, and the overall result being a set 
of many concentric circles, with the radii governed by the Bragg’s equation. 
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3.6.9.1 Apparatus and experimental procedure 
 
Solid phase analysis  
 
A possible formation of solvates and/or polymorphs in the chiral systems studied was verified 
analyzing the solid phases by X-Ray Powder Diffraction (XRPD). Crystalline materials were 
characterized on a PANalytical X`Pert Pro diffractometer (PANalytical GmbH) with Cu Kα 
radiation and compared with reference patterns. The samples were measured on Si sample 
holders and scanned from a diffraction angle of 3 to 40° with step size of 0.017° and counting 
time of 50s per step. 
The powder was ground so that there is uniform or evenly spread orientation of the 
crystallographic planes and all planes have an equal chance of being detected. If a particular 
plane is detected more often than the others, for example because of exact crystal 
morphology, the intensity of that peak is abnormally huge and “floods” the rest of the pattern. 
A schematic representation of the instrumentation required for XRPD is shown in Figure 39. 
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Figure 39: A schematic setup of X-ray powder diffractometer. 
 
3.6.10 C80 calvet calorimeter for dissolution enthalpy measurement 
 
To study the enthalpy of solvation (∆Hsolv; solvent-solute interaction), first of all it is required 
to measure the enthalpy of dissolution (∆Hdiss). Therefore C80 calvet calorimeter from 
Setaram, Germany was employed to measure the dissolution enthalpy. The enthalpies of 
dissolution (∆Hdiss) of the mandelic acid enantiomers in both chiral solvents (S)-ethyl lactate 
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and (2R,3R)-diethyl tartrate and also for N-methylephedrine enantiomers in (2R,3R)-diethyl 
tartrate were determined at ambient temperature (298.15 K). These systems were chosen 
based on the fact that resolution was possible here and it was worthwhile to study the solvent-
solute interaction. 
 
3.6.10.1 Apparatus and experimental procedure 
  
In the C80 calvet calorimeter is made up of two compartment separated by a PTFE 
membrane. The solute is placed in the lower compartment (2.5 mL), and the solvent is 
charged in the upper compartment (2.9 mL). Figure 40 shows the schematic setup of the C80 
calvet calorimeter with the sample chamber and the reference chamber specifically 
elaborated.  
Membrane separating the 
solvent from solute
Container 1 
with solute
Container 2 
with solvent
Stirrer / push rod
Reference
chamber
Sample
chamber
Insulating chamber
Heating element
 
Figure 40: Schematic setup of C80 calvet calorimeter. 
 
The setup of C80 calvet calorimeter is arranged such that the sample chamber is in the front 
side of the equipment whiles the reference chamber is at the rear. For the experiment, a 
defined solute amount of 0.065 g, which would dissolve completely in the solvent, was 
charged in the lower compartment of the sample chamber while the solvent of 2.5 g is placed 
in the upper chamber. The reference chamber upper compartment contained same amount of 
solvent as reference sample. However, care must be taken to ensure that equal amounts of 
solute and solvent are applied in both enantiomers experiments. At the beginning of the 
experiment, all weighing of the solutes and the solvents was made and charged into their right 
compartment of the calorimeter. The system was then programmed to the set temperature and 
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allowed to equilibrate. After equilibration of the set temperature, the experiment was started 
by perforating the two membranes simultaneously with the stirrer/push rod. The perforation of 
the membrane allowed the two substances to be brought together for mixing. Afterwards both 
stirrer/push rods were stirred continuously and rapidly until the solid dissolve in the solvent 
completely. The instrument measures the differences in temperature between the sample and 
reference pans for the period of heating or cooling, recording the amounts of heat added to or 
removed from the sample at a particular temperature, the sample pan requires more heat to 
keep inline with the reference pan. The area under the peak provided enthalpy changes 
associated with thermal event, as these are directly proportional to the heat absorbed by any 
thermal event or enthalpy of dissolution. 
 
3.6.11 DV-III ultra rheometer for viscosity measurement 
 
DV-III ultra rheometer from Brookfield Company, U.S.A with cone spindle CPE 40 was used 
to measures the viscosity of the chiral solvent applied in this thesis work. Basically, the 
internal friction of the fluid is measured. The greater the friction, the enormous the amount of 
force required to cause this movement, which is designated as shear. Highly viscous fluids, 
therefore, require more force to move than less viscous materials. So, viscosity can be 
expressed mathematically as; 
γ
τη =                                                                       Equation 33 
 
where η represents the viscosity, τ is the shear stress and γ represents the shear rate. The 
viscosity of the solvents was measured in (mPa.s) units. 
 
3.6.12 Fourier transform infra-red spectroscopy 
 
Infra-red (IR) energy is a small portion of the electromagnetic spectrum; typically divided into 
three segments, the near-, mid-, and far- IR regions, and with their individual 
energy/frequency limits. The infrared spectrum is highly sensitive to the structure, 
conformation and environment of molecules, and hence is a powerful tool for the analysis and 
characterization of organic compounds. Enantiomers and racemates can be identified using IR 
spectroscopy by comparing the spectrum of an unknown with that of a known sample. 
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Theory 
 
When a beam of infra-red radiation106,117 is incident on a sample, then absorption of different 
frequencies of the incident radiation occurs, at the same time as some frequencies passes 
through the sample without being absorbed. The molecule absorbs E = hv from the IR 
radiation source at each vibrational transition, resulting in the excitation of the molecule from 
its lowest, or ground vibrational state to a higher one. Since the molecules are highly selective 
with reference to the frequencies of radiation they absorb, resulting in their characteristic 
range of absorption allows for their identification. The energy absorbed by a sample at a 
specific frequency is measured by the detector. This is mostly illustrated as a transmission 
compared to a blank background. A transmission of 10% means most of a particular 
frequency has been absorbed by the sample. Frequency is measured in wavenumbers is 
expressed as follows; 
λ
1=wavenumber                                                                      Equation 34 
 
 
However, it is necessary to introduce the quantum aspect for species at the atomic level. Then 
the bonds holding the atoms together in a molecule vibrate with a particular vibrational 
energy Evib (Equation 35) owing to the attractive bonding forces and the repulsive non-bonded 
electron interactions. 
( )21+= VhEvib υ                                                                      Equation 35 
where V= 0, 1, 2….which is known as the vibrational quantum number, υ  represents the 
vibrational frequency and h is the Planck’s constant.  
Moreover, the vibrations of individual bonds of functional groups (localized vibrations) take 
place in the region between (1500 – 4000) cm-1 and are applied for the identification of 
functional groups. Figure 41 depicts the various vibrations of the individual bonds; stretching, 
bending, rocking, twisting and wagging modes, as illustrated by a methylene (CH2) group. 
 
 
Figure 41: Molecular vibrations in methylene. A characteristic stretching and bending vibrations in plane and 
out of plane.106 
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Often, bands that do not correspond to any of the fundamental vibrations of the molecule are 
observed in the region below 1500 cm-1, which is due to combination bands that result from 
interactions between two or more vibrations. The fingerprint region (625 – 1500 cm-1) is the 
highly sensitive section of the spectrum, where the pattern differs most from compound to 
compound. Assessment of the fingerprint area allows the identification of very comparable 
molecules as they may be characteristic of molecular symmetry or combination bands arising 
from simultaneous multiple bond deformations. 
The IR spectroscopic methods have considerably been enhanced using Fourier transform 
methods106,117, which permit measurement of all the frequencies at the same time, rather than 
successively recording individual frequencies, as is the case in dispersive spectrometers. In 
addition, spectra are recorded much more quickly, with less noise and therefore a better signal 
to noise ratio. A schematic setup of a Fourier transform spectrometer is shown in Figure 42. 
The infra-red radiation from the source goes through a beam splitter, which divides the planes 
of the fixed and moving mirrors and sends the light in two directions at right angles. Half of 
the light goes to the moving mirror and 50% reflected onto the fixed mirror. The motion of 
the moving mirror, versus that taken by the stationary-mirror beam, makes the total path 
length variable. Both beams are reflected back to the beam splitter, but the difference in path 
lengths creates constructive and destructive interference: an interferogram. The recombined 
beam is now passed through the sample, which absorbs specific frequencies of radiation, and 
the resultant beam transmitted to the detector. A reference for the instrument operation is 
provided by superimposing a laser beam. Fourier transformation by the computer converts the 
final interferogram into a single beam spectrum. A background corrected spectrum is usually 
displayed or printed. 
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Figure 42: Schematic setup of Fourier transform infra-red spectrometer. 
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3.6.12.1 Apparatus and experimental procedure 
 
A NICOLET 6700 FTIR spectrometer from Thermo Electron Corporation was used in 
conjunction with Nicolets OMNIC software v.5.1b, for data collection. An Attenuated Total 
Reflectance (ATR) accessory employing a germanium (Ge) crystal was used (Figure 43). This 
makes data collection easy, with little sample preparation required. Liquid samples were 
prepared at the same concentrations and placed directly on the crystal and spectra acquired, 
which is an average of 32 or 64 spectral acquisition and 4 cm-1 resolution. The passing wave 
penetrates the sample to an average depth of about 20 µm. A background spectrum of the 
crystal substrate is run prior to running the IR of the sample, and this is then automatically 
subtracted from subsequent spectra. 
 
 
Figure 43: NICOLET 6700 FTIR spectrometer. 
 
3.6.13 Raman spectrometer 
 
Raman spectroscopy106,117,118, the sample is irradiated by an intense monochromatic laser 
beam in the UV-vis-NIR region (vo), most of the radiation is transmitted unchanged, with only 
a small amount scattered by the molecules. The scattered light is usually observed in the 
direction perpendicular to the incident beam. The scattered light consists of two types: 
Rayleigh scattering, which is passed into the spectrometer and Raman scattering. Modern 
Raman instruments are designed to filter out the Rayleigh light as only one in every million 
photons will be Raman scattered.  
However, there is one other condition for a vibration to be Raman active when the molecule 
vibrates there must be a change in polarizability; a change in the shape, size or orientation of 
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the electron cloud that surrounds the molecules. The first case is strong and has the equal 
frequency as the incident beam (vo), whereas the second case is very feeble (10-5 of the 
incident beam) and has frequencies vo ± vm, where vm is a vibrational frequency of a molecule, 
making detection and measurement complicated. These Raman lines are due to absorption and 
re-emission of light together with vibrational excitation and decay correspondingly. The vo – 
vm, (the gain of energy by the irradiated molecule) and vo + vm (the loss of energy from the 
irradiated molecule) lines are the Stokes and anti-Stokes lines, respectively in Figure 44. 
Hence, Raman spectroscopy has the vibrational frequency (vm) as a shift from the incident 
beam frequency (vo) which is measured. Usually, the anti-Stokes lines are less strong than the 
Stokes lines because these transitions arise from higher vibrational energy levels with fewer 
molecules. Hence, the Stokes region of the spectrum is commonly used.  
 
 
Figure 44: The stokes and anti stokes energy levels in Raman spectroscopy.87 
 
Raman spectroscopy provides information about the vibrational frequency of excited 
molecules in a sample where the vibrational frequency is measured as a Raman shift, relative 
to the exciting energy source. 
 
3.6.13.1 Apparatus and experimental procedure 
 
In this work Raman spectroscopy is used to study interactions of the chiral molecules and the 
chiral solvent in the liquid phase. Raman spectra were collected with a MultiRAM 
spectrometer from Bruker Company, Germany. The system employed a laser beam at 1064 
nm operating at 300 mW. The analyses were carried out for liquid phase samples at ambient 
temperature. Figure 45 shows the MultiRAM spectrometer. 
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Figure 45: A MultiRAM spectrometer. 
 
The samples were scanned for a period of 10 seconds; the resolution was at 4 cm-1. Liquid 
phase samples of solute in solvent at a concentration of 8 wt % were used.  
 
3.7 Summary 
 
In this chapter, the various analytical techniques used have been described with details of the 
apparatus applied. Experimental work was performed for solubility data and nucleation points 
which were necessary for the enantioselective crystallization to be designed. Prior to the 
fundamental experiments, the “classical” chiral solvents were initially screened with NMR-
spectroscopy to select appropriate “classical” chiral solvents that can create chiral 
discrimination. The selected “classical” chiral solvents, the tailor-made chiral solvent and the 
chiral ionic liquids that were used in this thesis were characterized with FTIR spectroscopy 
and also regarding their physical properties (viscosity, melting point and boiling point). 
Subsequently, enantioselective crystallization experiments were designed and successfully 
conducted. Hereby, Raman spectroscopy and calorimetric methods were applied to study the 
interactions between the solvent and solute molecules.  
The next chapter will present the results achieved. 
 
Chapter 4 Results and discussion 
 
84
 
Chapter 4. Results and discussion 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 4 
 
4. Results and Discussion 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 4 Results and discussion 
 
85
4.1 Introduction 
 
This chapter will give and discuss the results obtained in this work. The outcome of the 
characterization experiments for the chiral solvents with FTIR will be shown and discussed. 
Moreover, details on the study of the fundamental solubility and metastable zone width data 
(primary nucleation) will be presented. A detailed description of the different enantioselective 
crystallization (preferential nucleation and preferential crystallization) carried out in this work 
will be discussed. Afterwards, results on the solvent-solute interactions related to the kinetic 
effect will be shown. Molecular modeling calculations results on solvent-solute interactions 
study which was carried out to get a deeper understanding of the system will be highlighted 
here. The FTIR results are included in Appendix A (since the measured FTIR spectra do not 
give measurable solvent-solute interaction in the liquid phase).  
The next section will discuss the results of the binary phase diagrams for the two chiral 
substances studied: mandelic acid and N-methylephedrine. These data were taken from 
literature, as these systems have been well studied by various researchers already. 
 
4.2 Binary phase diagrams 
 
It is always useful to characterize first the chiral substances by melting point studies. Melting 
temperatures and the enthalpies of melting will later be employed for the quantification of the 
binary phase diagram. The binary phase melting diagram gives an idea about which type of 
racemate the system studied belongs to. In the previous chapter a description of the various 
racemate types has been given. 
 
4.2.1 Mandelic acid 
 
A lot of work on the crystallization, stability, thermal analysis, solubility and phase diagram 
determination has been studied on both, the racemic and the enantiomeric mandelic acid 
dating as far back as 1899.119 Mandelic acid as a model system has been studied intensively 
by four different research groups48,100,120-123 all working on different aspects of its 
crystallization and thermodynamics. Through this research work, Mughal87 reported on the 
bases of IR that it was a metastable polymorph of (RS)-MA (denoted (RS)-MA II) that 
crystallized out from the racemic mandelic acid solution, not the conglomerate as reported by 
Profir et al.120 However, the stable racemic compound is denoted by (RS)-MA I. The 
Chapter 4 Results and discussion 
 
86
polymorph had been reported in the past but only from melt crystallizations,124 with no crystal 
structures determined. Mughal also observed that soon after her crystallization and successful 
characterization of (RS)-MA II its crystal structure was published.125 The binary phase 
diagram of MA has been determined by many authors100,122,123,126-130 and it is being described 
in the following sections. 
 
4.2.1.1 (RS)-MA Form I 
 
The melting point phase diagram determined by Brandstätter126 located the eutectic 
composition at 114 °C and 70% for (RS)-MA I. A more current study,100,122,123 dedicated to 
the determination of the mandelic acid binary and ternary phase diagrams (using DSC and 
classical isothermal method, respectively) specified the xeu at 69%, which is in close 
agreement with couple of studies done by Fouquey131 Brandstätter126 and Nishiguchi132 
eutectic composition of 70%. Figure 46 epitomizes the binary phase diagrams reported since 
1899. 
 
 
Figure 46: Binary phase diagram of MA enantiomers. Solid lines are 2nd Polynomial fitting to the Brandstätters 
data. (x and y represents composition and temperature, respectively). Diagram is taken from Mughal.87 
 
The experimental binary phase diagram determined by Lorenz122 was compared to that 
predicted using the Schröder-van Laar equation5 (see section 2.3, Equation 18) for the 
enantiomeric mixture, and the Prigogine-Defay equation5,39  (see section 2.3, Equation19) for 
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the racemic compound. This comparison is shown in Figure 47 which depicts accurately data 
points close to the pure enantiomer sides (x >0.605; x ≥ 0.799) when fitting the experimental 
data to the predicted phase diagram. As a result of this the (RS)-MA I eutectic composition is 
specified at 69%. This value for xeu will be applied in this thesis.  
 
 
Figure 47: Binary melting phase diagram of (RS)-MA Form I. Experimental and fitted values.122 
 
4.2.1.2 (RS)-MA Form II 
 
Kuhnert-Brandstätter126 identified the eutectic temperature of (RS)-MA II at 106 °C and xeu = 
63%. The results are illustrated in Figure 48. 
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Figure 48: Binary phase diagram of (RS)-MA polymorphs as reported by Brandstätter et al.126. Solid lines are 
2nd order polynomial fitting is used. Diagram is taken from Mughal.87 
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Profir et al.120 investigated the crystallization experiments of (RS)-MA II in various solvents: 
(water, a mixture of toluene and methyl isobutyl ketone (TMIK) in weight proportions 3:1, 
isobutyl acetate and pure acetic acid). Crystallizations experiments were carried out with 
lower starting solution concentration in acetic acid yield (RS)-MA II by nucleating at high 
cooling rates and at either high or low agitation rates. The metastable racemate ((RS)-MA II) 
has been crystallized from solutions of (RS)-MA in water, which were filtered with a 0.2 mm 
membrane filter. The solution was evaporated slowly at room temperature and after several 
weeks, crystals of (RS)-MA II were collected. Single crystal structure determination was 
carried out with the identity of the bulk solid verified using XRPD.125 Similarly, Lorenz et 
al.123 crystallized (RS)-MA II from water and ethanol by evaporative crystallization at room 
temperature and at atmospheric pressure. Crystallization from significantly enriched solutions 
(enantiomeric excess (ee) 0.07 – 0.95%) of 1:1 mixtures of enantiomers have also yielded 
(RS)-MA II, as did for freeze-drying from racemic solutions and sublimation under reduced 
pressure. 
 
4.2.1.3 Thermal properties and stability of mandelic acid 
 
C. D. Hurd and H. R. Raterink133 studied the thermal decomposition process of MA up to 250 
°C and established carbon monoxide (traces of carbon dioxide), water and benzaldehyde as 
the decomposition by products. Moreover, MA experiences considerable and irreversible 
decomposition134 on heating faintly over its melting point, the degree of decomposition 
depends on the temperature MA is heated at and the method of heating. This makes 
identification of the real melting point intricate, as the samples can not be heated twice. The 
decomposition of the MA is associated with mass loss which has been estimated by using the 
mass loss due to decomposition, which was estimated by means of TG-DSC coupling to be 
2.2 wt.% until the melting starts and 2.8 wt.% at the end of the melting peak.122 When 
comparing the melting points and enthalpies of melting reported in literature, great variation 
is observed. Profir et al135 reported that the variation in the ∆Hfus found in the literature ranges 
from 25 to 30 kJ/mol for (RS)-MA I and from 20 to 31 kJ/mol for the pure enantiomer. Some 
of the melting points and ∆Hfus reported for the (RS)-MA I and (S)-MA are tabulated below in 
Table 9. 
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Table 9: Melting points and melting enthalpies of (RS)-MA Form I and (S)- and (R)-MA reported in the 
literature 
Literature Source
(RS)-MA Form I 
 
      Tm (°C)           ∆Hfus (kJ/mol)
(S)-MA/(R)-MA 
 
Tm (°C)                     ∆Hfus (kJ/mol) 
Centnerszwer119 121 - 132.7 - 
Adriani127 118 - 132.8 - 
Angus128 118 - 133 - 
Fujita129 119.8 30 133.8/134.2 31.0/31.1 
Leclercq130 119 25.1 133 26.4 
Patil136 - - 136 - 
Jacques5 119 25.5 133 26.4 
Lorenz100,122 120.2 25.6 131.6 24.5 
Profir135 118.9±0.1 26.1±0.4 130.9±0.4 26.2±0.5 
Z. J. Li137 120.6 26.8 131.5 25.7 
Ullmann’s 
Encyclopedia99 
118-121 - 132-135 - 
Handbook of 
Chemistry & 
Physics138 
118-123 - 134-135/133-135 - 
Sigma Aldrich 
website 
 
www.sigma-aldrich.com 
119-121 - 131-133/131-134 - 
 
From this compiled physical data, it can be realized that the melting point ranges from 117 to 
123 °C and 130.9 to 136 °C with the corresponding ∆Hfus also ranging from 24.5 to 30 kJ/mol 
and 24.5 to 31.1 kJ/mol for (RS)-MA Form I and for the single enantiomers, respectively. 
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Several researchers have reported the melting point of (RS)-MA Form II. These results are 
summarized in Table 10.  
 
Table 10: Published melting and melting enthalpies of (RS)-MA Form II 
Literature Source Tm (°C) ∆Hfus (kJ/mol) 
Lorenz123 108 - 
Brandstätter126 108 - 
Rose124 108.4 24.6 
Profir135 103.6±2.2 20.7±2.1 
 
Potential energy surface for the decomposition of mandelic acid 
 
The decomposition of mandelic acid has been studied by ab initio calculations MP2/6-
31G.with the GAUSSIAN92/DFT program by Domingo et al.139 The potential energy surface 
(PES) for the gas phase decomposition of MA has been studied. Benzaldehyde, carbon 
monoxide and water are the products of the decomposition, which is homogenous, 
unimolecular and obeys first-order rate law.140 The PES studies show that there are three 
competitive reaction pathways associated with the decomposition of MA: pathways 1 and 2 
are stepwise processes. Step 1 represents the dehydration process, forming an α-lactone ring, 
as the second step is the ring opening of the α-lactone yielding benzaldehyde and carbon 
monoxide. In steps 1 and 2 the dehydration takes place by eliminating the hydroxyl on the 
chiral carbon atom (C3); the mechanism which yields the lactone intermediate is different. In 
step 1 the ring closure is from the nucleophilic attack of the carboxylic acid oxygen atom on 
the C3 centre, in step 2 this is carried out by the hydroxyl oxygen of the carboxyl group. 
Pathway 3 is a one step process where the decomposition takes place in a concerted manner. 
The decomposition process139 can be described schematically as follows in Figure 49: 
 
 
Figure 49: The decomposition process.139 
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So in the study, the conformer of (RS)-MA with intramolecular hydrogen bond is the most 
stable structure, found from the conformational analysis and was used as the starting 
reactants. The decomposition of MA is an endothermic process with the ∆Hdec for the overall 
process being 73.9 kJ/mol. At 300 °C this overall process is spontaneous, with a Gibbs free 
energy (∆G) value of –95.8 kJ/mol. The validity of the theoretical work has been confirmed 
using the experimentally obtained data showing good quantitative agreement. 
Furthermore, Chuchani and Martin140 also did similar work and reported that benzaldehyde; 
carbon monoxide and water are the molecular elimination products up to 60% of MA 
decomposition, after which some benzyl alcohol from the decarboxylation process and carbon 
dioxide are also produced. The reaction was carried out in a hardened static reaction vessel in 
the temperature ranges from 300.1 to 340 °C and pressure range from 15.2 to 52.1 Torr. The 
reaction is described in detailed in Figure 50. 
 
 
Figure 50: Molecular elimination of products of (RS)-MA.87 
 
4.2.2 N-methylephedrine 
 
The binary melting phase diagram of (+)-N-methylephedrine ((+)-ME) and (-)-N-
methylephedrine is given in the Figure 51, (taken from Wang et al.102). Considering the phase 
diagram the eutectic composition is located at same place as the racemic mixture composition 
(mole ratio: (+)/(-) = 0.5/0.5). This shows that N-methylephedrine forms a simple eutectic 
(conglomerate) system. The liquidus line is calculated from the melting point and the melting 
enthalpy of the single enantiomer (see Table 11), using the Schröder-van Laar equation (see 
chapter 2 in section 2.3, Equation.18). Table 11 gives details of some melting points (Tm) and 
enthalpy of fusion (∆Hfus) reported for the (+)-N-methylephedrine and (±)-N-methylephedrine 
which are tabulated below. 
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Figure 51: Binary phase diagram (melting point diagram) of N-methylephedrine ▲, heating rate 2 K/min ; ■ 
heating rate 5 K/min ; ● Heating rate 10 K/min ; ▬, simplified Schröder-van Laar equation (liquidus line) ; - - -, 
solidus line.102 
 
Table 11: Melting points and melting enthalpies of (+)-N-methylephedrine and (±)-N-methylephedrine reported 
in the literature. 
Literature Source
(+)-N-methylephedrine 
 
Tm (°C)              ∆Hfus (kJ/mol) 
(±)-N-methylephedrine 
 
Tm (°C)                     ∆Hfus (kJ/mol) 
Wang102  86.6 30.53 63.50 26.57 
Sigma Aldrich 
website 
 
www.sigma-aldrich.com 
87-90 - - - 
 
The following section will present the solid liquid equilibria results, considering the various 
solute and solvent systems studied in this work. 
 
4.3 Ternary phase diagrams 
 
This section will entail the results of the following solubility measurements that were carried 
out. The results will be presented in the following order:  
Mandelic acid and N-methylephedrine in the various “classical” chiral solvents 
1. Mandelic acid in (S)-methyl lactate, (S)-ethyl lactate, (S)-propyl lactate, (S)-butyl 
lactate and (2R,3R)-diethyl tartrate. 
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2. N-methylephedrine in (S)-methyl lactate, (S)-ethyl lactate, (S)-propyl lactate, (S)-butyl 
lactate and (2R,3R)-diethyl tartrate.  
 
N-methylephedrine in two chiral ionic liquids 
 
3. N-methylephedrine in the two chiral ionic liquids ((S)-2-(methoxycarbonyl) 
pyrrolidinium bis (trifluoromethylsulfonyl) amide and (1R, 2S)-(-)-
Dimethylephedrinium bis (trifluoromethylsulfonyl) amide).  
 
 
Mandelic acid in two tailor-made chiral solvents 
 
4. Mandelic acid and in the tailor-made chiral solvents ((S)-propyl mandelate and (S)-
isopropanol mandalate).  
 
4.3.1 Mandelic acid and N-methylephedrine in various “classical” chiral solvents 
 
The different results obtained in the various “classical” chiral solvents will be highlighted in 
this section. The first part of this section will deal with mandelic acid and the lactates. 
 
4.3.1.1 Mandelic acid in “classical” chiral solvent 
 
The solubility data measured are summarized in Tables 12. Figure 52 illustrates the ternary 
solubility phase diagrams of the mandelic acid enantiomers in (S)-ethyl lactate for the 
temperature range from 0 to 25 °C. The liquid phase is in equilibrium with the corresponding 
solid phase of the crystalline enantiomer (Figure 52, left upper corner, dashed tie lines) for 
ratios of the enantiomers within 0-31% and 69-100%, while compositions of 31-69 % of the 
enantiomers in the liquid phase are in equilibrium with the crystalline racemic compound 
(Figure 52, left upper corner, dotted tie lines). The solubility isotherms confirm the compound 
forming character of the mandelic acid system. The diagram shows symmetrical mirror image 
with respect to the racemic axis rather than asymmetry which could be possible in the case of 
chiral solvents. The symmetry verification was supported by detailed measurement of the 
solubility isotherm at 15  C. The ratio of the enantiomers at the symmetric eutectic 
compositions remained unchanged with temperature at 0.69 and 0.31 in this solvent as it was 
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also reported in earlier results for non-chiral solvents.47,100,123 The solubilities of the pure 
enantiomers, the racemate and the eutectic mixture increase with increasing temperature. 
 
Table 12: Mass fraction solubility (wi) of (S)-Mandelic acid (1) and (R)-Mandelic acid (2) in (S)-Ethyl Lactate at 
different enantiomeric excesses (ee) [ ])/( 2121 wwwwee +−=  and temperatures. 
100 ee 100 (w1+w2) 100 w1 100 w2   100 wsolvent 
   t = 0 °C   
100.00 17.22 17.22 0.00 82.78 
37.00 22.20 15.20 7.00 78.80 
0.00 21.18 10.59 10.59 78.82 
37.36 22.00 6.89 15.11 78.00 
100.00 17.20 0.00 17.20 82.80 
   t = 5 °C   
100.00 18.30 18.30 0.00 81.70 
38.32 23.78 16.45 7.33 76.22 
0.00 23.07 11.53 11.53 76.94 
40.74 24.17 7.16 17.01 75.83 
100.00 18.58 0.00 18.58 81.42 
  t = 15 °C   
100.00 21.50 21.50 0.00 78.50 
98.70 21.51 21.37 0.14 78.49 
90.34 21.85 20.79 1.06 78.15 
72.74 24.99 21.58 3.41 75.01 
61.38 24.72 19.95 4.77 75.28 
52.68 26.42 20.17 6.25 73.58 
42.96 26.78 19.14 7.64 73.22 
40.78 28.14 19.81 8.33 71.86 
32.16 27.41 18.11 9.30 72.59 
22.56 27.72 16.99 10.73 72.28 
12.36 25.91 14.56 11.35 74.09 
0.00 25.10 12.55 12.55 74.90 
2.82 25.17 12.23 12.94 74.83 
13.82 25.55 14.54 11.01 74.45 
23.96 26.69 16.54 10.15 73.31 
35.22 26.50 8.58 17.92 73.50 
43.62 27.80 7.84 19.96 72.20 
44.20 26.81 7.48 19.33 73.19 
55.50 24.95 5.55 19.40 75.05 
66.46 24.93 4.18 20.75 75.07 
78.08 24.25 2.66 21.59 75.75 
87.70 22.21 1.37 20.84 77.79 
87.84 22.86 1.39 21.47 77.14 
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Continuation of Table 12 
95.00 21.68 0.54 21.14 78.32 
100.00 21.50 0.00 21.50 78.50 
  t = 25 °C   
100.00 25.17 25.17 0.00 74.83 
38.00 32.27 22.26 10.01 67.73 
0.00 30.61 15.34 15.27 69.39 
38.00 32.27 10.01 22.26 67.73 
100.00 25.02 0.00 25.02 74.98 
 
The ternary solubility phase diagram shown in Figure 52 was evaluated from the solubility 
data in Table 12.  
 
Solvent
(S)-MA (R)-MA(rac)-MA
0.80
0.60
0.70
0.90 0.10
0.20
0.30
0.40
(S)-Ethyl lactate
(S)-MA (R)-MA
w ((S)-MA)
w ((R)-MA)
w ((S)-EL)
0 °C
5 °C
15 °C
25 °C
Rac. compound
 
Figure 52: Ternary phase diagram of the mandelic acid enantiomers in (S)-ethyl lactate. Axes in weight 
fractions; w(S)-MA and w(R)-MA ≤ 0.5 of the phase diagram is shown for four solubility isotherms between 0 and 25 
°C. Schematic overview (figure, upper left) with proposed tie lines linking the liquid phases with the 
corresponding solid phases with dash lines. The isothermal lines have been added as a visualization aid, and only 
the marked points show measured data. 
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Investigation into different chain length of the lactates 
 
Investigations were also carried out to verify the effect of chain length of the lactates, (S)-
methyl lactate, (S)-ethyl lactate, (S)-propyl lactate and (S)-butyl lactate on the ternary 
solubility phase diagrams. Here four different chiral solvents with varying chain length were 
employed. Figure 53 shows the ternary solubility phase diagram of mandelic acid in different 
“classical” chiral solvents at 25 °C. The phase diagram also shows no asymmetry, which 
implies that no measurable discrimination was observed. It is also evident that solubility 
increases with decreasing chain length from (S)-butyl lactate to methyl lactate. This is 
attributed to the fact that smaller chain length solvents have higher polarity, and as a 
consequence would dissolve more solute and vice versa. Moreover, the phase diagram shows 
again the typical feature of a compound forming system observed for all the lactates studied. 
The solubility data measured for the various lactates, (S)-methyl lactate, (S)-ethyl lactate, (S)-
propyl lactate are summarized in Tables 13. The ternary solubility phase diagram shown in 
Figure 53 was derived from the solubility data in Table 13.  
 
Table 13: Mass fraction solubility (wi) of (S)-Mandelic acid (1) and (R)-Mandelic acid (2) in different 
“classical” chiral solvents at different enantiomeric excesses (ee) [ ])/( 2121 wwwwee +−=  and at 
temperature 25 °C. 
100 ee 100 (w1+w2) 100 w1 100 w2   100 wsolvent 
  (S)-ML   
100.00 27.49 27.49 0.00 72.51 
38.01 35.04 24.18 10.86 64.96 
1.55 32.89 16.70 16.19 67.11 
37.97 34.89 10.82 24.07 65.11 
100.00 27.57 0.00 27.57 72.43 
  (S)-EL   
100.00 25.02 25.02 0.00 74.98 
38.08 32.27 22.28 9.99 67.73 
0.22 30.61 15.34 15.27 68.39 
38.20 32.27 9.97 22.30 67.73 
100.00 25.17 0.00 25.17 74.83 
  (S)-PL   
100.00 20.31 20.31 0.00 79.69 
38.20 27.35 18.90 8.45 72.65 
1.37 25.51 12.92 12.59 74.49 
38.42 27.51 8.47 19.04 72.49 
100.00 20.39 0.00 20.39 79.61 
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Continuation of Table 13 
  (S)-BL   
100.00 16.90 16.90 0.00 83.1 
38.09 23.23 16.04 7.19 76.77 
1.71 21.00 10.68 10.32 79.00 
38.08 23.00 7.12 15.88 77.00 
100.00 16.64 0.00 16.64 83.36 
(S)-ML, (S)-methyl lactate; (S)-EL, (S)-ethyl lactate; (S)-PL, (S)-methyl lactate; (S)-BL, (S)-butyl lactate 
 
w ((S)-MA)
0.8
0.6
0.7
0.9 0.1
0.2
0.3
0.4
Solvent
(S)-MA (R)-MA
w ((R)-MA)
w (solvent)
25 °C
(S)-BL
(S)-PL
(S)-EL
(S)-ML
 
Figure 53: Ternary phase diagram of mandelic acid in different “classical” chiral solvent at 25 °C. Axes in 
weight fractions; w(S)-MA and w(R)-MA ≤ 0.5. The isothermal lines have been added as a visualization aid and only 
the marked points show measured data. 
 
Molecular modeling calculations were performed to understand the effect of chain length of 
the chiral solvents and how it affects the potential for enantioselective crystallization. The 
molecular modeling calculations have revealed that the chain length has no influence on the 
chiral recognition since a change does not offer better interactions. The stabilization enthalpy 
( ionStabilizatformHΔ ) is derived from the enthalpy of formation of the dimer molecules ( DimerformHΔ ) 
minus the enthalpy of formation of the single molecules of the solute and also solvent 
( SoluteformHΔ + SolventformHΔ ). The stabilization enthalpy ( ionStabilizatformHΔ ) is derived by this means of 
subtracting the summation of the single molecules ( SoluteformHΔ + SolventformHΔ ) from that of the dimer 
( DimerformHΔ ), since Davey et al.89 reported that mandelic acid in all other solvents except 
chloroform in solution is strongly solvated. From thermodynamic point of view the dimer 
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with more negative ionStabilizatformHΔ  is suppose to be more stable thermodynamically. Figure 54 
illustrates a schematic representation of optimized molecular structures of the dimer of (a) (S)-
mandelic acid and (S)-methyl lactate with lactate part hydrogen interaction, and (b) (S)-
mandelic acid and (S)-methyl lactate with the carbon chain hydrogen interaction, respectively.  
 
 
Figure 54: Schematic representation of optimized molecular structures of the dimer of (a) (S)-mandelic acid and 
(S)-methyl lactate with hydrogen bond interactions only at the lactate part of the molecule and (b) (S)-mandelic 
acid and (S)-methyl lactate with carbon chain hydrogen interactions, respectively. 
 
The expected classical interaction is the one that would take place at the lactate part of the 
molecule (i.e. C=O….O-H at both points). This case of interaction is the one depicted in 
Figure 54(a), and should be stronger interactions compared to the (C=O….H-C and 
C=O….O-H) illustrated in Figure 54(b). Table 14 gives the geometry-optimized energy 
values for the single and dimer molecules considered. 
 
Table 14: Summary of results of ∆Hform of individual molecules and dimers of (S)-MA in (S)-methyl lactate 
(lactate base hydrogen interaction) and (S)-MA and (S)-methyl lactate (carbon chain hydrogen interaction). 
Single molecule energies Dimer energies 
Single 
molecules 
SolventSolute
formH
/Δ  
 
(kcal/mol) 
 
Dimer types 
 
Dimer
formHΔ  
 
(kcal/mol) 
Stabilization enthalpy 
 
ionStabilizat
formHΔ  
 
[ DimerformHΔ -
( SoluteformHΔ + SolventformHΔ )] 
 
(kcal/mol) 
(S)-MA -117.56    
(S)-ML -146.14 (S)-MA-(S)-MLlactate part -270.00 -6.30 
(S)-MA -117.56    
(S)-ML -146.14 (S)-MA-(S)-MLcarbon chain -268.07 -4.37 
MA, mandelic acid; ML, methyl lactate 
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The results obtained from the molecular modeling summarized in Table 14 indicate that 
ionStabilizat
formHΔ  of (S)-mandelic acid and (S)-methyl lactate dimer with hydrogen bond 
interactions only at the lactate part of the molecule is more negative (-6.3 kcal/mol) compared 
to that of (S)-mandelic acid and (S)-methyl lactate which is less negative (-4.37 kcal/mol). 
This shows that interaction with the lactate part of the molecule would be preferred to the 
carbon chain one. Therefore these molecular modeling calculations confirm that no 
asymmetry was observed for different chain lengths of the lactates.  
Furthermore, to understand why by increasing the chain length of “classical” chiral solvents 
(lactates) results in less solubilities and the vice versa, molecular modeling calculations were 
made between (S)-mandelic acid and two lactates, (S)-methyl lactate and (S)-butyl lactate. 
Figure 55 depicts a schematic representation of optimized molecular structures of the dimer of 
(a) (S)-mandelic acid and (S)-methyl lactate, and (b) (S)-mandelic acid and (S)-butyl lactate, 
respectively.  
 
 
Figure 55: Schematic representation of optimized molecular structures of the dimer of (a) (S)-mandelic acid and 
(S)-methyl lactate and (b) (S)-mandelic acid and (S)-butyl lactate, respectively. 
 
Table 15 gives the geometry-optimized energy values for the single and dimer molecules 
considered. The ionStabilizatformHΔ  of (S)-mandelic acid and (S)-methyl lactate dimer with hydrogen 
bond interactions at lactate and the carbon chain part of the molecule is more negative (-4.37 
kcal/mol) compared to that of (S)-mandelic acid and (S)-butyl lactate dimer with also 
hydrogen bond interactions at lactate and the carbon chain part of the molecule which is less 
negative (-3.27 kcal/mol). 
Therefore, according to thermodynamics the (S)-mandelic acid in (S)-methyl lactate dimer 
should be more stable and as a consequence should be more soluble compared to the (S)-
mandelic acid in (S)-butyl lactate dimer. So, the results from the molecular modeling support 
that the (S)-methyl lactate dissolves best compared to the other lactates studied (see Figure 
53). 
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Table 15: Summary of results of ∆Hform of individual molecules and dimers of (S)-MA in (S)-methyl lactate 
(lactate and carbon chain hydrogen interaction) and (S)-MA and (S)-butyl lactate (lactate and carbon chain 
hydrogen interaction). 
Single molecule energies Dimer energies 
Single molecules 
 
Dimer
formHΔ  
 
 
(kcal/mol) 
Dimer types 
Dimer
formHΔ  
 
 
(kcal/mol) 
Stabilization enthalpy 
 
ionStabilizat
formHΔ  
 
[ DimerformHΔ -
( SoluteformHΔ + SolventformHΔ )] 
 
(kcal/mol) 
 
(S)-MA -117.56    
(S)-ML -146.14 (S)-MA-(S)-ML -268.07 -4.37 
(S)-MA -117.56    
(S)-BL -164.17 (S)-MA-(S)-BL -285.00 -3.27 
MA, mandelic acid; ML, methyl lactate; BL, butyl lactate 
 
Solid phase analysis 
 
The solubility measurements were accompanied by XRPD solid phase analyses to check for 
new phases. The solid phase analyses were performed since there is the possibility, for 
example for mandelic acid to partially decompose at higher temperatures (see chapter 4, 
section 4.2.1.3).47,133,139,140 Figure 56 depicts experimental XRPD patterns for solid phases 
obtained during the solubility measurements of mandelic acid in (S)-ethyl lactate at 15 °C. 
Different compositions of the chiral species are included. In each case the reflexes of the 
racemic compound and/or the mandelic acid enantiomer are clearly distinguishable. Typical 
reflexes characterizing the different species are indicated by grey to black colors, e.g. the 
reflex at 6.0° is typical for the enantiomer, and reflex at 10.84° is typical for the racemic 
compound. The results for the eutectic compositions (~ 38 % ee) show consistently reflexes of 
both the enantiomer and the racemate. No new phases were found. 
The solid phase analysis was also performed for the mandelic acid/(S)-butyl lactate system. 
Also the other lactates were studied in this thesis. In the solid phase analysis no new phases 
were observed. This clearly confirms that the entire solid phases had no additional or new 
phases (neither polymorphs nor solvates) differing from those of the pure enantiomers 
identified from the results of the crystal lattice analysis by XRPD.  
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Figure 56: Experimental XRPD patterns for pure enantiomers and the racemate of mandelic acid, and the 
experimental compositions from (S)-ethyl lactate and mandelic acid at 15 °C. 
 
The other “classical” chiral solvent studied in this work is (2R,3R)-diethyl tartrate. The 
solubility data measured are summarized in Tables 16. Figure 57 illustrates the ternary 
solubility phase diagrams of the mandelic acid enantiomers in (2R,3R)-diethyl tartrate at 
temperature ranging from 25 to 60 °C. 
 
Table 16: Mass fraction solubility (wi) of (S)-Mandelic acid (1) and (R)-Mandelic acid (2) in (2R,3R)-diethyl 
tartrate at different enantiomeric excesses (ee) [ ])/( 2121 wwwwee +−=  and temperatures. 
100 ee 100 (w1+w2) 100 w1 100 w2   100 wsolvent 
  t = 25 °C   
100.00 13.34 13.34 0.00 86.66 
66.84 15.08 12.58 2.50 84.92 
55.26 17.03 13.22 3.81 82.97 
40.36 19.54 13.71 5.83 80.46 
1.32 16.84 8.53 8.31 83.16 
41.32 20.05 5.88 14.17 79.95 
100.00 13.24 0.00 13.24 86.76 
  t = 35 °C   
100.00 17.03 17.03 0.00 82.97 
70.00 19.26 16.37 2.89 80.74 
54.48 21.58 16.67 4.91 78.42 
Chapter 4 Results and discussion 
 
102
Continuation of Table 16 
38.18 24.93 17.22 7.71 75.07 
17.90 23.71 13.98 9.73 76.29 
37.02 24.93 7.85 17.08 75.07 
0.20 21.36 10.70 10.66 78.64 
100.00 17.01 0.00 17.01 82.99 
   t = 45 °C   
100.00 20.00 20.00 0.00 80.00 
76.86 23.25 20.56 2.69 76.75 
55.96 26.99 21.05 5.94 73.01 
39.94 31.12 21.77 9.35 68.88 
23.50 29.15 18.00 11.15 70.85 
37.80 31.15 9.69 21.46 68.85 
0.20 25.68 12.87 12.81 74.32 
100.00 19.11 0.00 19.11 80.89 
  t = 50 °C   
100.00 22.87 22.87 0.00 77.13 
36.72 32.49 22.21 10.28 67.51 
37.86 32.30 10.04 22.26 67.70 
0.54 29.44 14.80 14.64 70.56 
100.00 22.28 0.00 22.28 77.72 
  t = 55 °C   
100.00 24.15 24.15 0.00 75.85 
38.04 36.63 25.28 11.36 63.37 
39.02 35.95 10.96 24.99 64.05 
0.20 31.66 15.86 15.80 68.34 
100.00 24.10 0.00 24.10 75.90 
  t = 60 °C   
100.00 26.07 26.07 0.00 73.93 
36.82 41.98 28.72 13.26 58.02 
37.86 40.50 12.58 27.92 59.50 
0.54 36.45 18.32 18.13 63.55 
100.00 26.31 0.00 26.31 73.69 
 
The ternary solubility phase diagram (see Figure 57) was derived from the solubility data in 
Table 16. The solubility isotherms reveal again the compound forming character of the 
mandelic acid system. The diagram shows symmetry with respect to the racemic axis rather 
than asymmetry, which could be in principle possible in the case of chiral solvents. The ratio 
of the enantiomers at the symmetric eutectic compositions remained unchanged with 
temperature and was found at a fraction of 0.69 and 0.31. 
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Figure 57: Ternary phase diagram of the mandelic acid enantiomers in (2R,3R)-diethyl tartrate (solubility 
isotherms between 25 and 60 °C). Axes in weight fraction; w(S)-MA and w(R)-MA ≤ 0.5. The isothermal lines have 
been added as a visualization aid and only the marked points show measured data. 
 
 
The same general shape of the solubility isotherm was observed in the entire ternary solubility 
phase diagram as for the “classical” chiral solvents. Also it became obvious that there was no 
measurable chiral recognition of the mandelic acid and the “classical” chiral solvent studied.  
 
Raman spectra 
In this work also Raman spectroscopy was also used to investigate the interaction between the 
solute and the solvent molecules. The investigations were restricted to mandelic acid and the 
“classical” chiral solvents, because mandelic acid being a compound forming system is more 
difficult to resolve, and therefore a good candidate to check for whether there exists 
measurable chiral interaction between the solute-solvent molecules. Unfortunately, Raman 
spectra measurements were not feasible for the tailor-made chiral solvents used in this thesis 
work due to overlapping spectra of the mandelic acid functional groups and the mandelates. 
Moreover, since there are no differences between the (S)- and (R)-mandelic acid spectra in all 
the “classical” chiral solvent studied, only the spectra of (S)- and (R)-mandelic acid in the two 
“classical” chiral solvent, (S)-ethyl lactate and (2R,3R)-diethyl tartrate were measured. The 
Raman spectra of the other lactates, (S)-methyl lactate, (S)-propyl lactate and (S)-butyl lactate 
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are included in the Appendix D. The Raman spectra of (S)- and (R)-mandelic acid in both (S)-
ethyl lactate and (2R,3R)-diethyl tartrate respectively are shown in Figures 58 and 59.  
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Figure 58: Raman spectra of (S)- and (R)-mandelic acid in (S)-ethyl lactate (liquid phase samples, and 
concentration of 8 wt %). 
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Figure 59: Raman spectra of (S)- and (R)-mandelic acid in (2R,3R)-diethyl tartrate (liquid phase samples, and 
concentration of 8 wt %). 
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In both Figures 58 and 59, the Raman spectra of (S)- and (R)-mandelic acid in both (S)-ethyl 
lactate and (2R,3R)-diethyl tartrate are identical to each other. Since there are no differences 
in the spectra of (S)- and (R)-mandelic acid in both chiral solvents, the results indicate again 
the absence of measurable interactions of the chiral molecules and the chiral solvent in the 
liquid phase.  
 
Solid phase analysis 
 
Solid phase analysis was also conducted for the other “classical” chiral solvent, (2R,3R)-
diethyl tartrate. Figure 60 depicts experimental XRPD patterns for solid phases obtained from 
the solubility measurements at higher temperatures for mandelic acid in (2R,3R)-diethyl 
tartrate at 60 °C. The solid phase analyses were performed since there is the possibility for 
mandelic acid to partially decompose at higher temperatures which has been discussed 
already. Further, the absence of solvate phases was checked. Different compositions of the 
chiral species are included. It can be derived that in each case just the reflexes of the racemic 
compound and/or the mandelic acid enantiomer are clearly evident. Thus the absence of new 
phases in the working range of the crystallization experiments is confirmed. 
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Figure 60: Experimental XRPD patterns for pure enantiomers and the racemate of mandelic acid (MA), and 
different experimental compositions from (2R,3R)-diethyl tartrate and mandelic acid at 60 °C. 
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The standard deviations for the solubility data measured were calculated by Equation 22 with 
n being the numbers of experiments. The results of standard deviation of the solubility data 
for mandelic acid in the “classical” chiral solvents are compiled in Table 17. 
 
Table 17: Error Analysis of Solubility Determination Procedure (standard deviation SD according to Equation 
22 in chapter 3, number of experiments n). 
(S)- and (R)-mandelic acid in (S)-methyl lactate t / °C 
n SD 
25 4 0.46 
(S)- and (R)-mandelic acid in (S)-ethyl lactate  t / °C 
n SD 
0 4 0.36 
25 4 0.60 
(S)- and (R)-mandelic acid in (S)-propyl lactate t / °C 
n SD 
25 3 0.03 
(S)- and (R)-mandelic acid in (S)-butyl lactate t / °C 
n SD 
25 3 0.49 
(S)- and (R)-mandelic acid in (2R,3R)-diethyl tartrate t / °C 
n SD 
25 4 0.36 
60 4 0.51 
 
The standard deviation of the solubility data of the racemic mandelic acid are in the same range as the 
as the summarized SD in Table 17. 
  
4.3.1.2 N-methylephedrine in “classical” chiral solvent 
 
The solubility data are compiled in Tables 18 and 19 for N-methylephedrine enantiomers in 
(S)-ethyl lactate and (2R,3R)-diethyl tartrate, respectively. Whiles Figures 61 and 62 illustrate 
the resulting ternary solubility phase diagrams of the N-methylephedrine enantiomers in (S)-
ethyl lactate and (2R,3R)-diethyl tartrate, respectively. The diagram reveals symmetry with 
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respect to the racemic axis, rather than asymmetry which in principle is possible in chiral 
solvents. As known from the binary phase diagram of the chiral system, N-methylephedrine 
enantiomers do not form a racemic compound but rather a simple eutectic (conglomerate) 
system.101 This was confirmed by the determined ternary solubility phase diagrams. 
Symmetry verification was carried out by detailed measurement of selected solubility 
isotherms.  
 
Table 18: Mass fraction solubility (wi) of (1S,2R)-(+)-N-methylephedrine (3) and 
(1R,2S)-(-)-N-methylephedrine (4) in (S)-ethyl lactate at different enantiomeric excesses ee [ ])/( 4343 wwwwee +−=  in the liquid phase and for different temperatures.  
100 ee 100 (w3+w4) 100 w3 100 w4 100 wsolvent 
      t = 0  C   
100.00 11.68 11.68 0.00 88.32 
40.00 17.19 12.03 5.16 82.81 
0.00 21.96 10.98 10.98 78.04 
40.00 17.09 5.13 11.96 82.91 
100.00 11.10 0.00 11.10 88.90 
      t = 5  C   
100.00 15.00 15.00 0.00 85.00 
40.00 18.20 12.74 5.46 81.80 
0.00 27.75 13.88 13.87 72.25 
44.00 18.92 5.30 13.62 81.08 
100.00 15.10 0.00 15.10 84.90 
         t = 15  C   
100.00 18.73 18.73 0.00 81.27 
50.00 23.31 17.48 5.83 76.69 
0.00 34.50 17.25 17.25 65.50 
40.00 23.31 6.99 16.32 76.69 
100 19.26 0.00 19.26 80.74 
         t = 25 C   
100.00 21.12 21.12 0.00 78.88 
40.00 30.18 21.13 9.05 69.82 
0.00 41.82 20.91 20.91 58.18 
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40.00 30.28 9.08 21.20 69.72 
100.00 21.29 0.00 21.29 78.71 
 
Table 19: Mass Fraction Solubility (wi) of (1S, 2R)-(+)-N-methylephedrine (3) and 
(1R,2S)-(-)-N-methylephedrine (4) in (2R,3R)-diethyl tartrate at different enantiomeric excesses ee [ ])/( 4343 wwwwee +−=  in the liquid phase and for different temperatures. 
100 ee 100 (w3+w4) 100 w3 100 w4 100 wsolvent 
    t = 25  C   
100.00 23.67 23.67 0.00 76.33 
50.00 29.24 21.93 7.31 70.76 
0.00 42.00 21.00 21.00 58.00 
50.00 29.24 7.31 21.93 70.76 
100.00 23.67 0.00 23.67 76.33 
  t = 30  C   
100.00 28.00 28.00 00.00 72.00 
40.00 33.00 23.10  9.90 67.00 
0.00 46.50 23.25 23.25 53.50 
40.00 33.00 9.90 23.10 67.00 
100.00 29.00 29.00 0.00 71.00 
  t = 35  C   
100.00 30.29 30.29 0.00 69.71 
50.00 35.40 26.55 8.85 64.60 
 0.00 49.20 24.60 24.60 50.80 
50.00 35.40 8.85 26.55 64.60 
100 30.29 0.00 30.29 69.71 
   t = 40  C   
100.00 36.28 36.28 0.00 63.72 
30.00 44.75 29.09 15.66 55.25 
0.00 55.58 27.79 27.79 44.42 
50.00 40.99 10.25 30.74 59.01 
100.00 35.63 0.00 35.63 64.37 
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Figure 61: Ternary phase diagram of N-methylephedrine in (S)-ethyl lactate at different temperatures. Axes in 
weight fractions; w(S)-MA and w(R)-MA ≤ 0.5. The isothermal lines have been added as a visualization aid and only 
the marked points show measured data. 
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Figure 62: Ternary phase diagram of N-methylephedrine in (2R,3R)-diethyl tartrate at different temperatures. 
Axes in weight fractions; w(+)-NME and w(-)-NME ≤ 1.0. The isothermal lines have been added as a visualization aid 
and only the marked points show measured data. 
 
The same general shape was observed in both Figures, while the solubility isotherms are 
clearly steeper in (S)-ethyl lactate than in (2R,3R)-diethyl tartrate, which is quantified in the 
so called solubility ratio (αmol). The αmol is defined as the ratio of the racemate solubility to 
that of the enantiomers solubility (both evaluated in mole fractions). It has been determined 
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for (S)-ethyl lactate to be about 2 (1.95 and 2.14 at 0 °C and 25 °C, respectively) and for 
(2R,3R)-diethyl tartrate to be smaller than 2 (1.73 and 1.49 at 25 °C and 40 °C, respectively), 
which shows a clear deviation from ideal behavior. One has to be aware that this statement 
does hold only in one direction. An ideal systems always exhibits αmol=2 according to the 
“double solubility” rule by Meyerhoffer38, while also very nonideal systems like the N-
methylephedrine/(S)-ethyl lactate can have αmol close to two. A comprehensive discussion on 
αmol close to two but not ideal will be outlined in the next section which deals with the 
investigation of effect of chain length of lactates.  
The solubility ratio has a large influence on the metastable zone width (MSZW), smaller αmol 
values (αmol < 2) account for possibly larger MSZW35, which can be exploited for entrainment 
processes, i.e. preferential crystallization. Figure 63 depicts the different solubility isotherm 
slope and how they affect the αmol values. The Figure shows two examples, i.e. situation 
where the isotherm is really bent (αmol << 2), or steeper (αmol > 2). It is clearly shown in 
Figure 63(a) that the metastable solubility line allows a wider area for entrainment, as 
compared to Figure 63(b). The behavior of the ternary solubility phase diagram of N-
methylepherdrine in (2R,3R)-diethyl tartrate system resembles a situation in between the two 
cases, i.e. Figures 63(a) and 63(b), N-methylephedrine in (S)-ethyl lactate is related to Figure 
63(b). Therefore, (2R,3R)-diethyl tartrate is considered to be the better “classical” chiral 
solvent for a chiral separation of the considered pair of enantiomers due to lower 
corresponding αmol values. 
 
(+)-E
αmol << 2
Rac (-)-E
Solvent
Metastable 
solubility 
line 
Solubility 
isotherm
+
+
+
+
-
-
-
-
(+)-E
αmol > 2
Rac (-)-E
Solvent
Metastable 
solubility 
line 
Solubility 
isotherm
+
+
+
+
-
-
-
-
(a) (b)  
Figure 63: Schematic ternary solubility phase diagram course of showing metastable solubility line for a 
conglomerate system, with (a) αmol << 2 and (b) αmol > 2, respectively. 
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A comprehensive discussion of this aspect can be found by Collet et. al., Levilain et al. and 
Polenske et.al.33,141,142 Considering the solubility ratios evaluated from the determined ternary 
solubility phase diagrams of N-methylephedrine in (2R,3R)-diethyl tartrate there is the 
possibility for a wide area for entrainment, i.e. it should be in same cases possible even to 
enter the two phase region of the phase diagrams via crystallization, which would be more 
lucrative for obtaining enantiopure crystals. Thus, in particular (2R,3R)-diethyl tartrate seems 
to be the better solvent due to the lower αmol values. Thus, a well defined exploitation of 
selective kinetic effects for enantioselective crystallization appears to be promising. 
 
Investigation into different chain length of the lactates 
 
Investigations were also carried out to verify the effect of chain length of lactates on the shape 
of the isotherm in the ternary phase diagram. As a case study the different lactates, (S)-methyl 
lactate, (S)-ethyl lactate, (S)-propyl lactate and (S)-butyl lactate were studied. Thus, four 
different “classical” chiral solvents with varying chain length were employed.  
 
Table 20: Solubilities of Enantiomer and Racemate N-methylephedrine and αmol Values for the Different 
Lactates at 25 °C. 
Solvents 
Enantiomer 
solubility (mol %) 
Racemate 
solubility (mol %) 
       αmol values 
(S)-methyl lactate 15.791 32.350 2.05 
(S)-ethyl lactate 14.997 32.142 2.14 
(S)-propyl lactate 15.709 32.345 2.06 
(S)-butyl lactate 15.706 32.552 2.07 
 
Table 20 gives a compilation of the solubilities of enantiomer and the racemate and their 
corresponding αmol values of N-methylephedrine in the different lactates at 25 °C. Though the 
αmol values are close to 2, and which has been discussed in the previous section, but they do 
not show ideality. Illustration of the deviation of the (S)-butyl lactate with (αmol-value equal to 
2 is considered for the plot) from ideal behavior has been shown in Figure 64. The ideal 
solubilities were derived from the Schröder van Laar equation (Chapter 2, Equation 18), using 
the enthalpy of fusion ∆Hfus and the melting temperatures Tm for the N-methylephedrine 
enantiomers taken from Wang et al.102 
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Figure 64: Solubility in mole% of ▲, (1S,2R)-(+)-N-methylephedrine and □, (1R,2S)-(-)-N-methylephedrine in 
(S)-butyl lactate between 273 K and 298 K. Symbols are measurements, solid line: ideal solubility.  
 
The solvents considered are methyl lactate, ethyl lactate, propyl lactate and butyl lactate. 
Figure 65 illustrates ternary solubility phase diagram of N-methylephedrine in different 
classical chiral solvents at 25 °C. The diagrams also show no asymmetry which implies no 
measurable discrimination was observed. It is evident that solubility increases with decreasing 
chain length of the chiral solvents, from (S)-butyl lactate to methyl lactate, which is attributed 
to the increase in the polarity of smaller chain length for instance (S)-methyl lactate. This 
effect has also been explained by the molecular modeling calculations in the early discussions 
for mandelic acid system. A summary of all the entire solubility data obtained from the 
measurements is compiled in Table 21. 
 
Table 21: Mass Fraction Solubility (wi) of (1S, 2R)-(+)-N-methylephedrine (3) and (1R, 2S)-(-)-N-
methylephedrine (4) in different “classical” chiral solvents at different Enantiomeric Excesses (ee) [ ])/( 4343 wwwwee +−=  and at temperature 25 °C. 
100 ee 100 (w3+w4) 100 w3 100 w4 100 wsolvent 
  (S)-ML   
100.00 24.41 24.41 0.00 75.59 
39.09 35.06 24.38 10.68 64.94 
0.97 45.16 22.80 22.36 54.84 
39.40 35.06 10.62 24.44 64.94 
100.00 24.50 0.00 24.50 75.50 
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  (S)-EL   
Continuation Table 21 
100.00 21.12 21.12 0.00 78.88 
42.00 31.00 22.01 8.99 69.00 
0.47 41.82 21.01 20.81 58.18 
42.00 30.28 8.78 21.50 67.73 
100.00 21.29 0.00 21.29 74.83 
  (S)-PL   
100.00 20.18 20.18 0.00 79.82 
38.85 28.88 20.05 8.83 71.12 
0.84 39.34 19.84 19.50 60.66 
37.56 29.53 9.22 20.31 70.47 
100.00 20.76 0.00 20.76 79.24 
  (S)-BL   
100.00 18.60 18.60 0.00 81.40 
40.50 27.07 19.02 8.05 72.93 
1.43 37.18 18.85 18.33 62.82 
37.10 27.85 8.76 19.09 72.15 
100.00 18.55 0.00 18.55 81.45 
(S)-ML, (S)-methyl lactate; (S)-EL, (S)-ethyl lactate; (S)-PL, (S)-methyl lactate; (S)-BL, (S)-butyl lactate 
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Figure 65: Ternary phase diagram of N-methylephedrine in different “classical” chiral solvent at 25 °C. Axes in 
weight fractions; w(+)-NME and w(-)-NME  ≤ 0.5. The isothermal lines have been added as a visualization aid and 
only the marked points show measured data. 
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Here, molecular modeling calculations were not done since already for the mandelic acid 
system detailed discussion was made and the same trends were expected here. 
 
Solid phase analysis 
 
Figure 66 illustrates experimental XRPD patterns for the solid phases obtained in solubility 
measurement for N-methylephedrine in (S)-ethyl lactate at 15 °C. Since N-methylephedrine in 
(S)-ethyl lactate is clearly a conglomerate forming system (see Figure 65), so the reflexes of 
the enantiomers and the racemic mixture must be identical. Deviations in the patterns would 
indicate the presence of different phases like a solvate or a polymorph. The various 
compositions really mimic the reference reflexes in the XRPD patterns, i.e. no new phases 
exist. Also the solid phases for N-methylephedrine in (2R,3R)-diethyl tartrate were checked. 
In this case no additional or new phases were formed in the crystal lattice.  
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Figure 66: Experimental XRPD patterns for pure enantiomers and the racemate of N-methylephedrine, and the 
experimental compositions from (S)-ethyl lactate and N-methylephedrine at 15 °C. 
 
The solid phase analysis was conducted also for the other lactates, (S)-methyl lactate, (S)-
propyl lactate and (S)-butyl lactate studied. The standard deviations for the solubility data 
measured were calculated by Equation 22 in chapter 3 with n being again the number of 
experiments are compiled in Table 22. 
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Table 22: Error Analysis of Solubility Determination Procedure (standard deviation SD according to Equation 
22 in chapter 3, number of experiments n). 
(1S,2R)-(+)-N-methylephedrine in (S)-methyl lactate t / °C 
n SD 
25 3 0.34 
(1S,2R)-(+)-N-methylephedrine in (S)-ethyl lactate t / °C 
n SD 
0 6 0.04 
25 6 0.14 
(1S,2R)-(+)-N-methylephedrine in (S)-propyl lactate t / °C 
n SD 
25 4 0.54 
(1S,2R)-(+)-N-methylephedrine in (S)-butyl lactate t / °C 
n SD 
25 4 0.28 
(1S,2R)-(+)-N-methylephedrine in (2R,3R)-diethyl tartrate t / °C 
n SD 
25 6 0.24 
40 6 0.45 
 
The standard deviations for the counter enantiomers and the racemic mixture of N-
methylephedrine solubilities are in the same range.  
The subsequent section will deal with the usage of chiral ionic liquids for enantioselective 
crystallization of N-methylephedrine. 
 
4.3.2 N-methylephedrine in chiral ionic liquids 
 
This study is directed to the use of a chiral ionic liquid for enantioselective crystallization 
since the structured nature of these solvents might provide more appropriate chiral 
interactions. Reichert et al.104 reviewed and discussed the possibility of using complex 
solvents like ionic liquids for crystallization. Furthermore, lately Gausepohl et al.103 reported 
an example of an enantioselective asymmetric synthesis using a chiral ionic liquid as a 
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reaction medium. On that basis, it appears attractive to apply chiral ionic liquids as solvents in 
enantioselective crystallization.  
 
4.3.2.1 N-methylephedrine in (S)-2-(methoxycarbonyl) pyrrolidinium bis(trifluoromethyl 
sulfonyl) amide 
 
First, a HPLC method which was used to determine the concentrations and enantiomeric 
compositions has been elaborated.  
 
Chiral HPLC separation / analysis 
The analytical techniques made and applied for determining concentrations and enantiomeric 
compositions (ee) are described in detail in Figure 67. A typical chromatogram of a racemate 
of N-methylephedrine dissolved in [(S)-2-Pro-Me] [NTF2] / MeOH 70/30 v/v is shown. The 
separation factor (α) was determined according to Equation 36 which gives a measure of the 
separation or the selectivity between the enantiomers. 
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where t0 is the dead time, tR1 and tR2 are the retention times for both components 1 and 2, 
respectively. The separation factor was determined to be 1.5, almost a baseline separation was 
obtained. The (-)-enantiomer elutes before the (+)-enantiomer. 
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Figure 67: Chromatographic separation of racemic N-methylephedrine (NME) in [(S)-2-Pro-Me][NTF2] / 
MeOH 70/30 v/v. Injection volume, 5µl; flow rate, 1 ml/min; temperature 25 °C; detection, UV at 254 nm. 
Chiral stationary phase, Eurocel OD (Knauer, 5µm, 250x4.6mm); mobile phase, 85% n-Hexane, 15% 
isopropanol and 0.1% diethylamine. 
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Since in the lower temperature ranges the viscosity of the chiral ionic liquid increases, 
methanol as co-solvent was added in an appropriate ratio. As a result the solubility increased, 
and the viscosity decreased, allowing a more suitable window for crystallization processes. 
The obtained solubility data are summarized in Table 23. 
 
Table 23: Mass fraction Solubility (wi) of (1S,2R)-(+)-N-methylephedrine (3) and (1R,2S)-(-)-N-
methylephedrine (4) in (S)-2-(methoxycarbonyl) pyrrolidinium bis (trifluoromethylsulfonyl) amide / MeOH 
70/30 v/v at different enantiomeric excesses (ee) [ ])/( 4343 wwwwee +−=  and temperatures. 
       100 ee       100 (w3+w4)     100 w3 100 w4 100 wsolvent  
    t = 5 °C   
100.00 31.22 31.22 0.00 68.78 
49.08 36.00 26.83 9.17 64.00 
0.00 42.83 21.42 21.41 57.17 
49.74 36.30 27.17 9.13 63.70 
100.00 31.37 0.00 31.37 68.63 
       t = 15 °C   
100.00 34.00 34.00 00.00 66.00 
39.62 38.82 27.10 11.72 61.18 
0.00 45.56 22.78 22.78 54.44 
43.58 39.00 11.00 28.00 61.00 
100.00 33.58 00.00 33.58 66.42 
     t = 25 °C   
100.00 39.00 39.00 0.00 61.00 
35.80 45.42 30.84 14.58 54.58 
0.00 52.61 26.31 26.30 47.39 
31.98 43.84 14.91 28.93 56.16 
100 38.36 0.00 38.36 61.64 
    t = 30 °C   
100.00 41.63 41.63 0.00 58.37 
44.98 46.74 33.88 12.86 53.26 
0.00 55.58 27.79 27.79 44.42 
44.42 46.47 12.91 33.56 53.53 
100.00 41.00 0.00 41.00 59.00 
   t = 35 °C   
100.00 43.23 43.23 0.00 56.77 
50.00 50.00 37.50 12.50 50.00 
0.00 59.00 29.50 29.50 41.00 
50.00 49.78 12.44 37.34 50.22 
100.00 43.19 0.00 43.19 56.81 
 
Figure 68 depicts the phase diagram of N-methylephedrine in [(S)-2-Pro-Me][NTF2] / MeOH 
70/30 v/v at different temperatures. The ternary solubility phase diagram has been derived 
from the summarized solubility phase diagram in Table 23. The solubility data measured in 
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Table 23 were derived from taken the mean values from the two sets of obtained data. It was 
impossible to calculate the standard deviation due to the fact that experiments were conducted 
only two times, since the chiral ionic liquid was very expensive. 
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Figure 68: Ternary phase diagram for N-methylephedrine in (S)-2-(methoxycarbonyl) pyrrolidinium bis 
(trifluoromethylsulfonyl) amide / MeOH 70/30 v/v temperatures from 5 °C to 35 °C. Axes in weight fractions; 
w(+)-NME and w(-)-NME ≤ 1.0. The isothermal lines have been added as a visualization aid and only the marked 
points show measured data. 
 
In fact, also this diagram shows symmetry with respect to the racemic axis rather than 
asymmetry. Also in the ternary system investigated the solubilities of pure enantiomers, 
racemates and enantiomeric compositions between the pure enantiomers and the racemate 
increase with increasing temperature. As identified already for the binary chiral system, the 
N-methylephedrine enantiomers do not form a racemic compound but rather a simple eutectic 
(conglomerate) system.102  
 
Solid phase analysis 
 
Also for this system a thorough analytical checks were conducted regarding the solid phase. 
This was done to ascertain that there is no formation of solvates and/or polymorphs in the 
chiral systems. Figure 69 illustrates experimental XRPD patterns for the solid phases obtained 
in solubility measurements for N-methylephedrine in (S)-2-(methoxycarbonyl) pyrrolidinium 
bis (trifluoromethylsulfonyl) amide / MeOH 70/30 v/v at 35 °C. Since N-methylephedrine in 
[(S)-2-Pro-Me][NTF2] / MeOH 70/30 v/v is obviously a conglomerate forming system (see 
Figure 68) the reflexes of the enantiomers and the racemic mixture must be identical.  
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Figure 69 Experimental XRPD patterns for pure enantiomers, the racemate of N-methylephedrine, and the 
experimental compositions from (S)-2-(methoxycarbonyl) pyrrolidinium bis (trifluoromethylsulfonyl) amide / 
MeOH 70/30 v/v and N-methylephedrine at 35 °C. 
 
No additional or new phases differing from those of the pure enantiomers were identified from the 
results of the crystal lattice analysis by XRPD. The various compositions really mimic the 
reference reflexes in the XRPD patterns. 
The solubility isotherms in Figure 68 are more curved or bent compared to isotherms of the 
N-methylephedrine/“classical” chiral solvent system. It has been discussed already in the 
above section that the shape of the solubility isotherm influences the possible productivity of 
preferential crystallization strategies. The more bent the solubility isotherm is the smaller the 
αmol value. The solubility ratio (αmol) which was determined here to be ~1.3 is much lower 
than 2 (characterizing an ideal solubility case). As it has been discussed extensively in Figure 
63 concerning the slope of the solubility isotherms and how they affect the productivity of the 
preferential crystallization process. So, comparing the case of “classical” chiral solvent, 
(2R,3R)-diethyl tartrate and chiral ionic liquid, (S)-2-(methoxycarbonyl) pyrrolidinium bis 
(trifluoromethylsulfonyl) amide / MeOH 70/30 v/v, it can be deduced that the chiral ionic 
liquid should be a better solvent for chiral separation of the pair of enantiomers studied since 
it has the lower αmol value. The subsequent section will also deal with N-methylephedrine in, 
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(1R,2S)-(-)-Dimethylephedrinium bis (trifluoromethylsulfonyl) amide as another chiral ionic 
liquid. 
4.3.2.2 N-methylephedrine in (1R,2S)-(-)-Dimethylephedrinium bis (trifluoromethylsulfonyl) 
amide 
 
First of all a successful HPLC method which was used to determine the concentrations and 
enantiomeric compositions has been discussed in detailed. The reason for this has already 
been given in the above section with the chiral ionic liquid, (S)-2-(methoxycarbonyl) 
pyrrolidinium bis (trifluoromethylsulfonyl) amide. 
 
Chiral HPLC separation / analysis 
 
The analytical method prepared and employed for determining concentrations and 
enantiomeric compositions is described in Figure 70 showing a characteristic chromatogram 
of a racemate of N-methylephedrine dissolved in (1R,2S)-(-)-Dimethylephedrinium bis 
(trifluoromethylsulfonyl) amide. The separation factor (α) was determined according to 
Equation 36 which gives a measure of the separation or the selectivity between the 
enantiomers. The separation factor was determined to be 1.6 and a baseline separation was 
obtained. The (-)-enantiomer eluted before the (+)-enantiomer. 
 
-3
2
7
12
17
22
0 5 10 15 20 25 30
Time (min)
Si
gn
al
 (m
A
U
)
tR1    tR2    t0
(1R,2S)-(-)-NME
(1S,2R)-(+)-NME
 
Figure 70: Chromatographic separation of racemic N-methylephedrine (1R,2S)-(-)-Dimethylephedrinium bis 
(trifluoromethylsulfonyl) amide. Injection volume, 5µl; flow rate, 1 ml/min; temperature 25 °C; detection, 
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UV at 254 nm. Chiral stationary phase, Eurocel OD (Knauer, 5µm, 250x4.6mm); mobile phase, 85% n-
Hexane, 15% isopropanol and 0.1% diethylamine. 
 
Though the viscosity of the chiral ionic liquid, (1R,2S)-(-)-Dimethylephedrinium bis 
(trifluoromethylsulfonyl) amide is very high no co-solvent was added. This was done to 
maintain the structure properties of the solvent which was expected to improve the 
interactions between the solvent and solute molecules.  
 
Table 24: Mass fraction solubility (wi) of (1S,2R)-(+)-N-methylephedrine (3) and (1R,2S)-(-)-N-
methylephedrine (4) in (1R,2S)-(-)-Dimethylephedrinium bis (trifluoromethylsulfonyl) amide at different 
enantiomeric excesses (ee) [ ])/( 4343 wwwwee +−= . 
       100 ee       100 (w3+w4)     100 w3 100 w4 100 wsolvent 
  
 
t = 35 °C 
  
100.00 11.21 11.21 0.00 88.79 
5.32 19.26 10.14 9.12 80.74 
100.00 9.28 0.00 9.28 90.72 
 
A summary of the solubility data in mass fraction (wi) of both enantiomers of N-
methylephedrine in (1R,2S)-(-)-Dimethylephedrinium bis (trifluoromethylsulfonyl) amide at 
35 °C has been compiled in Table 24. The ternary solubility phase diagram has been 
constructed based on these data. 
 
(1R,2S)-(-)-NME
(1R, 2S)-(-)-Dimethylephedrinium 
bis(trifluoromethylsulfonyl) amide 
w ((-)-NME)0.8
0.6
0.7
0.9 0.1
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0.4
(1S, 2R)-(+)-NME
w (solvent)
w ((+)-NME)  
Figure 71: Ternary phase diagram of N-methylephedrine in (1R,2S)-(-)-Dimethylephedrinium bis 
(trifluoromethylsulfonyl) amide at 35 °C. Axes in weight fractions; w(+)-NME and w(-)-NME  ≤ 0.5. The isothermal 
lines have been added as a visualization aid and only the marked points show measured data. 
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Solubility experiments were only possible at higher temperatures, because the solvent has a 
very high viscosity (481.6 mPa s, at 23.10°C). A ternary solubility phase diagram of N-
methylephedrine enantiomers in chiral ionic liquid, (1R,2S)-(-)-Dimethylephedrinium bis 
(trifluoromethylsulfonyl) amide at 35 °C is shown in Figure 71. The phase diagram depicts a 
typical simple eutectic (conglomerate) system. The solubility measurements were repeated 
twice and the mean values were used for the derivation of the ternary solubility phase 
diagram. The phase diagram shows an asymmetry, which reveals that the chiral ionic liquid 
(1R,2S)-(-)-Dimethylephedrinium bis (trifluoromethylsulfonyl) amide has a measurable chiral 
recognition with the N-methylephedrine enantiomers. The shape of the isotherms in the 
ternary phase diagram for one side is steeper compared to the other. The αmol values ranges 
between 1.5 to 1.8 for (1S,2R)-(+)-N-methylephedrine and (1R,2S)-(-)-N-methylephedrine 
enantiomers, respectively. This is due to the asymmetry behavior of the phase diagram. 
Nevertheless, in both cases the αmol values are smaller than 2 (ideal case). Thus, the system 
would be favorable for a preferential crystallization processes, and would provide wide area 
for entrainment. It should eventually be feasible to enter the two phase region of the phase 
diagrams via crystallization, which would be more lucrative for obtaining single enantiomers.  
According to the determined ternary solubility phase diagram it can be deduced that the 
studied chiral ionic liquids seems to be a promising solvent for the enantioseparation of N-
methylephedrine due to the lower αmol values via preferential crystallization. 
 
Solid phase analysis 
 
Figure 72 illustrates experimental XRPD patterns for the solid phases obtained during the 
solubility measurements for N-methylephedrine in (1R,2S)-(-)-Dimethylephedrinium bis 
(trifluoromethylsulfonyl) amide at 35 °C. Since N-methylephedrine in (1R,2S)-(-)-
Dimethylephedrinium bis (trifluoromethylsulfonyl) amide is evidently a conglomerate 
forming system (see Figure 71) so the reflexes of the enantiomers and the racemic mixture 
must be identical. Indeed, no additional or new phases, differing from those of the pure 
enantiomers, were identified from the results of the crystal lattice analysis by XRPD. The various 
compositions really mimicked the reference reflexes in the XRPD patterns. 
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Figure 72: Experimental XRPD patterns for pure enantiomers, the racemate of N-methylephedrine, and the 
experimental compositions from (1R,2S)-(-)-Dimethylephedrinium bis (trifluoromethylsulfonyl) amide and N-
methylephedrine at 35 °C. 
 
4.3.3 Mandelic acid in tailor-made chiral solvents  
 
The enantioselective crystallization of conglomerate forming systems by the use of pure 
enantiomers or tailor-made additives has been well studied by several research groups.55,143-145 
Furthermore, Mughal et al.48,146 and Leeman et al.147 have successfully applied tailor-made 
additives to compound forming substance. Motivation for the use of tailor-made additive 
comes from the above mentioned examples. Therefore, tailor-made chiral solvents were 
synthesized with criteria set such that the structure of the solvent resembles the mandelic acid 
chemical structure stereochemically. 
Unfortunately, no HPLC method was available for this system and alternative measuring and 
analytical techniques were used. Crystal16TM (polythermal method) and refractometry have 
been employed for concentration measurements in preliminary experiments. 
 
4.3.3.1 Mandelic acid in (S)-propyl mandelate 
 
The tailor-made chiral solvent, (S)-propyl mandelate was employed as solvent in solubility 
measurements of mandelic acid. Here, a polythermal method with the crystal16TM was used in 
as preliminary experiment conducted to verify the potential of the tailor-made chiral solvents 
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for chiral discrimination. The results obtained from the solubility measurements of (S)-
mandelic acid and (R)-mandelic acid in (S)-propyl mandelate are shown in Figure 73.  
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Figure 73: Solubility in wt % of (S)-mandelic acid ((S)-MA) and (R)-mandelic acid ((R)-MA) in (S)-propyl 
mandelate as a function of temperature. 
 
Depicts is a plot of concentrations as a function of temperature. There is a clear trend that 
increase in temperature resulted in solubility increments. The Figure clearly shows differences 
in the solubility of the (S)- and (R)-mandelic acid enantiomers. The results indicate the 
existence of measurable interactions of the chiral molecules and the chiral solvent in the 
liquid phase. From the results can be deduced, that there is a measurable chiral recognition in 
the liquid phase provided by the (S)-propyl mandelate. Based on these results of preliminary 
measurements, subsequent solvent was now applied to see the effect of different chain lengths 
of the tailor-made chiral solvents. Thus, further studies were conducted for (S)-isopropyl 
mandelate. Solubility experiments were performed for the enantiomers and the racemic 
mandelic acid. Thorough solubility measurements were not possible to be carried out for the 
single enantiomers, the eutectic and the racemic compositions, because there was no HPLC 
method available to analyze the enantiomeric compositions.  
Molecular modeling studies were also performed to get a deeper understanding of the solvent-
solute interactions in the system. Figure 74 shows a schematic representation of optimized 
molecular structures of the dimer of (a) (S)-mandelic acid and (S)-propyl mandelate and (b) 
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(R)-mandelic acid and (S)-propyl mandelate, respectively, and with connection of hydrogen 
bonds.  
 
Figure 74: Schematic representation of optimized molecular structures of the dimer of (a) (S)-mandelic acid and 
(S)-propyl mandelate and (b) (R)-mandelic acid and (S)-propyl mandelate, respectively, and the molecules are 
connected by hydrogen bonds. 
 
The optimized structure of mandelic acid/(S)-isopropyl mandelate system is not being shown, 
as there are only slight differences in the two.  
 
Table 25: Summary of results of ∆Hform of individual molecules and dimers of (S)- and (R)-MA in (S)-propyl 
mandelate and (S)-isopropyl mandelate. 
Single molecule energies Dimer energies 
Single molecules 
solventSolute
formH
/Δ
 (kcal/mol) 
Dimer types 
Dimer
formHΔ  
(kcal/mol) 
Stabilization enthalpy 
 
ionStabilizat
formHΔ  
 
[ DimerformHΔ -
( SoluteformHΔ + SolventformHΔ )] 
(kcal/mol) 
(S)-MA -117.56    
(S)-PM -122.97 (S)-MA-(S)-PM -243.31 -2.78 
(R)-MA -117.56                  
(S)-PM -122.97 (R)-MA-(S)-PM -246.00 -5.47 
(S)-MA -117.56                  
(S)-IPM -120.99 (S)-MA-(S)-IPM -242.52 -3.97 
(R)-MA -117.56                 
(S)-IPM -120.99 (R)-MA-(S)-IPM -244.42 -5.87 
MA, mandelic acid; PM, Propyl mandelate; IPM, isopropyl mandelate. 
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The optimized structures were used in the calculations of the heat of formation (∆Hform) and 
their corresponding stabilization energies. The results obtained from the molecular modeling, 
compiled in Table 25 indicate that the ionStabilizatformHΔ  of (R)-mandelic acid and (S)-propyl 
mandelate dimer is more negative (-5.96 kcal/mol) compared to that of (S)-mandelic acid and 
(S)-propyl mandelate which is less negative (-2.78 kcal/mol). Thus, it can be expected that the 
most stable dimer ((R)-mandelic acid and (S)-propyl mandelate) should be more soluble 
compared to the less stable dimer ((S)-mandelic acid and (S)-propyl mandelate). The observed 
solubility differences for both enantiomers in (S)-propyl mandelate point in the same direction 
as the molecular modeling results. 
 
4.3.3.2 Mandelic acid in (S)-isopropyl mandelate 
 
A summary of the obtained solubility results of the enantiomers and racemic mandelic acid in 
the tailor-made chiral solvent, (S)-isopropyl mandelate at 50 °C is given in Table 26. 
 
Table 26: Summary of mandelic acid solubilities in the tailor-made synthesized chiral solvent at 50 °C. 
Solvent (S)-MA  wt % 
(R)-MA 
wt % 
(racemic)-MA 
wt % 
(S)-isopropyl mandelate 18.44 21.82 35.96 
 
Table 26 depicts a distinct solubility difference between the two pure enantiomers of mandelic 
acid. Additional molecular modeling calculations were performed to explain these 
differences. The outcome of the calculations is summarized in Table 25. Table 25 indicates 
that the ionStabilizatformHΔ  of (R)-mandelic acid and (S)-isopropyl mandelate dimer is more negative 
(-5.86 kcal/mol) compared to that of (S)-mandelic acid and (S)-propyl mandelate (-3.96 
kcal/mol). Hence, (R)-mandelic acid/(S)-isopropyl mandelate should form a rather stable 
dimer and as a result of this should be more soluble This is contrary to the case of (S)-
mandelic acid/(S)-isopropyl mandelate. 
As discussed earlier, thorough solubility measurements were not feasible in this case. A 
literature search revealed few studies with quantifiable solubility differences between the two 
pure enantiomers using chiral solvents. For instance, Yamamoto et al.6 reported pure 
enantiomer solubilities for a chiral cobalt salt in (2R,3R)-(+)-diethyl tartrate and described 
measurable differences between them. Thus, the observed solubility differences in this present 
work are in line with previously reported work on chiral solvents. The difference of our work 
Chapter 4 Results and discussion 
 
127
is that a special synthesized tailor-made chiral solvent was applied for the measurement, 
which provided appreciable solubility differences. These differences might be employed for 
resolution purposes. Unfortunately, in this current work no phase diagrams could be 
determined, due to the fact that no suitable HPLC method was available for enantiomeric 
compositions determination.  
 
Solid Phase Analysis 
 
Figure 75 depicts experimental XRPD patterns for solid phases obtained during the solubility 
measurements of mandelic acid in (S)-isopropyl mandelate at 50 °C. In each case the reflexes 
of the racemic compound and/or the mandelic acid enantiomer are clearly distinguishable. 
Typical reflexes characterizing the different species are indicated by grey to black colors, e.g. 
reflex at 6.0° is typical for the enantiomer, and reflex at 10.84° is typical for the racemic 
compound. No additional or new phases were identified (other than the racemic compound 
and the enantiomers) from the crystal lattice analysis by XRPD. 
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Figure 75: Experimental XRPD patterns for pure enantiomers, the racemate of mandelic acid, and the 
experimental compositions from (S)-isopropyl mandelate and mandelic acid at 50 °C. 
 
Also the solid phases for both pure enantiomers of mandelic acid in (S)-propyl mandelate 
were checked, and there were no additional or new phases formed in the crystal lattice.  
Chapter 4 Results and discussion 
 
128
The next section will give a discussion on nucleation points and how they affect the design of 
enantioselective crystallization processes. 
 
4.4 Nucleation points (MSZW and Induction time) 
 
Nucleation point experiments are needed in designing enantioselective crystallization 
processes. There were two main types of experiments applied to evaluate the nucleation 
points namely, the metastable zone width with regard to primary nucleation and induction 
times.  
 
4.4.1 Mandelic acid and N-methylephedrine in “classical” chiral solvents  
 
The solubility results obtained for of mandelic acid and N-methylephedrine in different chiral 
solvents were employed for the MSZW experiments.  
4.4.1.1 Mandelic acid in “classical” chiral solvents 
 
Figures 76 and 77 depict the metastable zone width with respect to primary nucleation for 
mandelic acid in (2R, 3R)-diethyl tartrate at 55 °C and 60 °C, respectively. The obtained data 
for all studied temperatures are summarized in Table 27. It can be seen that the metastable 
zone is most extended for racemic mandelic acid (racemic-MA), followed by (S)-mandelic 
acid ((S)-MA) and (R)-mandelic acid ((R)-MA), respectively. The maximum possible 
subcooling ∆Tmax and the maximum possible nucleation-free supersaturation ∆Cmax of 
racemic-MA in (2R,3R)-diethyl tartrate are rather remarkable and increase significantly when 
the temperature is increased. In the case of the pure enantiomers there was no clear trend 
found.  
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Figure 76: Experimentally determined metastable zone 
width with respect to primary nucleation for mandelic 
acid in (2R,3R)-diethyl tartrate at Tsat = 55 °C. 
Figure 77: Experimentally determined metastable 
zone width with respect to primary nucleation for 
mandelic acid in (2R,3R)-diethyl tartrate at Tsat = 60 
°C. 
 
Table 27: Metastable Zone Width Data for the Mandelic acid / (2R, 3R)-diethyl tartrate System. 
Tsat (K) 
(S)-MA 
∆Tmax (K)   ∆Cmax (wt %)     
         (R)-MA 
∆Tmax (K)  ∆Cmax (wt %)    
Racemic-MA 
∆Tmax (K)    ∆Cmax(wt %)   
323.15 8.9                             3.67 8.2                         3.08 14.3                        8.44 
328.15 7.7                             3.05 6.4                         2.65 15.9                        9.16 
333.15 9.2                             3.57 8.1                         3.31 19.5                       13.46 
 
Since the MSZW of (R)-MA is smaller compared to that of (S)-MA and in particular to that of 
racemic-MA, preferential nucleation of (R)-MA, and thus kinetically controlled selective 
production of the (R)-MA enantiomer might be feasible from this solvent. 
Figure 78 depicts the metastable zone width (primary nucleation) for mandelic acid in (S)-
ethyl lactate at Tsat = 15 °C. It can be clearly seen that the MSZW increases with increasing 
cooling rate. Racemic-MA nucleates before (S)-MA. For (R)-MA it is obvious that there 
exists a specific kinetic inhibition for crystallization from (S)-ethyl lactate. No nucleation was 
observed, independent on the cooling rate used. Due to the experimental limitation in 
subcooling temperature coupled with a high viscosity of the (S)-ethyl lactate measurements 
could not be carried out below -15 °C.  
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Figure 78: Experimentally determined metastable zone width with respect to primary nucleation for mandelic 
acid in (S)-ethyl lactate at Tsat = 15 °C. ((R)-MA: no nucleation in the range of measurement). 
 
According to Lorenz et al.47 metastable zone width measurements for mandelic acid in water 
illustrated that the ∆Tmax values, both with regard to primary and secondary nucleation, 
respectively were larger for racemic-MA than for the pure enantiomers. Here the opposite 
case is observed: racemic-MA nucleates first. This should be due to the effect of the chiral 
solvent. Thus, preferential nucleation of pure enantiomers is not possible for this system. 
However, considering the fact that (R)-MA never nucleates, initiating preferential 
crystallization of (S)-MA by adding seeds of (S)-MA might be an option to selectively 
produce pure (S)-MA from (S)-ethyl lactate. 
Complementary molecular modeling studies were performed again to get deeper 
understanding of the solvent-solute interactions in the system. A detail explanation how this 
molecular modeling was conducted was already given in the above section. The same 
procedure was applied here. The optimized structures of the dimers which were used in the 
calculations are shown below. Figure 79 illustrates a schematic representation of optimized 
molecular structures of the dimer of (a) (S)-mandelic acid and (S)-ethyl lactate and (b) (R)-
mandelic acid and (S)-ethyl lactate, respectively. 
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Figure 79: Schematic representation of optimized molecular structure of the dimer of (a) (S)-mandelic acid and 
(S)-ethyl lactate and (b) (R)-mandelic acid and (S)-ethyl lactate, respectively, and showing connected by 
hydrogen bonds. 
 
The other pair of the schematic representation of the optimized molecular structures of the 
dimer of (a) (S)-mandelic acid and (2R,3R)-diethyl tartrate and (b) (R)-mandelic acid and 
(2R,3R)-diethyl tartrate, respectively is represented in Figure 80. 
 
 
Figure 80: Schematic representation of optimized molecular structures of the dimer of (a) (S)-mandelic acid and 
(2R,3R)-diethyl tartrate and (b) (R)-mandelic acid and (2R,3R)-diethyl tartrate, respectively, and showing 
connected by hydrogen bonds. 
 
The results derived from the molecular modeling calculations are compiled in Table 28. They 
also explain the inhibition effects observed during the MSZW measurements. It can be seen 
that, the stabilization enthalpies ionStabilizatformHΔ  for (R)-mandelic acid in (S)-ethyl lactate and (S)-
MA in (2R,3R)-diethyl tartrate are with -5.96 kcal/mol and -4.39 kcal/mol respectively, more 
negative than for the counter-enantiomers (-4.29 kcal/mol and -0.63 kcal/mol, respectively). 
From a thermodynamic point of view the dimer with the most negative ionStabilizatformHΔ  is the 
most thermodynamically stable dimer and would remain in solution. The contrary would be 
the case for the dimer with the less negative ionStabilizatformHΔ , i.e. thermodynamically less stable 
would crystallize easily from solution first. The results of these calculations explain the 
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results obtained in the MSZW experiments, where (S)-mandelic acid in (S)-ethyl lactate and 
(R)-mandelic acid in (2R,3R)-diethyl tartrate crystallized first. 
 
Table 28: Summary of results of ∆Hform of individual molecules and dimers of (S)- and (R)-MA in (S)-ethyl 
lactate and (2R, 3R)-diethyl tartrate. 
Single molecule energies Dimer energies 
Single 
molecules 
SolventSolute
formH
/Δ
 
 
 (kcal/mol) 
Dimer types 
Dimer
formHΔ  
 
(kcal/mol) 
Stabilization enthalpy 
 
ionStabilizat
formHΔ  
 
[ DimerformHΔ -
( SoluteformHΔ + SolventformHΔ )] 
 
(kcal/mol) 
(S)-MA -117.56    
(S)-EL -152.00 (S)-MA-(S)-EL -273.85 -4.29 
(R)-MA -117.56                  
(S)-EL -152.00 (R)-MA-(S)-EL -275.52 -5.96 
(S)-MA -117.56                  
(2R,3R)-
DT -282.46 (S)-MA-(2R,3R)-DT -404.41 -4.39 
(R)-MA -117.56                 
(2R,3R)-
DT -282.46 (R)-MA-(2R,3R)-DT -400.65 -0.63 
MA, mandelic acid; EL, ethyl lactate; DT, diethyl tartrate. 
 
Investigation of different chain lengths of the lactates 
 
Investigations were also carried out to verify how the chain lengths of the lactates, (S)-methyl 
lactate, (S)-ethyl lactate, (S)-propyl lactate and (S)-butyl lactate affects the MSZW 
measurements. Unfortunately, there were no definite trends observed. Thus, the results are not 
discussed here but are included in Appendix D.  
 
4.4.1.2 N-methylephedrine in “classical” chiral solvents 
 
Figure 81 depicts the results of the MSZW measurements (primary nucleation) for N-
methylephedrine in (S)-ethyl lactate. Contrary to the mandelic acid/(S)-ethyl lactate system, 
for N-methylephedrine both enantiomers crystallized at higher subcooling compared to the 
racemate. Thus, the use of preferential nucleation as a resolution method is not expected to be 
feasible for NME. However, preferential crystallization might be a possible resolution method 
to be employed here.  
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 Figure 81: Experimentally determined metastable zone width (primary nucleation) for N-methylephedrine 
(NME) in (S)-ethyl lactate at Tsat = 15°C. 
 
Also, in the case of N-methylephedrine in (2R,3R)-diethyl tartrate MSZW measurements were 
not possible, due to the high viscosity of the solvent. Therefore, induction time experiments 
were carried out instead. Primary nucleation experiments were performed for racemic-N-
methylephedrine, (1S,2R)-(+)-N-methylephedrine and (1R,2S)-(-)-N-methylephedrine in (2R, 
3R)-diethyl tartrate at 35 °C. There was a pronounced delay of the appearance of first crystals 
for racemic-N-methylephedrine observed. The induction time tind was determined to be 
around 500 seconds, which was longer time compared to (1S,2R)-(+)-N-methylephedrine with 
364 seconds and (1R,2S)-(-)-N-methylephedrine with 240 seconds, respectively. This 
nucleation delay behavior of the racemic-N-methylephedrine was expected based on the αmol 
values determined to be ~1.5 to 1.7 (see section 4.3.1.2) for this system. Wang et al35 reported 
that classical nucleation theory can explain this observed phenomenon. According to this 
theory, the induction time (tind) of the racemic mixture will depend on the concentrations of 
the two enantiomers. The solubility of the racemate is larger than that of the enantiomer, but 
the αmol is smaller than 2. In this situation, though more molecules are in solution, the (1S,2R)-
(+)-N-methylephedrine-molecules and the (1R,2S)-(-)-N-methylephedrine-molecules are 
required to arrange in equal quantities to form racemic-N-methylephedrine. Consequently, the 
effective concentration to form nuclei is in reality only half the total concentration. If αmol < 2, 
implies the effective enantiomer concentration ((+)-NME:(-)-NME = 0.5:0.5) is smaller than 
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that of the pure enantiomer. Hence, the tind of the racemate should be longer than that of the 
pure enantiomer. According to the results obtained from the nucleation experiment, the 
determine induction time (tind) of the (+)-NME with the less time might selectively crystallize 
out first (preferential nucleation/crystallization) after cooling a racemic mixture of N-
methylephedrine in (2R,3R)-diethyl tartrate solution. This is considered as a possible 
resolution method.  
 
4.4.2 N-methylephedrine and chiral ionic liquid  
 
In this system it was really impossible to perform metastable zone width with regard to 
primary nucleation because only a limited amount of solvent was available. This was due to 
the fact that the chiral ionic liquid, (S)-2-(methoxycarbonyl) pyrrolidinium bis 
(trifluoromethylsulfonyl) amide is very expensive. In this case the appropriate experiment for 
the determination of the nucleation point was the induction time experiments which require a 
smaller amount. 
In primary nucleation tests carried out for racemic-N-methylephedrine, (1S,2R)-(+)-N-
methylephedrine and (1R,2S)-(-)-N-methylephedrine in [(S)-2-Pro-Me] [NTF2] / methanol 
70/30 v/v at 35 °C it was observed that there was a pronounced delay of the appearance of 
first crystals for racemic-N-methylephedrine, i.e. the induction time tind was determined to be 
437 seconds, which was long time compared to (1R,2S)-(-)-N-methylephedrine with 314 
seconds and (1S,2R)-(+)-N-methylephedrine with 124 seconds, respectively. The solubility 
ratio (αmol) has been determined to be ~1.3 (see section 4.3.2.1). This nucleation delay 
behavior of the racemic-N-methylephedrine was expected based on this αmol values. Thus, the 
same trend of induction time was found, as discussed in the above section. Therefore the 
racemic mixture of the N-methylephedrine would have wider MSZW compared to the single 
enantiomers. According to the results obtained from the nucleation experiment, the determine 
induction time (tind) of the (+)-NME might selectively crystallize out first (preferential 
nucleation/crystallization) after cooling and without/with seeding a racemic mixture of N-
methylephedrine in [(S)-2-Pro-Me][NTF2] / MeOH 70/30 v/v solution with (+)-NME crystals. 
This was considered as a possible resolution method.  
In the case of the other system, N-methylephedrine/(1R,2S)-(-)-Dimethylephedrinium bis 
(trifluoromethylsulfonyl) amide it was not feasible to determine the nucleation points since 
the solvent is extremely viscous (481.6 mPa.s at 23.10 °C) and difficult to stir at lower 
temperatures. 
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4.4.3 Mandelic acid in “tailor-made” chiral solvent  
 
Figures 82 depicts the metastable zone width with respect to primary nucleation for mandelic 
acid in (S)-propyl mandelate at 50 °C. It can be clearly seen that the MSZW increases with 
increasing cooling rate. (S)-MA nucleates before (S)-MA. For (Racemic)-MA it became 
evident that there exists a particular kinetic inhibition for crystallization from (S)-propyl 
mandelate. Hence no nucleation was observed independent of the cooling rate used. The same 
type of effect was noticed in the case of mandelic acid/(S)-ethyl lactate system, but in contrast 
here one of the enantiomers did not nucleates.There was an experimental limitation to 
subcooled the solution below 20.5 °C since the solvent will freeze at this temperature. 
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Figure 82: Experimentally determined metastable zone width with respect to primary nucleation for mandelic 
acid in (S)-propyl mandelate at Tsat = 50 °C. ((Racemic)-MA: no nucleation in the range of measurement). 
 
It can be seen that the metastable zone is most extended for racemic mandelic acid 
((Racemic)-MA), followed by (R)-mandelic acid ((R)-MA) and (S)-mandelic acid ((S)-MA), 
respectively. Moreover, at higher the cooling rate gives better gap between the MSZW of the 
(S)-MA and the (R)-MA. Since the MSZW of (S)-MA is smaller compared to that of (R)-MA 
and in particular to that of racemic-MA, preferential nucleation of (S)-MA, and thus selective 
production of the (S)-MA enantiomer might be feasible from this tailor-made chiral solvent.  
The molecular modeling results summarized in Table 25 also support the MSZW 
measurements results. The Stabilization enthalpies ( ionStabilizatformHΔ ) for (R)-MA in (S)-propyl 
mandelate and (S)-MA in (S)-propyl mandelate are with -5.96 kcal/mol and -2.78kcal/mol 
respectively. The more negative ionStabilizatformHΔ  indicates the thermodynamically more stable 
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dimer which would stay in solution, whilst the less negative case indicates the 
thermodynamically less stable dimer which would crystallize first. In the course of a 
resolution process the yield of the less soluble enantiomer ((S)-MA) can be increased by 
exploiting the wide MSZW of the more soluble counter enantiomer ((R)-MA). The 
crystallization of the counter-enantiomer can be prevented exclusively by the differences in 
the solubilities of the two enantiomers.44 It could be possible to drive the crystallization 
further, by creating conditions where the more soluble enantiomer is supersaturated but still in 
the metastable zone, so that it does not crystallize. In the case of the other tailor-made chiral 
solvent used ((S)-isopropyl mandelate), it was impossible to carry out the metastable zone 
width measurements due to the high viscosity (solid at room temperature) of the solvent.  
The following section will discuss the enthalpy of dissolution results in relation to the 
observed kinetic effects in the MSZW measurements. 
 
4.5 Enthalpy of dissolution 
 
Generally, dissolution processes involve two different steps. First, there is the breakage of the 
crystal lattice which is connected to the fusion enthalpy (∆Hfus). As a result the solvent gets in 
contact with the solute molecules (solvent-solute-interaction). This interaction leads to a 
particular solvation (second step), which is connected with a certain solvation enthalpy 
(ΔHsolv). From both enthalpies of fusion and dissolution, which are measurable, it is possible 
to derive the enthalpy of solvation for nonideal systems from the following relation:148 
 
fusdisssolv HHH Δ−Δ=Δ                                                                      Equation 37 
 
The solvation enthalpy is a relevant thermodynamic measure for the degree of interaction of 
the solvent and the solute molecules. It has an importance in describing many aspects of 
crystallization such as growth and nucleation kinetics. The extent of solvent-solute interaction 
has impact on the solid-liquid interfacial energy, which is a significant physical property 
influencing nucleation and growth of crystals.148-151  
Based on the experimentally determined dissolution enthalpies for the MA enantiomers in 
(S)-ethyl lactate and (2R, 3R)-diethyl tartrate and the enthalpies of fusion of (S)-/(R)-MA 
(taken from previous work100), the subsequent solvation enthalpies (∆Hsolv) were derived from 
Equation 37. The results are summarized in Table 29.  
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Table 29: Mean enthalpies of dissolution (∆Hdiss), and solvation enthalpy (∆Hsolv) of mandelic acid in (S)-ethyl 
lactate and (2R,3R)-diethyl tartrate. (T = 298.15 K, nMA /nchiral solvent = 1: 50, in kJ/mol) 
MA species (S)-ethyl lactate 
 
  ∆Hdiss                                   ∆Hsolv 
(2R, 3R)-diethyl tartrate 
 
∆Hdiss                                ∆Hsolv 
(S)-MA  +7.81 ± 0.35                         -16.7 +4.27 ± 0.28                         -20.2 
(R)-MA  +6.41 ± 0.31                         -18.1 +7.35 ± 0.26                         -17.2 
( fusHΔ (S)-/(R)-MA = +24.5 kJ/mol)100 
 
As can be seen, the solvation enthalpies for (R)-MA in (S)-ethyl lactate and (S)-MA in 
(2R,3R)-diethyl tartrate are with -18.1 kJ/mol and -20.2 kJ/mol respectively, more negative 
than for the counter-enantiomers (-16.7 kJ/mol and -17.2 kJ/mol, respectively). Large 
negative enthalpies of solvation (i.e. higher absolute solvation enthalpy value) indicate strong 
solvent-solute interactions. Generally, stronger solvent-solute interactions mean that the solute 
is surrounded by a solvation shell in the liquid phase. So, for the nucleation process to take 
place the shell needs to be removed. The higher the absolute enthalpy value, the more energy 
is required152, which supports the hindrance of the nucleation process. Since for a nucleation 
process to take place there should be the addition of the solute molecule, which acts as a 
nuclei or surface for the subsequent solute deposition. Afterwards, the aggregated solute 
molecule is changed from the liquid to the solid phase. The whole process would be hindered 
if the solute and solvent in solution forms a strong solvated dimer. Hence, the enantiomer with 
the more absolute solvation enthalpy value is the one that would create a solute-solvent dimer, 
which is strongly solvated and would stay in solution, whilst its counter-enantiomer with the 
less absolute solvation enthalpy would crystallize out first. This explains the results obtained 
in the MSZW (see Figures 76 and 78) and resolution experiments (see Figures 83 and 85), 
where (R)-mandelic acid in (2R,3R)-diethyl tartrate and (S)-mandelic acid in (S)-ethyl lactate 
crystallized first. For this reason, the dissolution enthalpy of N-methylephedrine in (2R,3R)-
diethyl tartrate was measured to understand the reason why resolution was feasible. 
According to the experimentally determined dissolution enthalpies for the NME enantiomers 
in (2R,3R)-diethyl tartrate and the enthalpy of fusion of (+)-/(-)-NME (taken from 
literature102), solvation enthalpies (∆Hsolv) were derived from Equation 37, as described 
above. The obtained results are summarized in Table 30.  
 
Chapter 4 Results and discussion 
 
138
Table 30 Mean enthalpies of dissolution (∆Hdiss), and solvation enthalpy (∆Hsolv) of N-methylephedrine in 
(2R,3R)-diethyl tartrate. (T = 298.15 K, nNME /nchiral solvent = 1: 50, in kJ/mol) 
NME species 
 
∆Hdiss 
 
∆Hsolv 
(1S,2R)-(+)-NME +1.208 -29.3 
(1R,2S)-(-)-NME +2.162 -28.4 
( fusHΔ (+)-/(-)-NME = +30.531 kJ/mol)102  
 
It can be seen in Table 30 that the solvation enthalpies for (1S,2R)-(+)-NME in (2R,3R)-
diethyl tartrate is with -29.3 kJ/mol more negative than for the counter-enantiomers (-28.4 
kJ/mol, respectively). Hence, (1S,2R)-(+)-NME stays in solution whilst (1R,2S)-(-)-NME 
would crystallize first. The dissolution enthalpy determination which allowed estimating 
solvation enthalpies gave an understanding of the observed kinetic effects regarding the 
induction time and the results of resolution experiments (see Figure 86).  
The following section will discuss the results of the feasible enantioselective crystallization 
experiments which were performed. 
 
4.6 Application of chiral solvents for crystallization-based racemate 
resolution 
 
Enantioselective crystallization is the implementation of cooling crystallization in such a way 
that the pure enantiomer can be separated from its respective racemates. The following 
sections describe how different enantioselective crystallization techniques have been 
exploited to obtain for selected systems pure enantiomers. 
In this thesis investigations have been done to verify the potential of chiral solvents for 
racemate resolution. With respect to kinetics a chiral solvent can modify the rate of growth of 
enantiomeric crystals. More precisely, can influence the nucleation/crystal growth rates of the 
chiral substrates in different ways, depending on the nature, stereospecificity and the 
effectiveness of solvent-substrate interaction.5 Hence, this section will deal with how the 
interactions identified for the chiral solvents were used to perform separation. 
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4.6.1 Preferential nucleation of mandelic acid in (2R, 3R)-diethyl tartrate 
 
On the basis of the measured solubility and metastable zone width data first resolution 
experiments of racemic-mandelic acid in (2R, 3R)-diethyl tartrate were designed and 
conducted. The width of the metastable zone determined at 55 °C is favorable for preferential 
nucleation. This is due to the fact that the difference between ∆Tmax values for (S)-mandelic 
acid and (R)-mandelic acid is wider compared to the other temperatures (Table 27). 
Figure 83 depicts a typical result of a preferential nucleation experiment for racemic-mandelic 
acid in (2R, 3R)-diethyl tartrate at 55 °C. To observe the course of the crystallization process 
the profiles of the optical rotation and the solution density are presented. 
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Figure 83: Polarimeter and densitymeter signal for a preferential nucleation experiment starting with racemic-
MA in (2R, 3R)-diethyl tartrate at Tsat = 55 °C, (Optical rotation in black color and density in gray color). 
 
Before nucleation occurred, both the polarimeter and the densitymeter signals remained 
roughly constant at 10.849° and 1.1881 g/cm3, respectively, characterizing the optical rotation 
of the starting solution of racemic-mandelic acid in (2R,3R)-diethyl tartrate (wsat = 31.66 wt 
%). As nucleation started the trajectory of the polarimeter signal increased continuously for ~ 
45 min and remained constant later on. Consistently, the densitymeter signal decreased 
continuously until it became contant. Since the filter in the sampling line got blocked with 
very fine crystals the process was stopped after 90 min. The results show that (S)-mandelic 
acid enriches in the liquid phase, which consequently implies that (R)-mandelic acid is 
crystallizing selectively. This course is in agreement with the MSZW measurements. From 
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the densitymeter and polarimeter signals, the enantiomeric excess reached in the liquid phase 
was evaluated to be around 55% (S)-mandelic acid. In the experiments carried out about 0.98 
g of (R)-mandelic acid crystallized. 
In order to directly compare the results to the situation with water as the solvent, in Figure 84 
a similar experiment for racemic-MA in water carried out at 33 °C is shown. The experiments 
were conducted at the same initial concentration as used for the chiral solvent (wsat = 32 wt %) 
before. 
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Figure 84: Polarimeter and densitymeter signal for a preferential nucleation experiment starting with racemic-
MA in water at Tsat = 33 °C, (Optical rotation in black color and density in gray color). 
 
As can be seen, before nucleation the optical rotation and densitymeter signals were at 0.067° 
and 1.065 g/cm3, respectively characterizing the starting (racemic) solution. The slight 
deviation of the optical rotation signal from the zero line is due to a slight initial enrichment in 
the racemic-MA used. Nucleation is indicated by a sharp decrease in the solution density to 
about 1.052 g/cm3. However, the optical rotation remained unchanged, measuring that just 
racemic-MA has crystallized and, thus, no enantioselective crystallization occurred.  
Mughal et al.48 conducted similar work on primary nucleation in the mandelic acid/water 
system by starting with eutectic composition of the mandelic acid enantiomers in water ((S)-
enantiomer in excess) using an additive. The authors could demonstrate an enantiomeric 
enrichment of the (S)-MA in the crystallized material for a certain period of time. This is 
expected since the MSZW of the mandelic acid enantiomers in water is explicitly lower than 
that of the racemic compound in the temperature range studied.47 However, this 
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enantioselective crystallization process needs to start with a solution containing the 
enantiomers (more or less) in eutectic composition. In our work the racemate was directly 
resolved using a chiral solvent. 
4.6.2 Preferential crystallization of mandelic acid in (S)-ethyl lactate 
 
According to the results obtained from the metastable zone width measurements for primary 
nucleation (see Figure 78), (S)-mandelic acid should selectively crystallize out after seeding a 
racemic-mandelic acid in (S)-ethyl lactate solution with (S)-mandelic acid crystals. This was 
considered as the starting point for possible resolution method. 
Figure 85 illustrates the result of such a seeded experiment presented as course of the 
enantiomeric excess of (R)-mandelic acid in the mother liquor as a function of time after the 
onset of crystallization.  
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Figure 85: Course of preferential crystallization of (S)-mandelic acid over a certain period of time from (S)-
ethyl lactate as solvent. 
 
The sudden jump of the enantiomeric excess to almost 5% ee of (R)-mandelic acid in the 
solution indicates a rapid crystallization of (S)-mandelic acid after seeding. For further 40 min 
the enantiomeric excess of (R)-mandelic acid in the liquid phase remained at that value. 
Afterward, the enantiomeric excess decreased since (R)-mandelic acid also started to 
crystallize out. The solution composition then tended towards the racemic composition (i.e. to 
ee = 0).  
Moreover, Hüttenhain and Dickenhof81 conducted an investigation on asymmetric induction 
by using same chiral solvents ((S)-ethyl lactate) to realize enantioselectivity. The main aim of 
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their work was to convert acetophenone to phenyl ethanol. Thus, acetophenone was 
successfully converted to 33% ee of (R)-phenyl ethanol in the liquid phase with the aid of the 
chiral solvent (S)-ethyl lactate at 0 °C. The authors could demonstrate an enantiomeric excess 
of (R)-phenyl ethanol (i.e. the (R)-form) which is similar to our work where also (R)-mandelic 
acid was enantiomerically in excess in liquid phase. In both investigations (S)-ethyl lactate 
was applied as solvent. 
 
4.6.3 Preferential nucleation of N-methylephedrine in (2R, 3R)-diethyl tartrate 
 
Based on the induction time results this system was a very obvious candidate for a preferential 
nucleation experiments to might be feasible here. As already discussed in detailed in the 
above section in this chapter, there was a clear observation about a distinct delay of the 
appearance of first crystals for racemic-N-methylephedrine the induction time tind was 
determined to be 500 seconds, which was longer time compared with the (1R,2S)-(-)-N-
methylephedrine with 364 seconds and (1S,2R)-(+)-N-methylephedrine with 200 seconds, 
respectively.  
In Figure 86 the enantiomeric excess is presented as function of time for a preferential 
nucleation experiment of (1R,2S)-(-)-N-methylephedrine in (2R,3R)-diethyl tartrate at 35 °C.  
 
 
Figure 86: Enantiomeric excess of (1S,2R)-(+)-N-methylephedrine in the liquid phase over a certain period of 
time. Preferential nucleation experiment of (1R,2S)-(-)-N-methylephedrine in (2R,3R)-diethyl tartrate at 35 °C. 
Dotted vertical line represents sampling point.  
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It illustrates the course of the enantiomeric excess of (1S,2R)-(+)-N-methylephedrine in the 
mother liquor as function of time, after onset of nucleation. The sudden jump of the 
enantiomeric excess to almost 6% ee of (1S,2R)-(+)-N-methylephedrine in the solution for 
some time period indicates a rapid crystallization of (1R,2S)-(-)-N-methylephedrine after 
nucleation. The dashed line designates the onset of nucleation point. Afterward, the counter-
enantiomer (1S,2R)-(+)-N-methylephedrine started crystallizing, and resulted in enantiomeric 
excess of (1R,2S)-(-)-N-methylephedrine in the liquid phase. Eventually, the enantiomeric 
excess decreased since the (1S,2R)-(+)-N-methylephedrine also started to crystallize out. 
The solution composition then tended in the direction of the racemic composition (ee = 0). 
After the composition reached 0 % ee (racemic mixture), further crystallization of (1S,2R)-
(+)-N-methylephedrine gave rise to (1R,2S)-(-)-N-methylephedrine in the liquid phase to a 
maximum point. At this maximum point (1R,2S)-(-)-N-methylephedrine crystallizes again 
increasing the trajectory and finally, became equal in amount of enantiomeric excess of both 
enantiomers. The resolution of N-methylephedrine is cumbersome based on the fact that there 
is oscillatory behavior of the resolution trajectory, i.e. one phase crystallizes followed by the 
other phase. This makes the resolution difficult to understand. Further work conducted in our 
group devoted to characterize the solid phase of N-methylephedrine has shown that two 
polymorphic forms as proven by both XRPD and DSC. Therefore this behavior could be 
attributed to the fact that there are that modifications of N-methylephedrine and they could 
crystallize with different rates. 
 
4.6.4 Preliminary preferential crystallization of mandelic acid in (S)-propyl mandelate 
 
On the basis of the differences in the solubility and metastable zone width of the enantiomers 
observed, initial resolution experiments of mandelic acid in (S)-propyl mandelate were 
planned and performed. Based on the measurement data from the HPLC analysis for the 
harvested crystals after crystallization the enantiomeric excess (ee) was derived. The product 
purity was appreciable with a value of 97.2% ee of (S)-MA. A product purity of 100% was 
not expected since the purity of the seeds was just 99%. The objective of this experiment is to 
get a first hand knowledge about which phase could crystallize out. The harvested crystals 
were examined with XRPD and no additional or new phases were formed in the crystal 
lattice. Also the reflexes identified mimicked the typical enantiomers reflex which implies 
that the product crystals are 100% ee of enantiomer. The results are in agreement with the 
solubility and the MSZW measurements. 
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4.7 Summary 
 
In this chapter the results obtained in the experimental study were comprehensively discussed. 
First, the binary phase diagrams of the selected model systems mandelic acid and N-
methylephedrine from literature data were introduced. Afterward, different forms of racemic 
mandelic acid (Form I and Form II) were discussed subsequently. Later the fundamental 
experiments, solid liquid equilibria and nucleation points measurements required for 
enantioselective crystallization.  
In this section also the use of molecular modeling calculations applied to support the derived 
results was presented. Furthermore, Raman spectra results were described the solvent-solute 
interaction in the liquid phase were correlated to solid liquid equilibria. Also, the outcome of 
the FTIR spectroscopy measurements was discussed in the Appendix A. Then enthalpy of 
dissolution measurements to characterize the solvent-solute interaction has been discussed. 
Finally, successful resolution experiments designed based on the derived fundamental 
experiments results are discussed.  
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5.1 Summary and Conclusions 
 
In this PhD thesis, the primary goal was to effect enantioselective crystallization with the aid 
of chiral solvents by using mandelic acid and N-methylephedrine as model compounds. Three 
different types of chiral solvents were studied: (a) “classical” chiral solvents, (b) chiral ionic 
liquids and (c) tailor-made chiral solvents. In this work, initial investigations were carried out 
to identify appropriate “classical” chiral solvents for the discrimination of enantiomers with 
the aid of nuclear magnetic resonance (NMR) spectroscopy.153 The screening of the 
“classical” chiral solvent was specifically performed with mandelic acid, since this 
component belongs to the class of compound forming systems which are difficult to be 
resolved. 
1H NMR screening measurements and the corresponding Raman spectra showed that the 
twelve “classical" chiral solvents that were evaluate had no measurable influence on the chiral 
system studied. It was found that these solvents had small or no interactions which was not 
sufficient enough to be exploited for thermodynamically based discrimination of two 
enantiomers. The ternary solubility phase diagrams for the “classical” chiral solvents and the 
chosen model systems determined at different temperatures were also found to be 
symmetrical. In the case of N-methylephedrine in the chiral ionic liquid, (1R,2S)-(-)-
dimethylephedrinium bis (trifluoromethylsulfonyl) amide there was asymmetry found in the 
ternary solubility phase diagram. This result shows that there was for this system a 
stereospecific interaction between the solute and the solvent molecules, resulting in the 
differentiation of the enantiomers. Furthermore, in the case of mandelic acid and the tailor-
made chiral solvents (S)-propyl mandelate and (S)-isopropyl mandelate systems, there was 
also an asymmetry in the phase diagram, indicating strong selective interactions between the 
solute-solvent molecules. This important observation made in this thesis work was supported 
also by the results of molecular modeling calculations carried out in parallel. These results are 
a clear indication that, whilst the “classical” chiral solvents studied in this work had less or no 
influence on solution thermodynamics of the chiral systems mandelic acid and N-
methylephedrine, the chiral ionic liquid (1R,2S)-(-)-Dimethylephedrinium bis 
(trifluoromethylsulfonyl) amide and the two tailor-made chiral solvents (S)-propyl mandelate 
and (S)-isopropyl mandelate had a strong selective chiral influence on solution 
thermodynamics. These results confirm various experimental works on chiral solvents 
reported in the literature regarding differences in interactions with single enantiomers.6-8 It 
was rather unfortunate that for the systems mandelic acid and the tailor-made chiral solvents 
which showed a significant asymmetry, it was not possible to quantify the eutectic point, as 
there was no suitable HPLC method available to analyzed the enantiomeric compositions. The 
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ratio of the enantiomers at the symmetric eutectic compositions remained unchanged with 
temperature at 0.69 and 0.31 in both solvents as it was also reported for non-chiral solvents.100 
Only two systems in this thesis showed measurable effect on solution thermodynamics, i.e. 
the two single enantiomers exhibited differences in their solubilities leading to asymmetric 
solubility phase diagrams, but most of the chiral solvent showed no effect. The literature 
survey revealed a couple of successful chiral resolutions by employing kinetic effects for 
enantioselective crystallization with the help of chiral solvents.46,74,75 However, all the studies 
apply only to conglomerate systems. In the present work during first nucleation measurements 
certain observations indicated that selective effects on the rate of nucleation and/or growth of 
one of the enantiomers by the chiral solvent occur also for compound forming systems. Thus, 
might be exploited for kinetic resolution of racemic compounds. Therefore detailed nucleation 
point experiments were performed in order to realize enantioselective crystallization of 
compound forming systems from chiral solvents.  
The resolution of racemic-mandelic acid as a typical compound forming system, which cannot 
be resolved by convectional crystallization methods without any chiral selector alone, is 
presented. Lorenz et al.47 and Mughal et al.48 illustrated the possibility of enantioselective 
crystallization in this system starting with a solution having (almost) eutectic composition of 
the racemic compound and one of the pure enantiomers. In this work chiral solvents have 
been used in order to facilitate selective nucleation/crystallization directly from the racemic 
solution.154 
Though most of the chiral solvents did not show any measurable chiral recognition in terms of 
solution thermodynamics, regarding kinetics pronounced selective inhibition effects were 
observed as indicated by differences in MSZW and induction times. The data determined for 
metastable zone width with regard to primary nucleation illustrated that in (S)-ethyl lactate as 
chiral solvent nucleation of the (R)-mandelic acid is significantly inhibited compared to 
racemic-mandelic acid and the (S)-enantiomer. Although resolution of racemic-MA was not 
feasible by preferential nucleation, so adding (S)-mandelic acid seeds, i.e. preferential 
crystallization allowed for selective crystallization of (S)-MA for a certain time period. In the 
case of the (2R,3R)-diethyl tartrate system, the MSZW for the racemic-MA was significantly 
higher compared to the single enantiomers. Moreover, the MSZW of (S)-MA exceeded that of 
(R)-MA enantiomer. Experiments performed on that basis clearly confirmed the feasibility of 
crystallizing selectively (R)-MA from a racemic mixture for a certain time period. 
Furthermore, a racemic-mixture of N-methylephedrine/(2R,3R)-diethyl tartrate was 
successfully resolved by applying a preferential nucleation method. According to the 
induction time experiments racemic mixtures of N-methylehpedrine required a long time to 
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crystallize (inhibited). There were also differences in the induction times of the single 
enantiomers ((1R,2S)-(-)-N-methylephedrine crystallizes first followed by its counter 
enantiomers).The only problem was the observation of the oscillatory behavior of the 
resolution trajectory because one phase crystallize at first followed by another phase. This 
makes the resolution difficult attributed to the fact that there are two modifications of N-
methylephedrine as identified during the modification tests using both XRPD and DSC.  
Usually, in the presence of a chiral selective additive the so called ،،rule of reversalۥۥ55,69 holds. 
This means that the additive is stereoselectively adsorbed at the surface of growing crystals of 
the enantiomer of the same absolute configuration, resulting in a strong reduction in the 
growth rate and, thus, allowing for preferential crystallization of the counter-enantiomer. 
Considering the results of this work and considering the solvent as a chiral selective additive 
obviously the ،،rule of reversalۥۥ is not obeyed. In our work it was found that in presence of (S)-
ethyl lactate, (R)-MA was inhibited and the (S)-MA could grow. Also in the case of (2R,3R)-
diethyl tartrate, (S)-MA was inhibited and promoted (R)-MA to grow. The determined 
solvation enthalpies of (S)-MA in (2R,3R)-diethyl tartrate, (R)-MA in (S)-ethyl lactate and 
(1S,2R)-NME in (2R,3R)-diethyl tartrate, respectively were more negative than (R)-MA in 
(2R,3R)-diethyl tartrate, (S)-MA in (S)-ethyl lactate and (1R,2S)-NME in (2R,3R)-diethyl 
tartrate, respectively, indicating stronger solvent-solute interactions than for the counter-
enantiomer. This explains the observed selective inhibition effects and the results of the 
resolution experiments in the systems. The determination of the solvation enthalpy and 
molecular modeling calculations could be used as a useful ،،screening toolۥۥ to estimate the 
degree of interaction between the solvent and the solute molecules and consequently to screen 
for appropriate chiral solvents. 
 
5.2 Recommendations for future work 
 
In the subsequent sections, some recommendations for future work are given for different 
fields of research. 
 
5.2.1 Solution thermodynamics 
 
The potential of chiral solvents for enantioselective crystallization has been studied. Further 
research can be carried out using molecular modeling studies to get a deeper understanding of 
the solvent-solute interactions in systems with chiral ionic liquids and tailor-made chiral 
solvents, since these two types of chiral solvents showed clear differences in the solubilities of 
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the single enantiomers. Molecular modeling calculations coupled with enthalpy of dissolution 
measurements should serve as a “screening tool” for the chiral solvents that could give better 
chiral recognitions. 
More focus should be directed towards developing HPLC method for the tailor-made chiral 
solvents to render it possible to analyze the enantiomeric compositions from liquid samples 
drawn from the solubility measurements. The availability of HPLC method would make it 
feasible to generate more reliable ternary solubility phase diagrams. This will give more 
precise eutectic points and solubility isotherms.  
 
5.2.2 Resolution experiments 
 
The induction time experiments were performed for the examples of N-methylephedrine and 
(S)-2-(methoxycarbonyl) pyrrolidinium bis (trifluoromethylsulfonyl) amide. The outcome of 
further experiments could be very lucrative. There, future work should be carried out to 
realize for example the resolution of the racemic mixture of N-methylephedrine using the 
described entrainment process.  
Solubility and metastable zone width of mandelic acid and the tailor-made chiral solvent (S)-
propyl mandelate were studied. Both the solution thermodynamics and kinetics showed chiral 
discrimination. The racemic mandelic acid did not crystallize in the range covered in the 
MSZW experiments. This makes it a good candidate for enantioselective crystallization 
(possibly selective crystallization). Future work should be directed towards the realization of 
optimized enantioselective crystallization. Further research should be focused also on other 
tailor-made chiral solvents with different chain length since they already showed chiral 
recognition in both thermodynamics and kinetic sense. 
 
5.2.3 Areas for future investigations 
 
Further investigation should be performed on chiral solvents by using liquid crystals and 
chiral ionic liquids for enantioselective crystallization since their structured nature might 
provide more exploitable chiral interactions. Also, future work should be directed towards 
characterizing and applying chiral solvents which can provide stronger stereospecific 
interactions. In principle a classical three-point attachment155,156 which is up to now not 
sufficiently investigated should be favourable for improved chiral differentiation. 
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A. Appendix A-FTIR measurements 
 
The various peaks observed in the FTIR spectra can be assigned to functional groups. The 
assignment of the hydroxyl groups is extremely complicated just from applying the bands in 
the FTIR spectra. Every form has two hydroxyl peaks which require to be assigned; one sharp 
band at about 3400 cm-1 and a broad peak around 2500 – 3000 cm-1. From literature106,157 the 
broad O–H stretching vibrations observed at ~2550 – 3050 cm-1 are characteristic of 
carboxylic acid hydroxyl groups, while more rigidly bound –OH groups tend to give sharper 
bands at higher frequency. 
 
 
Figure A.87: Overlay of (S)-MA in (S)-ML, (R)-MA in (S)-ML and (S)-ML FTIR spectra. 
 
 
Figure A.88: Overlay of (S)-MA in (S)-EL, (R)-MA in (S)-EL and (S)-EL FTIR spectra. 
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Figure A.89: Overlay of (S)-MA in (S)-PL, (R)-MA in (S)-PL and (S)-PL FTIR spectra. 
 
 
Figure A.90: Overlay of (S)-MA in (S)-BL, (R)-MA in (S)-BL and (S)-BL FTIR spectra. 
 
 
Figure A.91: Overlay of (S)-MA in (2R, 3R)-DT, (R)-MA in (2R, 3R)-DT and (2R, 3R)-DT FTIR spectra. 
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Figure A.92: Overlay of (+)-NME in (S)-ML, (-)-NME in (S)-ML and (S)-ML FTIR spectra. 
 
 
Figure A.93: Overlay of (+)-NME in (S)-EL, (-)-NME in (S)-EL and (S)-EL FTIR spectra. 
 
 
Figure A.94: Overlay of (+)-NME in (S)-PL, (-)-NME in (S)-PL and (S)-PL FTIR spectra. 
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Figure A.95: Overlay of (+)-NME in (S)-BL, (-)-NME in (S)-BL and (S)-BL FTIR spectra. 
 
 
Figure A.96: Overlay of (+)-NME in (2R, 3R)-DT, (-)-NME in (2R, 3R)-DT and (2R, 3R)-DT FTIR spectra. 
 
 
Figure A.97: Overlay of (+)-NME in Proline based CIL/Me0H 70/30 v/v, (-)-NME in Proline based CIL/Me0H 
70/30 v/v and Proline based CIL/Me0H 70/30 v/v FTIR spectra. 
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Figure A.98: Overlay of (S)-MA in (S)-PM, (R)-MA in (S)-PM and (S)-PM FTIR spectra. 
 
 
Figure A.99: Overlay of (S)-MA in water, (R)-MA in water and water FTIR spectra. 
 
 
Figure A.100: Overlay of (+)-NME in Eph CIL, (-)-NME in Eph CIL and Eph CIL FTIR spectra. 
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Figure A.101: Overlay of (S)-MA in Butyl lactate, (R)-MA in Butyl lactate and (S)-Butyl lactate FTIR spectra. 
 
 
Figure A.102: Water FTIR spectra. 
 
 
Figure A.103: Eph CIL FTIR spectra. 
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Figure A.104: Proline based CIL/Me0H 70/30 v/v FTIR spectra. 
 
 
Figure A.105: (S)-propyl mandelate FTIR spectra. 
 
 
Figure A.106: (S)-methyl lactate FTIR spectra. 
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Figure A.107: (S)-ethyl lactate FTIR spectra. 
 
 
Figure A.108: (S)-propyl lactate FTIR spectra. 
 
 
Figure A.109: (S)-butyl lactate FTIR spectra. 
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Figure A.110: (2R, 3R)-DT FTIR spectra. 
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B. Appendix B-Tables with a summary solubility data 
 
B1. Tables of solubility data of mandelic acid in the different “classical” chiral solvent 
 
Table B.31: Mass Fraction Solubility (wi) of (S)-Mandelic acid (1) and (R)-Mandelic acid (2) in (S)-Methyl 
Lactate at different Enantiomeric Excesses (ee) [ ])/( 2121 wwwwee +−=  and Temperatures. 
100 ee 100 (w1+w2) 100 w1 100 w2   100 wsolvent 
   t = 0 °C   
100.00 19.83 19.83 0.00 80.17 
38.00 27.90 19.25 8.65 72.10 
0.00 25.66 12.83 12.83 74.34 
38.00 27.97  8.67 19.30 72.03 
100.00 19.80 0.00 19.80 80.20 
   t = 5 °C   
100.00 22.37 22.37 0.00 77.63 
38.08 29.40 20.30 9.10 70.60 
0.00 27.08 13.54 13.54 72.92 
38.10 29.50 9.13 20.37 70.50 
100.00 22.15 0.00 22.15 77.85 
  t = 15 °C   
100.00 24.09 24.09 0.00 75.91 
38.48 31.03 21.49 9.54 68.97 
0.32 29.44 14.67 14.77 70.56 
38.10 30.66 9.58 21.08 69.34 
100.00 24.00 0.00 24.00 76.00 
  t = 25 °C   
100.00 27.57 27.57 0.00 72.43 
90.90 28.46 27.17 1.29 71.54 
78.42 29.79 26.58 3.21 70.21 
71.32 31.34 26.85 4.49 68.66 
51.78 33.93 25.75 8.18 66.07 
38.08 35.04 24.19 10.85 64.96 
28.60 33.93 21.82 12.11 66.07 
19.20 33.26 19.82 13.44 66.74 
0.00 32.89 16.44 16.44 67.11 
21.22 33.21 13.08 20.13 66.79 
27.80 33.79 12.20 21.59 66.21 
38.10 34.89 10.80 24.09 65.11 
49.30 33.80 8.57 25.23 66.20 
69.60 31.20 4.74 26.46 68.80 
77.80 30.10 3.34 26.76 69.90 
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Continuation of Table B.31 
89.50 27.90 1.46 26.44 72.10 
100.00 27.49 0.00 27.49 72.51 
  t = 35 °C   
100.00 29.45 29.45 0.00 70.55 
38.08 38.46 26.55 11.91 61.54 
0.00 35.80 17.90 17.90 64.20 
38.10 38.79 12.01 26.78 61.21 
100.00 29.15 0.00 29.15 70.85 
 
Table B.32: Mass Fraction Solubility (wi) of (S)-Mandelic acid (1) and (R)-Mandelic acid (2) in (S)-Propyl 
Lactate at different Enantiomeric Excesses (ee) [ ])/( 2121 wwwwee +−=  and Temperatures. 
100 ee 100 (w1+w2) 100 w1 100 w2   100 wsolvent 
  t = 5 °C   
100.00 16.10 16.10 0.00 83.90 
38.08 21.37 14.75 6.62 78.63 
0.00 20.17 10.08 10.08 79.83 
38.10 21.21 6.56 14.65 78.79 
100.00 15.70 0.00 15.70 84.30 
  t = 15 °C   
100.00 18.11 18.11 0.00 81.89 
38.32 24.00 16.60 7.40 76.00 
0.38 22.41 11.25 11.16 77.59 
38.30 23.68 7.31 16.37 76.32 
100.00 18.03 0.00 18.03 81.97 
  t = 25 °C   
100.00 20.15 20.15 0.00 79.85 
90.10 21.83 20.75 1.08 78.17 
79.70 23.12 20.77 2.35 76.88 
69.94 24.40 20.73 3.67 75.60 
49.74 26.87 20.12 6.75 73.13 
38.22 27.51 19.01 8.50 72.49 
30.40 26.79 17.47 9.32 73.21 
19.74 25.99 15.56 10.43 74.01 
0.00 25.51 12.76 12.76 74.49 
19.98 26.95 10.78 16.17 73.05 
38.20 27.35 8.45 18.90 72.65 
50.22 27.75 6.91 20.84 72.25 
69.94 24.24 3.64 20.60 75.76 
80.08 23.28 2.32 20.96 76.72 
89.90 22.15 1.12 21.03 77.85 
100.00 20.31 0.00 20.31 79.69 
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Continuation of Table B.32 
  t = 35 °C   
100.00 24.64 24.64 0.00 75.36 
38.08 32.72 22.59 10.13 67.28 
0.00 30.39 15.20 15.20 69.61 
38.10 33.36 10.32 23.04 66.64 
100.00 24.24 0.00 24.24 75.76 
 
Table B.33: Mass Fraction Solubility (wi) of (S)-Mandelic acid (1) and (R)-Mandelic acid (2) in (S)-Butyl 
Lactate at different Enantiomeric Excesses (ee) [ ])/( 2121 wwwwee +−=  and Temperatures. 
100 ee 100 (w1+w2) 100 w1 100 w2 100 wsolvent 
  t = 0 °C   
100.00 12.72 12.72 0.00 87.28 
38.00 17.28 11.92 5.36 82.72 
0.00 15.05 7.53 7.53 84.95 
38.00 17.45 5.41 12.04 82.55 
100.00 12.63 0.00 12.63 87.37 
  t = 5 °C   
100.00 13.23 13.23 0.00 86.77 
38.5 18.83 13.04 5.79 81.17 
0.24 16.94 8.45 8.49 83.04 
38.44 19.00 5.85 13.15 81.00 
100.00 13.23 0.00 13.23 86.77 
  t = 15 °C   
100.00 15.28 15.28 0.00 84.72 
38.28 21.00 14.52 6.48 79.00 
0.00 19.34 9.67 9.67 80.66 
38.36 21.23 6.54 14.69 78.77 
100.00 15.01 0.00 15.01 84.99 
  t = 25 °C   
100.00 16.90 16.90 0.00 83.10 
84.00 19.17 17.64 1.53 80.83 
74.48 20.43 17.82 2.61 79.57 
68.00 21.36 17.94 3.42 78.64 
48.00 23.39 17.31 6.08 76.61 
46.98 24.06 17.68 6.38 75.94 
45.90 23.89 17.43 6.46 76.11 
38.08 23.23 16.04 7.19 76.77 
24.92 24.47 15.28 9.19 75.53 
0.00 21.00 10.50 10.50 79.00 
38.10 23.00 7.12 15.88 77.00 
45.90 23.35 6.32 17.03 76.65 
46.98 23.33 6.18 17.15 76.67 
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Continuation of Table B.33 
48.34 22.71 5.87 16.84 77.29 
67.78 20.88 3.36 17.52 79.12 
74.48 19.79 2.53 17.26 80.21 
83.62 18.85 1.54 17.31 81.15 
100.00 16.64 0.00 16.64 83.36 
  t = 35 °C   
100.00 20.50 20.50 0.00 79.50 
38.58 27.36 18.96 8.40 72.64 
0.00 26.31 13.16 13.16 73.69 
38.46 27.28 8.39 18.89 72.72 
100.00 20.51 0.00 20.51 79.49 
  t = 45 °C   
100.00 22.29 22.29 0.00 77.71 
37.76 30.90 21.28 9.62 69.10 
0.00 28.44 14.22 14.22 71.56 
38.10 30.90 9.56 21.34 72.72 
100.00 22.29 0.00 22.29 77.71 
 
B2. Tables of solubility data of N-methylephedrine in the different “classical” chiral 
solvent 
 
Table B.34: Mass Fraction Solubility (wi) of (+)-N-methylephedrine (3) and (-)-N-methylephdrine (4) in (S)-
Methyl Lactate at different Enantiomeric Excesses (ee) [ ])/( 4343 wwwwee +−=  and Temperatures. 
100 ee 100 (w3+w4) 100 w3 100 w4 100 wsolvent 
  t = 0 °C   
100.00 13.32 13.32 0.00 86.68 
40.46 18.50 12.99 5.51 81.50 
1.19 23.87 12.08 11.79 76.13 
42.22 18.80 5.43 13.37 81.20 
100.00 12.99 0.00 12.99 87.01 
  t = 5 °C   
100.00 16.50 16.50 0.00 83.50 
46.40 21.12 15.46 5.66 78.88 
0.00 29.03 14.52 14.52 70.97 
46.84 21.22 5.64 15.58 78.78 
100.00 16.56 0.00 16.56 83.44 
  t = 10 °C   
100.00 18.74 18.74 0.00 81.26 
46.50 23.45 17.18 6.27 76.55 
0.00 31.42 15.71 15.71 68.58 
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Continuation of Table B.34 
47.00 22.98 6.09 16.89 77.02 
100.00 18.79 0.00 18.79 71.21 
  t = 15 °C   
100.00 21.00 21.00 0.00 79.00 
46.70 26.60 19.51 7.09 73.40 
0.00 36.20 18.10 18.10 63.80 
47.70 26.40 6.90 19.50 73.60 
100.00 21.15 0.00 21.15 78.85 
  t = 20 °C   
100.00 23.04 23.04 0.00 76.96 
42.88 31.02 22.16 8.86 68.98 
0.22 40.36 20.22 20.12 59.64 
45.94 30.95 8.37 22.58 69.05 
100.00 23.11 0.00 23.11 76.89 
  t = 25 °C   
100.00 24.41 24.41 0.00 75.59 
39.09 35.06 24.38 10.68 64.94 
0.97 45.16 22.80 22.36 54.84 
39.40 35.06 10.62 24.44 64.94 
100.00 24.50 0.00 24.50 75.50 
 
Table B.35: Mass Fraction Solubility (wi) of (+)-N-methylephedrine (3) and (-)-N-methylephdrine(4) in (S)-
Propyl Lactate at different Enantiomeric Excesses (ee) [ ])/( 4343 wwwwee +−=  and Temperatures. 
100 ee 100 (w3+w4) 100 w3 100 w4 100 wsolvent 
  t = 0 °C   
100.00 11.19 11.19 0.00 88.81 
46.57 14.68 10.76 3.92 85.32 
1.19 22.25 11.26 10.99 77.75 
47.01 16.15 4.28 11.87 83.85 
100.00 11.25 0.00 11.25 88.75 
  t = 5 °C   
100.00 14.00 14.00 0.00 86.00 
46.50 19.00 13.92 5.08 81.00 
0.00 26.00 13.00 13.00 74.00 
47.00 19.00 5.04 13.96 81.00 
100.00 13.98 0.00 13.98 86.02 
  t = 10 °C   
100.00 15.25 15.25 0.00 84.75 
50.30 19.80 14.88 4.92 80.20 
0.00 27.62 13.81 13.81 72.38 
51.00 19.70 4.83 14.87 80.30 
100.00 15.15 0.00 15.15 84.85 
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Continuation of Table B.35 
  t = 15 °C   
100.00 17.51 17.51 0.00 82.49 
39.09 23.69 16.47 7.21 76.31 
0.97 30.80 15.55 15.25 69.20 
38.40 23.75 7.43 16.55 76.25 
100.00 16.92 0.00 16.92 83.08 
  t = 20 °C   
100.00 19.25 19.25 0.00 80.75 
39.09 26.00 18.08 7.92 74.00 
0.97 34.00 17.16 16.83 66.00 
38.40 26.00 8.14 18.12 74.00 
100.00 19.30 0.00 19.30 80.70 
  t = 25 °C   
100.00 20.18 20.18 0.00 79.82 
38.85 28.88 20.05 8.83 71.12 
0.84 39.34 19.84 19.50 60.66 
37.56 29.53 9.22 20.31 70.47 
100.00 20.76 0.00 20.76 79.24 
 
Table B.36: Mass Fraction Solubility (wi) of (+)-N-methylephedrine (3) and (-)-N-methylephdrine (4) in (S)-
Butyl Lactate at different Enantiomeric Excesses (ee) [ ])/( 4343 wwwwee +−=  and Temperatures. 
100 ee 100 (w3+w4) 100 w3 100 w4 100 wsolvent 
  t = 0 °C   
100.00 10.08 10.08 0.00 89.92 
46.19 13.86 10.13 3.73 86.14 
0.00 19.42 9.71 9.71 80.58 
43.95 14.36 4.02 10.34 85.64 
100.00 10.38 0.00 10.38 89.62 
  t = 5 °C   
100.00 12.61 12.61 0.00 87.39 
40.00 16.93 11.85 5.08 83.07 
0.00 22.00 11.00 11.00 78.00 
42.00 17.26 5.01 14.25 82.74 
100.00 12.90 0.00 12.90 87.10 
  t = 10 °C   
100.00 13.74 13.74 0.00 86.26 
52.30 17.40 13.25 4.15 82.60 
0.00 25.00 12.50 12.50 75.00 
50.00 17.50 4.38 13.12 82.50 
100.00 13.60 0.00 13.60 86.40 
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Continuation of Table B.36 
  t = 15 °C   
100.00 15.26 15.26 0.00 84.74 
53.70 19.89 15.29 4.60 80.11 
0.00 29.26 14.63 14.63 70.74 
50.00 20.95 5.24 15.71 79.05 
100.00 15.81 0.00 15.81 84.19 
     
  t = 20 °C   
100.00 17.50 17.50 0.00 82.50 
46.30 23.90 17.48 6.42 76.10 
0.00 32.00 16.00 16.00 68.00 
48.30 24.00 6.20 17.80 76.00 
100.00 17.40 0.00 17.40 82.60 
  t = 25 °C   
100.00 18.60 18.60 0.00 81.40 
40.50 27.07 19.02 8.05 72.93 
1.43 37.18 18.85 18.33 62.82 
37.10 27.85 8.76 19.09 72.15 
100.00 18.55 0.00 18.55 81.45 
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C. Appendix C-Ternary solubility phase diagram 
 
C1. Mandelic acid ternary solubility phase diagrams 
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Figure C.111: Ternary phase diagram of mandelic acid in (S)-methyl lactate at different temperatures. Axes in 
weight fractions; w(S)-MA and w(R)-MA ≤ 0.5. The isothermal lines have been added as a visualization aid and only 
the marked points show measured data. 
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Figure C.112: Ternary phase diagram of mandelic acid in (S)-propyl lactate at different temperatures. Axes in 
weight fractions; w(S)-MA and w(R)-MA ≤ 0.5. The isothermal lines have been added as a visualization aid and only 
the marked points show measured data. 
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Figure C.113: Ternary phase diagram of mandelic acid in (S)-butyl lactate at different temperatures. Axes in 
weight fractions; w(S)-MA and w(R)-MA ≤ 0.5. The isothermal lines have been added as a visualization aid and only 
the marked points show measured data. 
 
C2. N-methylephedrine ternary solubility phase diagrams 
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Figure C.114: Ternary phase diagram of N-methylephedrine in (S)-methyl lactate at different temperatures. 
Axes in weight fractions; w(S)-MA and w(R)-MA ≤ 0.5. The isothermal lines have been added as a visualization aid 
and only the marked points show measured data. 
 
Appendix 
 
169
0.8
0.6
0.7
0.9 0.1
0.2
0.3
0.4
(S)-Propyl Lactate
(+)-NME (-)-NME
w ((-)-NME)
w ((+)-NME)
w ((S)-PL)
0 °C
5 °C
10 °C
15 °C
20 °C
25 °C
 
 
Figure C.115: Ternary phase diagram of N-methylephedrine in (S)-propyl lactate at different temperatures. 
Axes in weight fractions; w(S)-MA and w(R)-MA ≤ 0.5. The isothermal lines have been added as a visualization aid 
and only the marked points show measured data. 
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Figure C.116: Ternary phase diagram of N-methylephedrine in (S)-butyl lactate at different temperatures. Axes 
in weight fractions; w(S)-MA and w(R)-MA ≤ 0.5. The isothermal lines have been added as a visualization aid and 
only the marked points show measured data. 
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D. Appendix D-Nucleation points (MSZW) 
 
D1. MSZW for mandelic acid 
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Figure D.117: Experimentally determined metastable zone width with respect to primary nucleation for 
mandelic acid in (S)-methyl lactate at Tsat = 25 °C. ((Racemic)-MA: no nucleation in the range of measurement). 
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Figure D.118: Experimentally determined metastable zone width with respect to primary nucleation for 
mandelic acid in (S)-propyl lactate at Tsat = 25 °C. 
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Figure D.119: Experimentally determined metastable zone width with respect to primary nucleation for 
mandelic acid in (S)-butyl lactate at Tsat = 25 °C. 
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Figure D.120: Experimentally determined metastable zone width with respect to primary nucleation for N-
methylephedrine in (S)-methyl lactate at Tsat = 25 °C. 
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Figure D.121: Experimentally determined metastable zone width with respect to primary nucleation for N-
methylephedrine in (S)-propyl lactate at Tsat = 25 °C. ((Racemic)-NME: no nucleation in the range of 
measurement). 
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Figure D.122: Experimentally determined metastable zone width with respect to primary nucleation for N-
methylephedrine in (S)-butyl lactate at Tsat = 25 °C. 
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E Appendix E Raman spectroscopy 
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Figure E.123: Raman spectra of (S)- and (R)-mandelic acid in (S)-methyl lactate (liquid phase samples, and 
concentration of 8 wt %). 
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Figure E.124: Raman spectra of (S)- and (R)-mandelic acid in (S)-propyl lactate (liquid phase samples, and 
concentration of 8 wt %). 
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Figure E.125: Raman spectra of (S)- and (R)-mandelic acid in (S)-butyl lactate (liquid phase samples, and 
concentration of 8 wt %). 
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